INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY WORLD HEALTH ORGANIZATION SAFETY EVALUATION OF CERTAIN FOOD ADDITIVES AND CONTAMINANTS WHO FOOD ADDITIVES SERIES: 44 Prepared by the Fifty-third meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) World Health Organization, Geneva, 2000 IPCS - International Programme on Chemical Safety METHYLMERCURY First draft prepared by Dr D.C. Bellinger1, Dr M. Bolger2, Dr C. Carrington2, Dr E. Dewailly3, Dr L.P.A. Magos4 and Dr B. Petersen5 1Harvard Medical School, Boston, Massachusetts, USA;, 2US Food and Drug Administration, Washington DC, USA; 3Centre de Sante Publique du Québec, Québec, Canada, 4TNO BIBRA International Ltd, Carshalton, Surrey, United Kingdom; and 5Novigen Sciences Inc., Washington DC, USA Explanation Biological data Pharmacokinetics Absorption Distribution Transfer from mother to offspring Placental transfer Lactation Clearance Biochemical aspects Cleavage of carbon-mercury bond Complexes with thiol radicals Interaction with selenium Toxicological studies Acute toxicity Renal and hepatic toxicity Anorexia Neurotoxicity Small rodents Non-human primates Domestic animals Reproductive and developmental toxicity (other than neurotoxicity) Developmental neurotoxicity Exposure in utero Exposure in utero and postnatally Exposure after parturition Carcinogenicity Immunomodulation Extrapolation between species Observations in humans Case series Childhood development Neurological status Developmental milestones Early development Development later in childhood Sensory, neurophysiological and other end-points Adult neurological, neurophysiological, and sensory function Bias: Covariates, confounders and effect modifiers Study in the Faroe Islands Study in the Seychelles Study in the Amazon Basin Study in New Zealand Study in Peru Reanalysis of the study in Iraq Estimates of dietary intake Environmental mercury Biomarkers of exposure Intake assessment Residues National intake estimates Estimates based on WHO GEMS/Food diets Estimates of intake by fish consumers at the 95th percentile Comments Evaluation References 1. EXPLANATION The Committee first evaluated methylmercury at its sixteenth meeting (Annex 1, reference 30), when it established a provisional tolerable weekly intake (PTWI) of 300 µg of total mercury per person, of which no more than 200 µg should be present as methylmercury. At its twenty-second and thirty-third meetings (Annex 1, references 47 and 83), the Committee confirmed the PTWI of 200 µg of methylmercury (3.3 µg/kg bw) for the general population. At its thirty-third meeting, the Committee noted that pregnant women and nursing mothers may be at greater risk than the general population from the adverse effects of methylmercury. The Committee considered the available data insufficient to recommend a specific intake for this population group, and it recommended that more detailed studies be undertaken. At its present meeting, the Committee reviewed information that had become available since the previous evaluation. The PTWI was not reconsidered and was maintained at its present value. Two other WHO publications have dealt with the effects of mercury and methylmercury on human health (WHO, 1976, 1990). Relevant information from those documents and the studies published since the report of the thirty-third meeting are summarized and discussed in this monograph, and the data were used to estimate the risks associated with exposure to methylmercury. It should be noted that the doses given refer to the mercury constituent of the organic mercury compound. 2. BIOLOGICAL DATA 2.1 Pharmacokinetics 2.1.1 Absorption The dermal absorption of methylmercury is similar to that of inorganic mercury salts (Friberg et al., 1961). Studies of occupational exposure and studies on rats (Fang, 1980) and mice (Ostlund, 1969) both indicate that pulmonary absorption accounts for 95% of the dose. Methylmercury in ligated segments of intestines was absorbed 17-35 times faster than was an inorganic mercury salt (Sasser et al., 1978). In volunteers (Aberg et al., 1969; Kershaw et al., 1980), in squirrel monkeys (Berlin et al, 1975a), and in macaque monkeys (Rice et al., 1989), the peak concentration in blood was reached within 6 h of ingestion; 95% of an ingested dose was absorbed by volunteers (Nittinen et al., 1973), squirrel monkeys (Berlin et al., 1975a), and rats (Walsh, 1982). 2.1.2 Distribution The distribution of methylmercury has three characteristics: (i) a high concentration of mercury in blood and a high ratio of the concentration in erythrocytes:plasma; (ii) greater ease of transfer across the blood-brain and blood-placenta barriers than any other mercury compound with the exception of elemental mercury vapour (although the transfer of the latter is limited by its rapid oxidation; Magos et al., 1989); and (iii) less renal deposition than any other mercury compound. Three days after a single intravenous dose of methylmercury to rats at 0.5 µg/g, the blood concentration of mercury was 2.1 µg/ml and that in the brain was 0.14 µg/g. In rats given the same dose as mercuric acetate, the concentration of phenyl and methoxyethylmercury was 0.042-0.068 µg/ml in blood and 0.018-036 µg/g in brain. The renal concentration was 87% less in rats given methylmercury than in those given the other mercury compounds (Swensson & Ulfvarson, 1967). A high concentration of mercury in blood is associated with a high concentration ratio in erythrocytes:plasma in every species tested. The reported ratios are about 20 in humans (Miettinen, 1973; Kershaw et al., 1980) and nearly 20 in squirrel monkeys (Berlin et al., 1975a), guinea-pigs (Iverson et al., 1973), and sheep (Kostyniak, 1983). The ratio was 12 in hamsters (Omata et al., 1986), 9 in pigs (Gyrd-Hansen, 1981), and 5-9 in mice (Ostlund, 1969; Sundberg et al., 1998a) and rabbits (Berlin, 1963). In cats, the ratio was 42 (Hollins et al., 1975), and in rats the reported ratios ranged from 128 to 288 (Ulfvarson, 1962; Norseth & Clarkson, 1970; Vostal & Clarkson, 1973). The high ratio in rats has been attributed to the greater number of thiol groups in rat haemoglobin (Naganuma & Imura, 1980), which results in an eight times greater release of methylmercury from human than from rat erythrocytes suspended in albumin (Doi & Tagawa, 1983). Rat haemoglobin also has an increased capacity to bind alkyltin, which has little affinity for thiol radicals (Rose & Aldridge, 1968). The accumulation of methylmercury in rat blood is associated with organ:blood concentration ratios of mercury that are lower than in any other species. Except in rats, the brain:blood ratios were greater than 1 in all species tested (Table 1). The ratio was consistently high in monkeys, and in all species it was higher after multiple dosing than after the administration of a single dose. Differences in strain and sex affected the concentration of mercury in blood of mice more than that in brain. The concentration in the brain was higher in female than in male mice. A similar sex difference in brain mercury concentrations, but without a difference in the brain:blood ratio, was seen in rats. Six to 12 days after four daily oral doses of methylmercury chloride at 8 mg/kg bw, the concentration of mercury in brain was 8.8 µg/g in female and 6.7 µg/g in male rats (Magos et al., 1981). In heavily exposed squirrel monkeys, the brain stem had approximately the same concentration as the cerebellum and most of the cerebral regions, with the exception of the occipital lobe, which had the highest concentration (Berlin et al., 1975c). The thalamus had somewhat higher concentrations than the occipital pole (Vahter et al. 1994). In pigs, the concentrations in the cerebrum, cerebellum, and optic nerve differed only slightly, and all had higher concentrations than the spinal cord (Platonow, 1968). In guinea-pigs, the cerebellum had the lowest concentration (Iverson et al., 1974). In rats, the highest concentration was found in the spinal roots and ganglia, closely followed by the cerebral cortex and the cerebellum (Somjen et al., 1973a), but the concentrations in the cerebellum, medulla oblongata and various areas of the cerebrum differed only slightly (Magos et al., 1981). Table 1. Organ:blood concentration ratios of mercury after treatment with methylmercury Species Treatmenta Blood Organ:blood ratio Reference (µg/g) Brain Liver Kidney Squirrel monkey Single dose, 0.63 3.1 (cc) 5.9 5.1 Berlin et al. 8 days (1975b) Squirrel monkey < 2 months, 1.4 5.3 - - Berlin et al. 9-22 days (1975c) Macaque monkey < 2 months, 2.4 2.7 13 21 Evans et al. 1 day (1977) Macaque monkey < 2 months, 2.0 3.1 - - Stinson et al. 1 day (1989) Macaque monkey < 2 months, 1.1 4.4 (o) - - Vahter et al. 1 day (1994) Macaque and < 2 months, 0.45 3.1 12 47 Kawasaki et rhesus monkeys 1 day al. (1986) Pig Single dose, 0.39 3.3 12 17 Gyrd-Hansen 28 days (1981) Pig 4-10 doses, 1.8 1.8 (c) 11 8.5 Platonow 1 day (1968) Rabbit Single dose, 0.08 5.4 10 17 Petersson et 7 days al. (1989) Cat < 2 months, 14 2.1 (cc) 5.2 2.6 Charbonneau 1 day et al. (1974) Guinea-pig < 2 months, 3.4 1.8 (of) 8.2 21 Iverson et al. 1 day (1974) Table 1. (cont'd) Species Treatmenta Blood Organ:blood ratio Reference (µg/g) Brain Liver Kidney Guinea-pig Single dose, 3.5 1.3 4.0 6.7 Iverson et al. 7 days (1973) Rat, male Single dose, 3.5 0.08 - 1.2 Farris et al. 7 days (1977) Rat, female Single dose, 36 0.08 0.4 1.1 Fang (1980) 4 days Rat, male Single dose, 3.6 0.08 0.23 1.2 Thomas et al. Rat, female 4-10 days 3.3 0.10 0.25 2.0 (1986) Rat, male 4-10 doses, 40 0.07 (c) 0.3 1.7 Friberg (1959) 17 days Rat, female < 2 months, 95 0.07 0.03 1.2 Magos & 1 day Butler (1976) Hamster Single dose, 1.5 1.9 4.2 10 Omata et al. 16 days (1986) Hamster 4-10 doses, 9.0 3.8 (cc) 5.5 9.8 Omata et al. 9 days (1986) Table 1. (cont'd) Species Treatmenta Blood Organ:blood ratio Reference (µg/g) Brain Liver Kidney Hamster Single dose. 1.7 2.5 5.1 12 Petersson et 7 days al. (1989) Mouse, CBA Single dose, 0.17 0.77 3.2 14 Kostyniak Mouse, CWV 8 days 0.04 1.4 3.3 16 (1980) Mouse, NMRI, male Single dose, 0.05 0.9 8.1 20 Nielsen at al. Mouse, NMRI, female 14 days 0.21 0.6 4.1 3 (1994) c, cerebrum; cc, cerebral cortex; o, occipital pole; of, occipital and frontal lobes a Type of dosing and number of days between last or single dose and sacrifice Histochemical localization (by silver amplification) of mercury showed a different distribution. The first deposits of mercury in rat brain became apparent 10 days after exposure to 16 mg/L of methylmercury chloride in drinking-water. The deposits were found initially in the brain stem, then in the cerebral cortex and supraoptic nucleus, and finally in the cerebellum and thalamus. After 20 days, the deposits in the cerebellar cortex were restricted to Purkinje cells and Golgi epithelial cells and those in the spinal cord to the anterior motor neurons; the granule cells of the cerebellar cortex remained unstained (Moller-Madsen, 1990, 1991). Similar staining was seen after daily intraperitoneal administration of methylmercury chloride at 0.16-0.8 mg/kg bw (Moller-Madsen, 1990). As the cerebellar granule cells are target cells for methylmercury (Chang, 1977), the absence of staining indicates that only demethylated mercury can be detected with the silver amplification method. When the cortex of the calcarine sulcus of macaque monkeys was stained by the same method, large deposits were seen in the astrocytes and microglia after six months, whereas staining of neurons appeared later and remained faint even after 18 months (Charleston et al., 1995). In squirrel monkeys given weekly doses of [3H]methylmercury, the amount in protein increased, and it was found in damaged but not in undamaged neurons (Berlin et al., 1975a). 2.1.3 Transfer from mothers to offspring 2.1.3.1 Placental transfer Methylmercury passes about 10 times more readily through the placenta than other mercury compounds, like mercuric mercury and phenylmercury (Suzuki et al., 1967). Consequently, when 2 mg of methylmercury chloride were infused intravenously into female rats, the whole-body retention 1 h later was higher in pregnant than in non-pregnant rats, but the deposition in blood, kidney, liver, and brain was lower, as the fetus acted as a sink for methylmercury (Aschner & Clarkson, 1987). When pregnant rats were given a single (King et al., 1976) or multiple doses of methylmercury (Magos et al., 1980a), the fetal content of mercury increased daily, with no increase in the fetal concentration. The concentration ratio in fetal brain:maternal brain is > 1, except in hamsters given a single dose of mercury at 0.32 mg /kg bw on day 2 or 9 of gestation. One day before parturition, the maternal brain concentration was higher than that of the fetus (Dock et al., 1994a). In macaque monkeys (Stinson et al., 1989), rats (Satoh et al., 1985a), and mice (Satoh & Suzuki, 1983) given longterm dietary exposure to methylmercury, the concentration of mercury in fetal brain consistently exceeded that of maternal brain by a factor of 1.5. Similarly, when methylmercury was given to dams during gestation, 1.7-4.8 times higher concentrations were found in fetal than in maternal brain in rats (Null et al., 1973; Aaseth, 1976; King et al., 1976) and mice (Inouye et al., 1985), although the ratio to whole-body concentration. was 1 in rats (Magos et al., 1980a) and < 1 in mice (Childs, 1973). The fetal:maternal concentration ratio was slightly > 1 in liver and 0.3-0.5 in kidney (King et al., 1976; Wannag, 1976; Inouye et al., 1986), and the ratio in blood was 1.1 (Burbacher et al., 1984) or 1.2 in macaque monkeys (Stinson et al., 1989) and 0.6 in rats (Wannag, 1976). In contrast to animals, the fetal: maternal blood ratio in humans is high. Thus, the cord blood:maternal blood ratio in Inuits with a high consumption of marine foods (Hansen et al., 1990) and in Swedish women who ate large amounts of fish (Skerfving, 1988) was 3.2. In the offspring of squirrel monkeys exposed to methylmercury, the highest concentration in the brain was found in the pituitary gland, followed by caudatus, striatum, thalamus, cerebrum, cerebellum, medulla, and cervical spinal cord (Lögdberg et al., 1993). In rats, the concentration was higher in the cerebellum than in the cerebrum (Yamaguchi & Nunotani, 1974; King et al., 1976). 2.1.3.2 Lactation The passage of methylmercury from blood to milk is low, in contrast to passage through the blood-brain and blood-placenta barriers. The average concentration ratio for milk:maternal blood was 0.2 in hamsters (Nordenhäll et al., 1995a), 0.03 in guinea-pigs (Yoshida et al., 1994), and 0.04 in mice (Sundberg et al, 1998a) and rats (Sundberg et al., 1991). Inorganic mercury passes more readily into milk than methylmercury: after injection of equivalent doses of inorganic and methylmercury, the concentration of mercury in the milk was five times higher with the inorganic form in lactating mice (Sundberg et al., 1998b) and 2.5 times higher in guinea-pigs. In guinea-pigs, the milk:maternal blood concentration ratio was 0.12 for inorganic mercury and 0.023 for methylmercury, but the milk:plasma concentration ratios were similar (Yoshida et al., 1994). One consequence of the difference in the passage of inorganic and methylmercury is that mothers poisoned with the organic form had 95% less mercury in their milk than in their blood, and 40% of the mercury in milk was inorganic (Bakir et al., 1973). This tendency was confirmed in studies on women who ate large quantities of fish (Skerfving, 1988; Oskarsson et al., 1996) and in experimental animals (Nordenhäll et al., 1995b; Sundberg et al., 1998a,b). In the milk of hamsters, the concentration of mercury decreased with a half-time of four days, and 5% of the injected dose was excreted in milk. The proportion of inorganic mercury in milk was 16% on the first day and 22% after five to six days (Nordenhäll et al., 1995a). An average of 1.7% of a maternal dose given on the day of parturition was transferred to a litter (Nordenhäll et al., 1995b). In suckling pups of mouse dams given a single intravenous injection of methylmercury chloride at 0.4 mg/kg bw, the concentrations of mercury in plasma and brain peaked after six to seven days. While that in plasma then immediately decreased, the concentration of mercury in brain showed no variation for a further four days (Sundberg et al., 1998a). In pups of hamster dams given a single dose of 3.2 mg/kg bw methylmercury chloride by gavage on the day 1 post partum, the whole-body and tissue concentrations of mercury increased for 10-15 days and then decreased. When the pups were 21 days of age, 50% of the body burden was in the pelt (Nordenhäll et al., 1995a). The body burden of mouse pups was increased to a lesser extent by exposure during lactation than by exposure in utero. In cross-fostering studies, the body burden at 14 days of age was twofold higher in pups exposed in utero than in those exposed by lactation (Nielsen & Andersen, 1992). Similar differences were observed in hamster pups (NordenhäIl et al., 1998). Although loss of methylmercury during lactation is too small to affect maternal clearance, the clearance half-time was significantly lower in lactating women (Greenwood et al., 1978), rats (Magos et al., 1981), and mice (Greenwood et al., 1978) than in non-lactating ones. 2.1.4 Clearance In animals, mercury is cleared by three main routes: in urine, faeces, and hair. Faecal excretion predominates over urinary excretion. While in humans excretion in hair is important only for biological monitoring, in furry animals this route of excretion can strongly alter clearance from the whole body and from toxicologically important soft tissues (Table 2). In volunteers who ingested a single dose, faecal excretion reached a peak faster than urinary excretion; faecal excretion peaked at 3% and urinary excretion at 0.11% of the dose (Miettinen, 1973). In another study, the cumulative faecal excretion was 31% and urinary excretion was 4% of the dose (Smith et al., 1994). In pigs, the ratio of cumulative faecal:urinary excretion during the first 15 days after a single dose was 17 (Gyrd-Hansen, 1981); in rats, the ratio was 4.8 in the first three days (Swensson & Ulfvarson, 1967). The ratio decreased in rats with increasing dose and prolonged exposure (Magos & Butler, 1976). In hamsters given a low dose, the ratio was 2.1 (Dock et al., 1994a), while urinary excretion was greater than faecal excretion after a renally toxic dose (Petersson et al., 1989), probably because of loss of mercury with desquamated tubular cells. Reports of concentrations in excreta also suggest the importance of faecal over urinary excretion, if it is assumed that the difference in volume (or mass) is not great. The faecal:urinary concentration ratio was 100 for squirrel monkeys (Berlin et al., 1975a) and 50 for cats (Hollins et al., 1975). Although faecal and urinary excretion could be used to calculate the clearance half-time for the whole body, this method (like chemical or radiochemical estimation of whole-body burden) results in an underestimate of clearance from the toxicologically important soft tissues in furry animals. In rats given repeated oral doses of methylmercury, the contribution of blood to the body burden declined to 28% and the contribution of the pelt increased to 38% (Magos & Butler, 1976); 98 days after a single dose, the body burden represented 12% of the dose and nearly 90% of the body burden was in the fur (Farris et al., 1993). In hamster pups exposed to methylmercury either in utero or by lactation, 80% of the body burden was in the pelt by 28 days of age (Nordenhäll et al., 1998). Correction for mercury in fur (Table 2) decreased the clearance half-time by 33% in cats and by 44% in rats. As the only toxicological significance of methylmercury in fur is as a source of intake during grooming (Farris et al., 1993), the clearance half-time in blood is more meaningful than that in the whole body; however, even values based on total mercury result in underestimates of clearance since decomposition is ignored. Clearance half-times show wide interspecies variation, depending on the body mass of the species: the larger the body mass, the longer the clearance half-time. In adult mice exposed to unlabelled methylmercury before and after a single dose of [203Hg]methylmercury, the clearance of radiolabelled compound was not affected (Nielsen & Andersen, 1996). Similarly, in rats, the biliary excretion of labelled mercury was not influenced by treatment with unlabelled compound (Cikrt et al., 1984), indicating complete distribution of label between the first and second injections. Clearance from offspring is slow during the first weeks of life. Thus, the body burden of rats declined by 5% of the dose during the first 10 days and by a further 25% during the next 12 days (Thomas et al., 1988). Suckling hamsters (Nordenhäll et al., 1998) and mice (Rowland et al., 1983; Sundberg et al., 1998a,b) show similar changes in distribution and clearance. Table 2. Clearance half-times (days) of methylmercury Species Compartment Reference Whole body Brain Blood Human 72 - - Aberg et al. (1969) - - 52 Kershaw et al. (1980) 74 - 50 WHO (1990) 44a - 44a Smith et al. (1994) Squirrel monkey 134 - 49 Berlin et al. (1975b) Macaque monkey - 47 14 Rice et al. (1989) - - 24 Stinson et al. (1989) - - 26 Vahter et al. (1994) Pig - - 27 Gyrd-Hansen (1981) Sheep - - 14 Kostyniak (1983) Cat - - 39 Charbonneau et al. (1974) 117 (76b) - - Hollins et al. (1975) Guinea-pig - - 13 Iverson et al. (1973) Rat, female 34 26 14 Magos & Butler (1976) Rat, male 24 - - Farris et al. (1993) Rat, male 13a - 11 Farris et al. (1993) Rat, male 11a,b - - Farris et al. (1993) Hamster 7.7 - - Dock et al. (1994a) Mouse, female 7.3 - - Clarkson et al. (1973) Mouse, CR1:CD, - - 7 - Sundberg et al. (1998a) female Mouse, CBA, male approx. 1 7.4 - Kostyniak (1980) Mouse, CFW, male 3.0 - - Kostyniak (1980) Mouse, BALB/c, male - 15 5.0 Doi & Kobayashi (1982) Mouse, C57Bl, male - 16 7.8 Doi & Kobayashi (1982) Mouse, NMRI, male 6.3 - - Nielsen & Andersen (1991) Mouse, NMRI, female 14 - - Nielsen & Andersen (1991) a Clearance includes decomposition to inorganic form b Half-time for whole body without hair 2.1.5 Biochemical aspects 2.1.5.1 Cleavage of carbon-mercury bond Methylmercury is the most stable organic mercury compound. The addition of even one carbon to the alkyl radical can accelerate decomposition in brain and other tissues (Magos et al., 1985a). The bond between the alkyl radical and mercury can be broken by hydroxy radicals (Suda & Hirayama, 1992) and other reactive oxygen species (Suda & Takahashi, 1992), which attack ethylmercury more readily than methylmercury. In rats given a single dose of methylmercury, the 1:1 ratio of organic: inorganic mercury was reached after 50 days in liver and after 14 days in kidney, the main site of accumulation of inorganic mercury. Inorganic mercury represented less than 4% of the mercury in brain during the first 23 days after a single dose (Norseth & Clarkson, 1970) and only 3.4% after prolonged daily treatment (Magos & Butler, 1976). Inorganic mercury in the brain is most likely formed by decomposition in situ, as pretreatment with methylmercury did not increase the concentration of mercury in the brains of rabbits treated with inorganic mercury (Dock et al., 1994b). The slower clearance from the brain may explain the 88% increase in the contribution of inorganic mercury to total mercury in the brains of macaque monkeys six months after a long exposure (Lind et al., 1988; Vahter et al., 1994), and the concentration of inorganic mercury in the hypothalamus was 6.6 times higher than that in monkeys exposed to inorganic mercury for two to three months (Vahter et al., 1994). The main site of decomposition of methylmercury is the intestinal tract, where the portion secreted with bile or with cells shed from the intestinal wall is decomposed and the remainder is reabsorbed (Norseth & Clarkson, 1971). Most of the decomposition is carried out by intestinal bacterial flora; disruption of this bacterial activity by antibiotics prolonged the clearance half-time and decreased faecal excretion in both rats and mice (Rowland et al., 1980, 1983). Both demethylation and methylation occur. Caecal bacteria from rats methylated 2.3% of inorganic mercury at a dose of < 0.1 µg/g and less of doses > 0.1 µg/g (Rowland et al., 1977). Extrapolation of this rate of synthesis to human populations with intakes of 4.6 µg of inorganic mercury and 2.4 µg of organic mercury would add only 0.1 µg to the daily intake of methylmercury. The biliary excretion of methylmercury varies by species: hamsters, rats, and mice excrete it readily, while guinea-pigs and rabbits excrete 5 and 25 times less. The 'slow excretors' also excreted significantly less reduced glutathione (GSH) than the 'fast excretors' (Stein et al., 1988). Biliary excretion also depends on age: in rats, the ability to excrete GSH and methylmercury develops between 2 and 4 weeks of age (Ballatori & Clarkson, 1982). 2.1.5.2 Complexes with thiol radicals Mercury compounds favour links with thiol ligands. Thiols of low relative molecular mass offer transport, and those of high relative molecular mass within cells offer anchorage for methylmercury, targeting sulfydryl enzymes (Rothstein, 1970). The change from one ligand to another ensures that diffusable thiol compounds can carry methylmercury from the extracellular space to intracellular proteins and vice versa. The high concentration of GSH within erythrocytes suggests that exchange occurs between protein and GSH in these cells (Rabenstein & Evans, 1978); however, other diffusable thiols, such as cysteine, and unphysiological ones such as pencillamine, N-acetylpenicillamine, and N-acetylcysteine, removed methylmercury from erythrocytes when their concentration approached the concentration of GSH (Kostyniak et al., 1975). Complexing with L-cysteine or glutathione has particular toxicological significance. In rats, injection of L-cysteine with methylmercury changed the short-term distribution of the latter by decreasing the plasma concentration and increasing the concentrations in brain, liver, and kidney. D-Cysteine had similar effects but did not increase the concentration of mercury in brain (Thomas & Smith, 1982). GSH had less effect on the brain uptake of methylmercury than L-cysteine (Kerper et al., 1992). Increased uptake by brain was also achieved by administration of a cysteine-supplemented diet (Farris et al., 1977). The stimulatory effect of L-cysteine may be due to the structural similarity between the methylmercury-cysteine complex and L-methionine, which permits use of the same L-amino acid transport system (Kerper et al., 1992). L-Cysteine can also increase the biliary excretion of methylmercury, after a delay for conversion to GSH (Magos et al., 1978). GSH plays a key role in biliary secretion of methylmercury. Consequently, compounds that deplete GSH decrease and compounds that stimulate glutathione S-transferase increase the biliary excretion of both GSH and methylmercury (Gregus & Varga, 1985). This effect is modulated by the transport molecule ligandin (a glutathione S-transferase): the biliary excretion of methylmercury was inhibited by indocyanine green, a non-substrate ligand for ligandin (Magos et al., 1979a). trans-Stilbene oxide, which induces glutathione S-transferase activity, had no effect on the biliary excretion of GSH or methylmercury (Gregus & Varga, 1985) but potentiated the effect of GSH in rats (Magos et al., 1985b). The excreted methylmercury is attached to GSH (Refsvik & Norseth, 1975) or to its metabolic product (Ohsawa & Magos, 1974; Urano et al., 1988). GSH also affects the renal handling of methylmercury. Depletion of hepatic GSH by 1,2-dichlorobenzene resulted in a reduced blood GSH concentration and a reduced renal content of methylmercury. Inhibition of renal gamma-glutamyl-transpeptidase, a membrane enzyme that catalyses the breakdown of GSH, decreased the renal deposition and increased the urinary excretion of methylmercury. The sex difference in the renal handling of methylmercury in some mouse strains may also depend on the concentration and metabolism of renal GSH (Tanaka et al., 1991) Physiological agents that complex thiols do not affect urinary excretion or whole-body clearance (Magos & Clarkson, 1976), while unphysiological thiols of low relative molecular mass, such as penicillamine, N-acetylpenicillamine, dimercaptosuccinic acid, and dimercaptopropanesulfonate, accelerate clearance in both humans (Clarkson et al., 1981) and experimental animals (Aaseth., 1976; Magos, 1976; Planas-Bohne, 1981). Although clearance was accelerated by dimercaptopropanol, this chelator consistently increased the deposition of methylmercury in the brains of mice (Berlin et al., 1965; Ogawa et al., 1976). Thiol-complexing agents mobilize methylmercury more efficiently than inorganic mercury, as shown with dimercaptosuccinic acid and penicillamine in mice (Friedheim & Corvi, 1975) and pencillamine in volunteers (Suzuki et al., 1976). 2.1.5.3 Interaction with selenium Methylmercury has a greater affinity for selenium than for sulfur, and the reaction of selenite with thiol groups such as GSH and the sulfur radicals of proteins extends the possibility of associations between selenium and methylmercury. The effects of selenite cannot be extrapolated to the effects of selenium present in food, however, because of differences in their decomposition to selenide in food. Thus, selenite is twice as potent as L-selenomethionine in forming volatile dimethylselenide (McConnel & Roth, 1977) and four times as potent as selenium-enriched liver in forming mercury-selenium complexes (Magos et al., 1983). The rate of selenide formation from selenite is important in the formation of an unstable adduct, bis(methylmercury)selenide, which carries methylmercury through the blood-brain barrier (Magos et al., 1979b; Naganuma & Imura, 1980). The availability of selenide for this reaction is limited by methylation to dimethyl-selenide, which is stimulated by methylmercury (Yonemoto et al., 1985). Selenite can change the distribution of methylmercury in rats by decreasing deposition in kidney and increasing deposition in brain, independently of whether selenite is given 30 min before (Chen et al., 1975), simultaneously with, or even days after methylmercury (Magos & Webb, 1977). Both low (0.6 mg/L) and high (3 mg/L) concentrations of selenium in drinking-water increased the uptake of mercury in the brains of mice, the high dose more persistently than the low dose (Wicklund Glynn & Lind, 1995). Within the brain, selenium did not alter the subcellular distribution of methylmercury, while the mercury compound shifted selenium from the cytosol to the mitochondrial fraction (Prohaska & Ganther, 1977). Selenite increased the fetal brain content of mercury without increasing the fetal concentration, depending on the dose of methylmercury given to mouse dams (Satoh & Suzuki, 1979). The concentration of mercury in rat fetal brain was also unchanged by 1.3 mg/kg of selenite when the dams were given 1.6 or 4.8 mg/kg bw as methylmercury on days 6-9 of gestation, although the fetal blood concentration of mercury was increased by 1.4-and 2.8-fold, respectively (Frederiksson et al., 1993). Seleno-L-methione had no effect on the deposition of methylmercury in pups exposed prenatally, but it increased the deposition of mercury in nearly all organs after exposure during lactation (Nielsen & Andersen, 1992, 1995). The role of selenite in the degradation of methylmercury is amibiguous. Addition of selenite to liver homogenates for 90 min increased the decomposition of phenylmercury but not of methylmercury (Fang, 1974). Selenite in the presence of a reducing agent like GSH (Iwata et al., 1982), cysteine (Baatrup et al., 1989), or hydroquinone in vitro (Moller-Madsen & Danscher, 1991) induced some decomposition, but the conditions were not physiological. Six months after exposure of macaque monkeys to methylmercury for 12 months, the concentration of inorganic mercury had declined, while the concentration of selenium remained unchanged (Björkman et al., 1994), which argues against a role for selenium in cleavage of methylmercury in the brain. The final molar ratio of inorganic mercury to selenium in these monkeys was 0.5. In contrast, persistent deposits with a 1:1 molar ratio were found in organs of rats treated with inorganic mercury and hydrogen selenide (Groth et al., 1976), in the livers of marine mammals (Koeman et al., 1973; Martoja & Viale, 1977), and in the brains of retired mercury miners (Kosta et al., 1975). 2.2 Toxicological studies 2.2.1 Acute toxicity Although methylmercury is almost completely absorbed from the gastrointestinal tract, the enteric and parenteral LD50 values differ widely. Thus, the LD50 values 24 h after intraperitoneal injection were 9.5 mg/kg bw in rats, 20 mg/kg bw in hamsters, and > 14 mg/kg bw in squirrel monkeys; after 30 days, the values were 8.1, 12, and 3.8-5.1 mg/kg bw, respectively. In these three species, most of the deaths occurred within the first 24 h (Hoskins & Hupp, 1978). The LD50 values after oral administration were 25 mg/kg bw in old rats (450 g bw) and 40 mg/kg bw in young rats (200 g bw) (Lin et al., 1975). The difference in the LD50 values after administration by these two routes may reflect the corrosive effect of methylmercury at the site of contact. The risk of corrosion depends on the route of administration, and it decreases in the order intraperitoneal = subcutaneous > intubation > dose given in a small volume of water or juice > supplemented food. The importance of corrosion is supported by the dramatic reaction seen in rats 15 min after intraperitoneal injection of doses > 3 mg/kg bw: the animals became lethargic, with drooping heads and dulled eyes; some died after developing dyspnoea, spasticity, and loss of the ability to walk. Animals given < 3 mg/kg bw became drowsy but survived (Hoskins & Hupp, 1978). The rapidity of this reaction suggests a corrosive effect and shock. The corrosive effect is also reflected by the ulcerative oesophagitis seen in cats dosed orally with methylmercury at 1.3 mg/kg bw per day (Davies & Nielsen, 1977) and by the necrosis, oedema, and congestion of the stomach in dogs dosed with 0.43 or 0.64 mg/kg bw per day (Davies et al., 1977) and in pigs given 0.64 or 0.86 mg/kg bw per day (Davies et al., 1976). All the affected animals also had renal and hepatic damage. These local effects should be taken into consideration in interpreting more subtle outcomes. In rats dosed orally for two days with 12 mg/kg bw per day as mercury or 8 mg/kg bw per day as methylmercury chloride, decreased wakefulness and increased slow-wave sleep peaked three days after the second dose, while the brain mercury concentration peaked after nine days (Arito & Takahashi, 1991). A confounding role of gastrointestinal inflammation could not be ruled out. A reduced ability of mice to stand on their hind legs and to move, seen 1 h but not 72 h after an intraperitoneal injection of 10 mg/kg bw as methylmercury chloride (Salvaterra et al., 1973), indicates peritoneal irritation and possibly peritonitis rather than systemic toxicity. 2.2.2 Renal and hepatic toxicity Mice Experiments in mice suggest that males are more sensitive than females. In long-term experiments, the incidence of chronic nephropathy was higher in male than in female mice given diets containing 10 mg/kg (equivalent to 1.5 mg/kg bw per day), and only male mice had nephropathy when given 2 mg/kg in the diet (Hirano et al., 1986; Mitsumori et al., 1990). Rats Clinical signs of neurotoxicity induced by methylmercury are always accompanied by renal damage. In female rats dosed orally five times a week with 0.84 mg/kg bw as methylmercury dicyandiamide for 8-12 weeks, the renal cortex was extensively damaged, with desquamated cells in the tubules and inflammatory reactions and fibrosis in the surrounding area. At the end of treatment, mild ataxia was observed in some but not all animals (Magos & Butler, 1972). Male rats receiving 0.8 mg/kg bw per day as methylmercury chloride developed severe diarrhoea and loss of appetite after two to four days, and necropsy after 10 days of treatment showed ultrastructural changes in the pars recta of the proximal tubules (Ware et al., 1975). Differences in the time of onset of renal damage rather than in its severity were seen in male rats given 8.5 or 1.7 mg/kg bw per day as methylmercury hydroxide: renal lesions, mainly in the proximal tubules, were seen one day after the last high dose and six days after the low dose (Klein et al., 1973). In comparisons of renal toxicity, male rats were usually more sensitive than females, as indicated by increased serum creatinine concentration and decreased bromosulphthalein excretion after single oral doses of methylmercury chloride ranging from 4 to 40 mg/kg bw (Yasutake et al., 1991); proteinurea in rats fed diets containing methylmercury chloride at 0.5, 2.5, or 25 mg/kg for 12 weeks (Verschuuren et al., 1976a); and deaths and renal lesions in rats given 0.05 or 0.25 mg/kg bw per day as methylmercury chloride in food (Munro et al., 1980). No difference in renal morphology was found between the sexes after exposure to 2.5 mg/kg of diet for two years (Verschuuren et al., 1976b), although the results suggested that females were more sensitive than males to diets containing 2 mg/kg of methylmercury chloride (equivalent to 0.2 mg/kg bw per day) for 84 or 142 days (Fowler, 1972). The effect of methylmercury on the liver can be rapid and lasting. Ultrastuctural changes were detected in the liver 1 h after a single subcutaneous dose of 8 mg/kg bw as methylmercury chloride to male rats, which developed into cytoplasmic degeneration during the first day (Desnoyers & Chang, 1975). Similar changes were seen in the livers of cats fed tuna fish containing 0.3-0.5 mg/kg of mercury daily for 7-11 months (Chang & Yamaguchi, 1974). 2.2.3 Anorexia A frequent response to methylmercury in experimental animals is anorexia resulting in decreased weight gain or even loss of weight. Anorexia precedes the neurological signs of methylmercury poisoning in rats (Hunter et al., 1940; Herman et al., 1973), rabbits (Jacobs et al., 1977), guinea-pigs (Falk et al., 1974), and mice (McDonald & Harbison, 1977). In cats (Davies & Nielsen, 1977) and non-human primates (Shaw et al., 1975; Evans et al., 1977), anorexia occurred only after the onset of disorders of coordination and vision. 2.2.4 Neurotoxicity 2.2.4.1 Small rodents The species studied most extensively for neurotoxicity is the rat, and few experiments have been conducted on other species. Guinea-pigs were used to study the effect of methymercury on the cochlea. Five weekly doses of 1.7 mg/kg bw as methylmercury hydroxide for two to six weeks decreased body weight and locomotor activity and damaged the outer rows of hair cells of the cochlea at two-and-a-half turns from the cochlear base. The auditory tract was not damaged (Falk et al., 1974). In a follow-up study, the damage was localized to the sensory nerve end (Konishi & Hamrick, 1979). The role of the granular layer of the cerebellum and the posterior root fibres as a target of methylmercury was identified in rats 60 years ago. The report of this study also described the clinical course of severe poisoning as weight loss, ataxia, paralysis, and death (Hunter et al., 1940). Axoplasmic and myelin degeneration of posterior root fibres was produced by daily doses of 0.8 mg/kg bw as methylmercury chloride (Chang & Hartmann, 1972), while the ventricular root fibres and the dorsal root nerves remained intact after administration of 1.6 mg/kg bw per day (Yup & Chang, 1981). The vulnerability of dorsal root ganglia was explained by the extent and duration of inhibition of amino acid incorporation (Cavanagh & Chen, 1971). Female rats dosed orally five times a week with 0.84, 1.68, or 3.32 mg/kg bw as methylmercury dicyandiamide showed signs of ataxia after 39, 25, and 10-12 doses, respectively. Owing to progressive weakness, animals at the intermediate dose had to be sacrificed after 34 doses and those at the highest dose after 16 doses, when their brain mercury concentrations were 10 and 16 µg/g, respectively. Histological examination of the brain showed necrosis in the granular layer of the cerebellum and, at the two higher doses, oedema in the white matter; at the low dose, only mild damage involving few cells was seen even after 59 doses, when the brain mercury concentration was about 5 µg/g (Magos & Butler, 1972). The lack of damage at this dose was corroborated by the lack of gross or histological effects in male rats dosed with 0.8 mg/kg bw per day as methylmercury chloride for 28 weeks. A dose of 4 mg/kg bw per day caused weight loss, early toxic signs, and decreased protein synthesis in the granule neurones. These pathological changes were precipitated when the brain mercury concentration was 3-6 µg/g. At higher concentrations, Purkinje cells were also affected (Syversen, 1982). After subcutaneous administration of 2 mg/kg bw as methylmercury hydroxide five times a week to male rats, the first signs of coordination disorder were detected after the fifteenth dose. The earliest morphological change in the central nervous system was shrinkage of cells and nuclear disintegration in the cerebellar internal granular layer, the vermis, and the depth of the folia of the hemispheres. These early changes progressed to more widespread necrosis involving the putamen, corpus striatum, and the visual cortex in the occipital lobe. The most severely affected parts of the peripheral nervous system were the dorsal roots and the sciatic and sural nerves (Herman et al., 1973). The concentration of mercury on the fifteenth day was about 30% lower in the cerebral cortex than in the cerebellum or spinal ganglia, but by day 29 the concentrations in each of these tissues was nearly 14 µg/g (Somjen et al., 1973b). Damage to the nervous system resulted in the formation of autoantibodies that reacted with neurotypic and gliotypic proteins, such as glial fibrillary acid protein, after seven days of exposure to 13 or 26 mg/kg of mercury as methylmercury chloride in the diet (El-Fawal et al., 1996). The dose-effect relationship for neurotoxicity differs in male and female rats, as suggested by the response to four or five doses of 8 mg/kg bw as methylmercury chloride given by intubation. The flailing reflex (rotation of the lower body when the animal is held loosely under the forelimbs), hind-leg crossing, and damage in the granular layer indicated that female rats were more affected than males. The difference may be due to the 24-40% higher concentration of mercury in the brains of female than of male rats (Magos et al., 1981). A difference was seen also with age: in young rats, an intraperitoneal injection of 8 mg/kg bw which resulted in approximately 2 µg/g of brain, the morphological changes in the cerebellar hemisphere were subtle, including nuclear swelling and increased heterochromatin, were reversible, and were not accompanied by the formation of dark cells in the granular layer. In older rats, 'dark cells' were a conspicious feature (Syversen et al., 1981) The relative merit of electrophysiology in the grading of methylmercury poisoning was the subject of several investigations (Somjen et al., 1973a; Fehling et al., 1975; Miyama et al., 1983). The results were not consistent, and its advantage over simple clinical observations remains questionable. In male mice, dietary intake of methylmercury caused no loss of body weight when the concentration was 10 mg/kg of diet as methylmercury chloride, but 32 mg/kg of diet caused loss after 30 days and 100 mg/kg of diet resulted nearly immediately in weight loss. Mice at the intermediate dose showed signs of coordination disorders which coincided with the onset of weight loss. A slight effect on head positioning was observed earlier. No neurological signs were seen in mice at the lowest dose (Suzuki & Miyama, 1971). In wild mice exposed to methyl-mercury in their natural diet, the concentration of mercury in hair correlated with deviant behaviour and decreased ability to swim (Burton et al., 1977). 2.2.4.2 Non-human primates In the first experiment performed on the toxicity of methylmercury, one female macaque monkey was exposed by inhalation to a concentration in air that was so high that it caused respiratory irritation. The clinical events were ataxia, prostration, inability to eat, and death after 21 days. The main damage to the nervous system was in the sciatic nerve, posterior root ganglia, brain stem, and cerebrum, where the frontal and occipital cortices were equally affected while the cerebellar cortex was spared (Hunter et al., 1940). Rhesus macaque and mulatta monkeys were given methylmercury in pellets at doses of 0.01, 0.03, 0.1, or 0.3 mg/kg bw per day for 52 months or until signs of severe poisoning appeared. Exposure to the lowest dose had no effect on body weight, and 0.03 mg/kg bw per day depressed body-weight gain only marginally; however, daily doses of 0.1 or 0.3 mg/kg bw per day caused severe poisoning, with ataxia, visual disturbances, blindness, tremor, spasms, paralysis, and death or moribund condition at six and three months, respectively. At the two lower doses, the average monthly concentrations of mercury in blood between 12 and 52 months were 0.4 and 1.1 µg/ml. The mean concentrations of mercury in the occipital lobe after 52 months were 0.7 µg/g and 2.3 µg/g at these doses; the cerebellum contained 10-26% less than the occipital lobe. Histological examination of the brain showed no abnormalities. In monkeys at the two highest doses, the concentrations in the occipital lobe were 13 and 24 µg/g; the most severe lesions were found in the occipital cortex and, within it, in the primary visual cortex. No changes were seen in the cerebellar cortex (Ikeda et al., 1973; Kawasaki et al., 1986). In this study, the threshold dose of methylmercury that induced toxic effects after long-term exposure was 0.03-0.1 mg/kg bw per day, resulting in concentrations of mercury of 2-13 µg/g in brain and 0.7-21 µg/ml in blood. The NOEL was 0.01 mg/kg bw per day. In corroboration of this finding, daily doses of 0.068-0.085 mg/kg bw as methylmercury hydroxide given orally through a hypodermic syringe for 68 weeks caused clinical signs or cortical lesions in only 3 of 15 macaque monkeys; the blood concentration of mercury was about 2 µg/ml. A daily dose of 1.1 mg/kg bw, resulting in a maximum blood concentration of about 3 µg/g, led to death or a moribund condition. The vision of these three monkeys was also affected (Finocchio et al., 1980). Another study with macaque monkeys showed loss of peripheral vision at blood concentrations > 2.2 µg/ml (Luschei et al., 1977). These concentrations of mercury in blood correspond to 6-10 µg/g in brain. In squirrel monkeys, the visual cortex was invariably damaged, and extension to adjacent areas increased with duration of exposure and increasing brain mercury concentration. In one monkey who was blinded, the maximum concentration in the occipital lobe 40 days after termination of exposure was 6.6 µg/g (Berlin et al., 1975b), which, assuming a 47-day half-time in brain, corresponds to 12 µg/g at the end of treatment. In macaque monkeys exposed for a long time but with no clinical signs of poisoning, sensitivity to visual stimuli of low luminiscene was reduced when the concentration of mercury was 2.6 µg/ml in blood and 8.7 µg/g in the primary visual cortex. The concentrations were somewhat higher in the calcarine side of the primary visual cortex and in the lateral geniculate of the optic thalamus, where the optic neurons from the retina are projected onto the primary visual cortex, than in the lateral side of the occipital cortex. The borderline between effect and no effect was not sharp: unaffected monkeys had slightly higher concentrations of mercury in blood and in the occipital cortex than monkeys that were moderately affected, although they also were exposed for a shorter time. Constricted vision field, somaesthetic impairment, and ataxia usually occurred together (Evans et al., 1977), The lesions seen in the brains of rhesus monkeys given methylmercury hydroxide in fruit juice differed when it was given for 6-17 days or for 6.3-12 months. Two of four monkeys exposed acutely and two of six exposed chronically had no clinical or histological signs of poisoning. The maximum concentrations of mercury in blood were < 1.1 µg/ml in unaffected monkeys and > 2.0 µg/ml in affected monkeys. The two acutely poisoned monkeys had a blood mercury concentration of 11 µg/ml. After acute poisoning, the most evident histological lesions were seen in the lateral geniculate nucleus and in large neurons in several areas. The cerebral and cerebellar cortices, including the calcarine and insular cortices, were not involved. Animals exposed chronically had damage to the cerebral cortex which was maximal around the calcarine and lateral cerebral sulci (Shaw et al., 1975). The entry of methylmercury into brain, even at concentrations below those that cause damage, precipitates an increase in the reactive glial population. A similar reaction was produced after infusion of inorganic mercury (Charleston et al., 1994). 2.2.4.3 Domestic animals Few experiments have been reported on the toxicity of methylmercury in domestic animals, and even fewer that would allow an approximation of the threshold toxic dose. The oral dose that had no effect was 0.1-0.2 mg/kg bw per day for calves exposed for 91 days (Herigstad et al., 1972), 0.19-0.35 mg/kg bw per day for pigs exposed for 60 days (Triphonas & Nielsen, 1973), 0.06-0.12 mg/kg per day for dogs exposed for 55 days (Davies et al., 1977), and < 0.25 mg/kg bw per day for cats exposed for 90 days, whether present naturally in fish or added in pure form to the diet (Charbonneau et al., 1974). In the central nervous system, the damage was more extensive in the cerebellar granular layer in calves and cats and in the cerebral cortex in pigs and dogs. In rabbits given one to four doses of mercury at 5.8 mg/kg bw as methyl-mercury acetate, the most sensitive areas of the nervous system were the dorsal root and trigeminal ganglia, which showed degeneration after two doses. In the cerebral and cerebellar cortices, damage was seen two days after four daily doses. The more severely affected areas were the II, III, and IV layers of the cerebral cortex and the molecular and granular layers of the cerebellar cortex, where mainly the cells of the small neurones, including granule and basket cells, were damaged and the Purkinje cells spared (Jacobs et al., 1977), as in a human case of methylmercury poisoning (Hunter & Russel, 1954). 2.2.5 Reproductive and developmental toxicity (other than neurotoxicity) Mice Treatment of male mice on seven consecutive days with methylmercury chloride at doses of 1, 2.5, or 5 mg/kg bw per day before mating with virgin females had no effect on fertility or postimplantation losses but marginally reduced the number of viable embryos (Khera, 1973). Intraperitoneal injection of male mice with 8.5 mg/kg bw per day as methylmercury hydroxide and serial matings with young virgin females increased the number of dead implants during the first 7.4 days in one strain but not in another. The same treatment of females of the unresponsive strain slightly reduced the total number of live implants (Suter, 1975). Exposure to methylmercury chloride prolonged the length of the menstrual cycle by 11% in mice fed 3.2 mg/kg of diet and by 27% at 6.4 mg/kg of diet. Exposure from 30 days before mating to day 18 of gestation decreased maternal weight gain at the high dose. The loss due to resorptions and deaths increased from 7.1% in the control group to 12% in mice at 3.2 mg/kg of diet and to 44% at 6.4 mg/kg of diet. The weight of fetuses on day 18 of gestation was also lowered. Both doses increased the frequency of malformations to 17% of fetuses at the low dose and 56% at the high dose (Nobunaga et al., 1979). A follow-up experiment confirmed that exposure to 3.2 mg/kg of mercury in the diet can cause postimplantation loss in some pregnant mice (Satoh & Suzuki, 1983). If their food consumption is assumed to be 150 g/kg bw per day, the daily doses of methylmercury were 0.48 and 0.96 mg/kg bw. When selenite was added to the drinking-water in these two studies, no effect was seen on postimplantation loss but the number of malformations was increased, at least at the high dose. Treatment of mouse dams on days 6-17 of gestation with 5 mg/kg bw per day as methylmercury chloride by intubation reduced the number of live pups, and pups born live died within two days. The number of live pups and survival were not affected by 1 mg/kg bw per day, but there was transitory inhibition of cerebellar cellular migration from the external granular layer (Khera & Tabacova, 1973). When methylmercury chloride was given orally on days 6-13 of gestation, the lowest dose of 2 mg/kg bw per day caused only a few malformations, 4 mg/kg bw per day decreased fetal weights and caused a large increase in the frequency of malformations, and 4.8 mg/kg bw per day also increased postimplantation loss (Fuyuta et al., 1978). Postimplantation loss was not observed when dams were given 3, 5, or 7 mg/kg bw per day as methylmercury chloride subcutaneously on days 13-15 of gestation, but the postnatal survival rates were 30%, 22%, and 0, respectively (Nishikido et al., 1987). The outcome was similar when mouse dams were given 16 mg/kg bw per day as methylmercury chloride orally on one of days 13-17 of gestation. Postimplantation loss was slight or nil, but only 11% of the liveborn pups survived for eight weeks, apparently as a consequence of their inability to suck. The spontaneous locomotor activity of live pups was depressed between 3 and 8 weeks, they had defects in righting and tail position, and, at the end of 8 weeks, they had smaller brains than controls (Inouye et al., 1985). Starvation, undernourishment, and the consequent general weakness were probable contributory factors. Rats Long-term intake of 2.5 mg/kg of diet as methylmercury chloride increased testicular but not ovarian weights in rats (Verschuuren et al., 1976c). Exposure of males and females had no effect on fertility, but the viability of their offspring was impaired (Verschuuren et al., 1976b). If their daily food consumption is assumed to be 100 g/kg bw, the daily dose was 0.25 mg/kg bw. Exposure of female rats to methylmercury chloride at 8 mg/kg of diet from weaning until delivery did not affect litter size, the frequency of stillbirths, birth weight, survival, or weight gain up to weaning (Nixon, 1977). The mating success of male rats declined by seven days after oral treatment with methylmercury chloride at 2.5 or 5 mg/kg bw per day but not at 1 mg/kg bw per day. The number of viable embryos per litter decreased transiently when 2.5 or 5 mg/kg bw per day was given for seven days, 1 mg/kg bw per day for 35 days, or 0.5 mg/kg bw per day for 90 days (Khera, 1973). Oral treatment of female rats with 0.25 mg/kg bw per day as methylmercury chloride from weaning had no apparent adverse effect on fetuses, and the only abnormality seen postnatally was eyelid lesions associated with hardening of the lachrymal glands. A dose of 0.05 mg/kg bw per day had no effect (Khera & Tabacova, 1973). Higher doses were usually used when administration was restricted to the gestation period. In rats given 2, 4 or 6 mg/kg bw per day as methylmercury chloride orally on days 7-14 or 18-20 of gestation, resorptions, deaths, and malformations were observed at 6 mg/kg bw per day. Malformations consisting mostly of cleft palate and vertebral defects were seen in the offspring of dams at the two higher doses (Fuyuta et al., 1978). When a single oral dose of 8, 16, or 24 mg/kg bw as methylmercury chloride was given orally in saline on day 7 of gestation, maternal body weight declined at all doses. The decrease in the number of live fetuses on day 20 of gestation was 60% at 8 mg/kg bw and > 90% at 16 mg/kg bw. A dose-dependent decrease in ossification centres was seen. The concentrations of mercury in maternal brain were 2.6, 9, and 21 µg/g, and those in fetal brain were 3.5, 11, and 15 µg/g (Lee & Han, 1995). Hamsters In hamsters, a single subcutaneous dose of 6.4 mg/kg bw as methylmercury chloride on day 3, 5, or 9 of gestation caused some maternal deaths, a high incidence of resorptions, decreased fetal weights, and moderate to severe malformations, consisting mainly of clubfoot and hydrocephalus. A dose of 1.6 mg/kg bw had no visible effect on dams or offspring, but when given on days 1-14 of gestation it increased the numbers of maternal deaths, resorptions, and malformations although it did not decrease fetal weights (Harris et al., 1972). Non-human primates In macaque monkeys, a daily oral dose of 50 or 70 µg/kg bw as methylmercury hydroxide in fruit juice for 20 weeks decreased sperm motility and increased the frequency of abnormal sperm tail forms, with no significant change in serum testosterone concentration or testicular morphology (Mohamed et al., 1987). In females given doses including 90 µg/kg bw per day, exposure did not affect the menstrual cycle, conception rate, or size of offspring at birth, but a maternal blood concentration > 1.5 µg/ml decreased the number of viable deliveries (Burbacher et al., 1988), and a concentration > 2 µg/ml was toxic to the dams (Burbacher et al., 1984, 1988). 2.2.5 Developmental neurotoxicity 2.2.5.1 Exposure in utero Mice Mouse dams were given methylmercury hydroxide subcutaneously as a single dose of 5.1, 6.8, or 10 mg/kg bw on day 10 of gestation. As the rate of mortality of the neonates of dams treated with 10 mg/kg was high, an additional group of dams were given 3.4 mg/kg bw on days 10-12. Central latency in the open-field behaviour test was increased in the pups of dams given 10 mg/kg bw as a single or three divided doses. Locomotion was decreased by exposure to 6.8 and 10 mg/kg bw at postnatal day 24 but not at day 44 (Su & Okita, 1976). The righting reflex and walking ability lagged behind those of controls consistently in the pups of dams given 6.8 mg/kg bw subcutaneously on day 9, but the difference was not significant (Satoh et al., 1985b). Rats Methylmercury given at a dose of 3.2 mg/kg bw to pregnant rats on day 8 of gestation caused no significant change in the appearance of pups, but samples of calcarine and cerebellar cortices, especially in the granule cells of the cerebellum, showed focal weakening of the nuclear envelope, myelin figure formation, focal cytoplasmic degradation, and phagocytosis of cellular debris by macrophages (Chang et al., 1977). In pups of hamster dams given methylmercury chloride either as a single dose of 8 mg/kg bw on day 10 of gestation or 1.6 mg/kg bw daily on days 10-15, the early cerebellar changes were seen in the external granular layer and in more extensively differentiated neural elements in the molecular and internal granular layer (Reuhl et al., 1981a). The sequelae of the early injuries, such as astrogliosis, may have had clinical or physiological significance when the pups reached the age of 275-300 days (Reuhl et al., 1981b). When methylmercury chloride was given by gavage to rat dams at doses of 0.02, 0.04, 0.4, or 4 mg/kg bw on days 6-9 of gestation, the highest dose impaired swimming behaviour at 4-35 days of age, and the doses of 0.04 and 4 mg/kg bw increased passiveness and decreased habituation to an auditory startle 60-210 days postnatally. The histological changes seen at the highest dose were mainly in the dendritic spines of the pyramidal neurones (Stoltenberg-Didinger & Markwort, 1990). Methylmercury chloride given in apple juice on the same days of gestation at a dose of 1.6 mg/kg bw per day caused no change in the clinical markers of adverse effects up to weaning. No deficits in behavioural function, such as spatial learning in a circular bath and maze learning for food reward, were seen at four to five months of age (Frederiksson et al., 1996). The effect of methylmercury on locomotion is ambiguous. When given orally to rat dams on day 8 or 15 of gestation at a dose of 4 or 6.4 mg/kg bw, no consistent changes in spontaneous locomotor activity were seen 4, 8, or 15 days postnatally. Activity was increased on postnatal day 4 when the low dose was given on day 8 of gestation, on postnatal day 8 when the low dose was given on day 15 or the high dose on day 8 of gestation, and on postnatal day 15 when the low dose was given on day 15 of gestation (Eccles & Annau, 1982a). The higher dose given on day 15 did not affect locomotor activity on postnatal day 14, 21, or 60 (Cagiano et al., 1990), but 8 mg/kg bw given on day 4 of gestation depressed locomotor activity at 110-140 days of age. Avoidance learning was also depressed (Schalock et al., 1980). The effect of 4 or 6.4 mg/kg bw as methylmercury chloride given to rats on day 8 or 15 of gestation on two-way avoidance was tested at nine weeks of age. Exposure increased the number of trials required to reach the preset criterion; however, owing to variations within groups, only the higher dose given on day 8 induced a significant difference in reacquisition and both doses given on day 15 for acquisition (Eccles & Annau, 1982b). The higher dose given on day 15 decreased the number of cortical muscarinic receptors by 53% in 14-day-old pups and by 21% in 21-day-old pups. Recovery from this defect was complete at the age of 60 days, but the results of a passive avoidance test even a few days before that age indicated learning and memory deficits (Zanoli et al., 1994). Non-human primates Female macaque monkeys were given methyl-mercury in apple juice at 0.04 or 0.06 mg/kg bw per day for 198-747 days before mating. Infants were separated from their mothers at birth and were tested 210 and 220 days after conception (50-60 days after birth). The test indicated randomness in visual attention to novel stimuli. The mean maternal blood concentrations at birth were 0.84 and 1.04 µg/ml, and the blood concentrations of the offspring were 0.88 and 1.7 µg/ml (Gunderson et al., 1988). The offspring of squirrel monkeys exposed to methylmercury during the second half or the last third of pregnancy, with maternal blood concentrations of 0.7-0.9 mg/ml, showed reduced sensitivity to changes in the source of reinforcement, indicating learning impairment at five to six years of age (Newland et al., 1994). 2.2.5.2 Exposure in utero and postnatally Mice Mouse dams were exposed to 3.2 mg/L as methylmercury in drinking-water from mating to parturition, and their pups were further exposed up to postnatal day 30 during lactation. The litter weights of exposed and control pups were similar. Males but not females showed some decrease in the width of the external granular layer in a region of the inferior lobe of the cerebellum on postnatal day 7, but not later. The density of migrating cells in the molecular layer was also decreased (Markowski et al., 1998). Rats The concentration of mercury was 10 µg/ml in blood and 1.4 µg/g in the brains of rat pups exposed throughout gestation and lactation via their dams and directly to the same concentration of mercury as methyl-mercury chloride at 3.9 mg/kg of diet. No adverse effect was seen clinically or histologically in the brain, even on morphological maturation of neurons and astrocytes. The only deviation from control values was an increase in noradrenaline activity in the cerebellum (Lindström et al., 1991). In a crossfostering study, rat dams received an approximate daily dose of 2.5 mg/kg bw of methylmercury chloride in drinking-water, and an additional group of pups was exposed only through drinking-water on postnatal days 21-30. Only pups exposed prenatally or directly after weaning had deficits in learning ability at day 30, and the effect lasted at least until postnatal day 50 (Zenick, 1974). At day 30, the action potential in the visual cortex was decreased in each group (Zenick, 1976). Offspring of rat dams exposed to 1.2 or 4 mg/L as methylmercury in drinking-water from two weeks before mating to weaning showed a dose-dependent deficit in correct response when the feedback was tactile kinetic perception. The methylmercury intake of the dams was 0.12 or 0.25-51 mg/kg bw per day before and during gestation and 0.22-0.38 or 0.53-0.95 mg/kg bw per day during lactation (Elsner, 1991). Non-human primates Macaque monkey dams were given methylmercury chloride orally three times a week at doses of 10, 25, or 50 µg/kg bw and were mated when their blood concentration of mercury approached 90% of the steady-state level. Treatment was continued during gestation. Infants were separated from their mothers immediately after birth and given the same dose of methylmercury until they were four years of age. The blood mercury concentration of the infants at birth was 0.45-2.7 µg/ml, and their steady-state concentration reached 0.22-0.78 µg/ml. Two of the five animals were severely intoxicated and could not be tested for spatial or temporal visual function. Some inconsistent defects in spatial vision at high and low luminescence and in temporal vision at high luminiscence were seen. Temporal vision at low luminescence was better in exposed than in control monkeys (Rice & Gilbert, 1990). The auditory response was tested in the same monkeys when they were 11 and 19 years of age, 7-15 years after the end of exposure. The deterioration in hearing between 11 and 19 years was more pronounced in exposed than in control monkeys. In 19-year-old monkeys, the thresholds for all frequencies were higher in exposed than in control monkeys (Rice, 1998). 2.2.5.3 Exposure after parturition Mice A single oral dose of 8 mg/kg bw as methylmercury chloride to two-day-old mice resulted in a brain mercury concentration of 2.7 µg/g, reductions in the number of cells and the percentage of late mitotic figures, and an increase in cells with reduced nuclear diameter (Sager et al., 1982). A smaller reduction in cell numbers in the granular layer of the cerebellum was seen after 4 mg/kg bw, but the number and proportion of late mitotic figures (anaphase) remained significantly lower than in controls at day 19 post partum (Sager et al., 1982). Rats Two-day-old rats were given methylmercury chloride at a dose of 5 mg/kg bw per day subcutaneously until loss of body weight and signs of neurological impairment, including impaired vision (weak visual placing response), became evident. At this point, the animals were necropsied, and their visual cortices were studied. Degenerating neurons were concentrated mainly in layer IV and were scattered in layers II, III, V, and VI (O'Kusky, 1985). The same treatment led to the spastic dyskinetic syndrome and to decreases in the specific activity of glutamic acid decarboxylase (which synthesizes gamma-aminobutyric acid) in the occipital cortex (O'Kusky et al., 1988a) and in the tissue concentrations of serotonin and dopamine and their metabolites (O'Kusky et al., 1988b). As the dose used in these studies was high, pain and local irritation could have been confounding factors at least on the concentrations of catecholamines and serotonin In addition, renal function was certainly affected, as even 0.85 mg/kg bw given as methylmercury hydroxide subcutane-ously daily from the day of birth impaired the kidneys (Slotkin et al., 1985). Non-human primates Four infant monkeys were given methylmercury chloride at 0.5 mg/kg bw per day orally for 28-29 days from day 1 after birth. They progressively became ataxic, blind, and comatose and were necropsied at 35-43 days. Histopathological changes were marked in the cerebrum and less severe in the cerebellum, where the Purkinje and granular cells appeared normal (Willes et al., 1978). In an experiment in which much lower doses were used, the blood mercury concentration of five newborn macaque monkeys given 0.05 mg/kg bw per day orally in fruit juice peaked at 1.2-1.4 µg/ml and declined after weaning to 0.6-0.9 µg/ml. At three to four years of age, they had impaired spatial vision at both high and low luminescence (Rice & Gilbert, 1982). Continuation of exposure to the same daily doses until seven years of age resulted in an increased auditory threshold in four of five monkeys, at high frequency (25 000 Hz) in one monkey and at middle frequencies in three monkeys (Rice & Gilbert, 1992). When these monkeys reached the age of 13 years, some appeared to be clumsy and hesitant in large exercise cages. Exposed monkeys required more time to collect 10 objects from a recessed square and had a higher vibration threshold, but their motor response time was normal (Rice, 1996). 2.2.7 Carcinogenicity In mice exposed for two years to methylmercury at 0.4, 2, or 10 mg/kg of diet, renal tumours developed only in males at 10 mg/kg of diet. The incidence of renal adenoma was 8% and that of carcinoma was 22% in B6C3F1 mice, the corresponding figures being 5% and 17% in ICR mice. Nearly all male and female B6C3F1 mice at 10 mg/kg of diet had chronic nephropathy, while only 78% male and 43% female ICR mice had this pathological change (Mitsumori et al., 1990). The chronic insult to the kidney may have contributed to the induction of cancer. In groups of male and female rats fed diets containing methylmercury at 0.1, 0.5, or 2.5 mg/kg of diet for two years, the incidence of pathological lesions and tumours was not increased (Verschuuren et al., 1975c). 2.2.8 Immunomodulation Exposure of mice to methylmercury in the diet at 3.2 mg/kg did not affect body weight or kidney, liver, or spleen weight, but the weight of the thymus and the number of thymocytes decreased by 22 and 50%, respectively. The lymphoproliferative response to T-and B-cell mitogens was increased in both thymus and spleen, and natural killer cell activity was decreased by 44% in spleen and by 75% in blood (Ilbäck, 1991). In a cross-fostering study, when rat dams were exposed to mercury as methylmercury at 3.2 mg/kg of diet 11 weeks before mating, no consistent alterations were seen in the body weight, lymphoid organ weights, or cell number and lymphoproliferative response to Bcell mitogens of pups at the age of 15 days. The response of thymocytes to T-cell mitogens increased by 30-48% and that of splenocytes decreased by 12% only in pups exposed throughout lactation; natural killer cell activity decreased by 42% after both doses (Ilbäck et al., 1991). Mouse dams and pups exposed to methylmercury at a concentration of 0.5 or 5 mg/kg of diet from 10 weeks before mating until weaning showed inconsistent effects on the immune system (Thuvander et al., 1996). 2.2.9 Extrapolation between species The doses used in experiments in rats and mice frequently exceeded 1 mg/kg bw per day, which is within the range of the intake of the Iraqi patients with severe methylmercury poisoning (Bakir et al., 1973) and 140-330 times higher than the daily intake that would cause paraesthesia in 5% of a population (WHO, 1976). Thus, extrapolation of doses on the basis of body weight clearly results in nonsense values. Table 3 shows that the clearance half-times of methylmercury increase with mass, in the order mouse < rat < macaque monkey < human, and that the concentrations in the whole body after a unit dose follow the same order. The data in the Table are based on the assumption that clearance from blood approximates clearance from the whole body, and the clearance half-times are given as the daily clearance in percent of the whole-body burden. The units for dose and concentration are identical. As the half-time increases with body mass, the concentration in the body after identical doses of methylmercury also increases with body mass. Thus, allometric extrapolation based on surface area can be used. The method of correction, for example from the dose for mouse to the human dose, is: human dose = mouse dose (0.3:70)0.3 With this allometric extrapolation, the dose in mice multiplied by 0.098 gives the equivalent human dose, while the multiplication factor for the dose in rats is 0.20 and that for macaques is 0.42. The effect of this extrapolation on steady-state concentrations is shown in Table 4. 2.3 Observations in humans Investigations of the possible neurodevelopmental effects of prenatal exposure to methylmercury followed a sequence similar to those of other neurotoxic exposures: case series of children who manifested clinical signs of poisoning and then prospective cohort studies of asymptomatic children considered to have 'low' exposure or at least exposure lower than that at which clinical signs and symptoms appear. The populations chosen were mostly those known to consume large amounts of fish, which contain variable amounts of methylmercury (see section 3). The goal of the latter studies is largely to determine whether a dose-response relationship can be identified for adverse neurodevelopmental effects associated with exposure to methylmercury, in order to assess the significance to public health of exposure in various populations. Table 3. Clearance half-times and whole-body concentrations of methylmercury Species Body Half-time Clearance Ratio of concentration:daily dosea weight (days) (% body (kg) burden) 10 days after After 10 At steady single dose doses state (long-term exposure) Human 70 52 0.014 0.87 9.4 75 Macaque 4 25 0.028 0.76 8.7 36 Rat 0.35 12 0.058 0.56 7.6 17 Mouse 0.03 7 0.099 0.37 6.3 10 a Same units as daily dose 2.3.1 Case series The mass poisoning of persons living near Minamata Bay in Japan in the 1950s first raised awareness of the severe neurological sequelae associated with methylmercury poisoning, particularly when experienced prenatally. The primary route of exposure in this episode was the consumption of fish contaminated by methylmercury, which bioaccumulated up the aquatic food chain. According to Harada (1995), all children identified as suffering from the most severe form of congenital Minamata disease showed mental retardation, primitive reflexes, cerebellar ataxia, disturbances in physical growth, dysarthria, and limb deformities, and most showed hyperkinesis (95%), hypersalivation (95%), seizures (82%), strabismus (77%), and pyramidal signs (75%). The incidence of cerebral palsy among children with the disease was also increased, involving 9% of 188 births in three villages. Some of the signs and symptoms, such as paroxysmal events, hypersalivation, primitive reflexes, and ataxia, abated somewhat in subsequent years, although others such as reduced intelligence and dysarthria did not. Most patients with the severe form of the disease were unable to function successfully in society. The mothers of many affected children experienced only transient paresthesia, indicating that fetal vulnerability exceeds that of mature individuals. Although measurements of the body burden of mercury were not available until several years after the episode, analyses of the mercury concentrations in archived umbilical cord tissue from patients with congenital Minamata disease suggest that the mean concentration in maternal hair may have been approximately 41 µg/g (25-75th percentile: 20-59) (Akagi et al., 1998). The uncertainty associated with this estimate is likely to be substantial, however, as case ascertainment was undoubtedly incomplete, particularly among individuals who suffered milder forms of the disease. For example, even if cases of known disease are excluded, the prevalence of mental retardation among children born between 1955 and 1958 in the contaminated area was 29%, which is far higher than would have been expected and suggests that congenital Minamata disease was not diagnosed in many children with less severe forms. Thus, these data cannot provide precise estimates of the minimum concentration of methylmercury required to produce this disease. A second episode of mass methylmercury poisoning occurred in Iraq in the early 1970s, when seed grain treated with a fungicide containing this compound was ground into flour and consumed and resulted in 600 deaths and 6000 cases of methylmercury poisoning. Thus, the exposure was probably more acute and involved higher doses than those experienced by the persons living around Minamata Bay. The results of early studies of the most severely affected children who were exposed during fetal development were concordant with those in Minamata: the children manifested severe sensory impairment (blindness, deafness), general paralysis, hyperactive reflexes, cerebral palsy, and impaired mental development (Amin-Zaki et al., 1974). Several follow-up studies of the exposed population were conducted. Marsh et al. (1987) identified 81 children who were in utero at the time of the episode and collected information on their neurodevelopmental outcomes from two sources: neurological examination of each child and an interview with the mother about the age at which the child achieved standard developmental milestones such as walking and talking. The maximum concentrations of mercury in maternal hair during the pregnancy, which were used as the index of fetal exposure, ranged from 1 to 674 µg/g. Developmental retardation was defined as a child's failure to walk a few steps unaided by 18 months of age or to say two or three meaningful words by 24 months of age. A point system was devised for the neurological examination, a score > 3 indicating a definite abnormality. The prevalences of these indicators of poor outcome were related to the concentrations of mercury in maternal hair. The most frequent neurological findings were increased limb tone and deep-tendon reflexes with persistent extensor plantar responses; ataxia, hypotonia, and athetoid movements were also reported. Boys appeared to be more severely affected than girls. Seven of the 28 children with the highest exposure and none of the 53 children with lower exposure had had seizures. Additional analyses of this data set were performed to identify more precisely the shape of the dose-response relationship and, in particular, the threshold for adverse neurodevelopmental effects, if indeed one exists. Cox et al. (1989) obtained more accurate estimates of peak exposure during pregnancy by applying an X-ray fluorescent method to single strands of maternal hair. Using logit, hockey-stick, and non-parametric kernel smoothing methods, they estimated a population threshold of around 10 µg/g for the outcomes investigated. The uncertainty associated with this estimate is heavily dependent, however, on the estimated background prevalence of the poor outcomes. For example, the upper bound of the 95% confidence interval for motor retardation increases from 14 to 190 µg/g if the estimate of background prevalence is changed from 0 to 4%. For neurological abnormality, the upper bound of the 95% confidence interval for the threshold estimate was 287 µg/g when a 9% background prevalence was assumede. In later re-analyses of these data, Crump et al. (1995) and Cox et al. (1995) demonstrated that the estimate of threshold depends on the model used and is sensitive to the definition of abnormality. In the case of delayed walking, the estimate was influenced by the only four cases of delayed walking among the children of women whose hair concentration of mercury was < 150 µg/g. The statistical variability of the estimates of threshold appears likely to be considerably greater than that of Cox et al. (1989). Crump et al. (1995) concluded that the data from the Iraqi episode do not provide convincing evidence of any adverse neurodevelopmental effect of methylmercury at concentrations in maternal hair < 80 µg/g. In evaluating these data, it is important to note that the interviews were conducted when the mean age of the children was 30 months, but some of the children must have been considerably older at this time, as the age at which children in the sample were reported to have walked or talked was as much as 72 months. In addition, the birth dates were generally not accorded significance, and maternal recollection of the ages at which their children achieved milestones were based on external events such as religious holidays. The extent of the imprecision of these data is suggested by the strong digit Table 4. Steady-state concentrations of methylmercury in humans after allometric extrapolation of unit doses from three experimental species and comparison of human and animal steady-state concentration ratios Animal Concentration Human concentration Ratio at steady state after equal doses (based on mass) (based on surface) Macaque 28 0.09 2.1 Rat 12 0.9 4.4 Mouse 6 1.0 7.5 Steady-state concentrations in animals are shown in the last column of Table 3. preferences in the mothers' responses. For instance, an even number of months was given for the estimated age at walking for 70 of the 78 children and for the estimated age at talking for 70 of 73 children; 75% of the estimates were multiples of six months. Finally, the extent of selection bias in this cohort cannot be characterized because the size of the base population from which it was drawn and the referral mechanism that brought mothers and children to medical attention are both unknown. For instance, women who knew that they had consumed large amounts of contaminated grain and were concerned about their children's welfare may have come forward, while women who consumed equally large amounts of contaminated grain but whose children were developing well may not. This issue is critical, because calculation of a threshold requires a denominator (the size of the exposed population) and the background prevalence of the adverse outcome in order to estimate the 'added risk' associated with the exposure of interest. In this regard, the background prevalence of developmental abnormality appears to have been extremely high among the Iraqi children who participated in the follow-up studies. The prevalence of delayed walking among children whose mothers had concentrations of mercury in hair < 10 µg/g, who can be viewed essentially as a control group for estimating background prevalence, was 36% (11/31). In contrast, in the population of children in the United States on whom the Bayley scales of infant development were standardized (Bayley, 1969), the prevalence of delayed walking by this criterion was approximately 5%. Similarly, the prevalence of delayed talking among the Iraqi children was 22% (6/27), whereas 95% of 24-month-old children in the standardization sample of the MacArthur communicative development inventory were saying 50 words or more (Fenson et al., 1993). 2.3.2 Childhood development 2.3.2.1 Neurological status McKeown-Eyssen et al. (1983) studied 234 Cree children aged 12-30 months living in four communities in northern Quebec, Canada, whose prenatal exposure to methylmercury was estimated on the basis of maternal hair samples. Hair samples were collected from 28% of the mothers during pregnancy, but the prenatal exposure of the rest of the cohort was estimated from hair segments assumed to date from the period of the pregnancy. The exposure index was the maximum concentration of mercury in the segment of hair corresponding most closely to the period from one month before conception to one month after delivery. The mean concentration of mercury in maternal hair was approximately 6 µg/g; it exceeded 20 µg/g in 6% of samples. One of four paediatric neurologists who were unaware of the child's status of exposure measured height, weight, and head circumference, identified dysmorphology, and conducted a neurological examination, assessing coordination, cranial nerves, and muscle tone and reflexes. The neurologist then made a summary clinical judgement about the presence of a neurological abnormality. None of the children was judged to have an abnormal physical finding, but 3.5% of the boys ( n = 4) and 4.1% of the girls ( n = 5) were considered to have a neurological abnormality. The most frequent abnormality involved tendon reflexes, which was seen in 11% of boys ( n = 13) and 12% of girls ( n = 14). The only neurological finding that was significantly associated with prenatal exposure to methylmercury, either before or after adjustment for confounding, was abnormal muscle tone ( n = 2; increased tone in legs only) or reflexes ( n = 13; five with isolated decreased reflexes, six with generalized decreases, and two with generalized increases) in boys ( p = 0.05). The risk for abnormal tone or reflexes increased seven times with each 10-µg/g increase in prenatal exposure to methylmercury (95% confidence interval, 1-51). After log transformation of prenatal exposure, however, the p value for this association increased to 0.14. When exposure was categorized, the prevalence of tone or reflex abnormality did not increase in a clear dose-related manner across the categories. In girls, the only association identified was an unexpected inverse relationship between prenatal exposure to methylmercury and incoordination, with a 60% decrease in the probability of incoordination for each 10-µg/g increment (odds ratio, 0.3; 95% confidence interval, 0.1-0.9; p = 0.02). The authors noted several caveats with regard to the one significant adverse association identified: the abnormalities of muscle tone and reflexes in boys were isolated, mild, and of doubtful clinical importance; the finding is not consistent with previous results which suggest that increased exposure is expressed as severe generalized neurological disease, including increases in tone and reflexes; there was no coherent dose-response relationship; and there was no consistency between the sexes. The finding may reflect chance, lack of normality in the distribution of the exposure index, or residual confounding. A study was conducted in Mancora, a fishing community on the northern coast of Peru, in which hair samples and clinical data were obtained for 131 infant-mother pairs. The mean concentration of mercury in maternal hair was 7 µg/g (range, 0.9-28), with an average peak of 8.3 µg/g. The small difference between the mean and the peak was probably due to the stability of the fish consumption of the mothers. The major outcomes measured were anthropmorphic end-points (birth weight, head circumference, and height), maternal reports of infant development (age at which the infant sat, stood, walked, and talked), and neurological status (Marsh et al., 1995). The specific elements of the neurological assessment conducted and the age at which the infants were examined were not described. Tone was decreased in two children, limb weakness was seen in one child, reflexes were decreased in one child and increased in four, and an abnormal Babinski reflex was seen in one child; increased tone, primitive reflexes, and ataxia were not observed. None of the signs was significantly associated with either the mean or the peak concentration of mercury in maternal hair. In the pilot phase of a cross-sectional cohort study of child development in the Seychelles, 789 infants aged 5-109 weeks were evaluated by one paediatric neurologist who was unaware of their exposure status (Myers et al., 1995a). The mean concentration of mercury in maternal hair was 6.1 µg/g (range, 0.6-36 µg/g). The features assessed included mental status, attention, social interactions, vocalization, behaviour, coordination, posture and movements, cranial nerves II-XII, muscle strength and tone, primitive and deep-tendon reflexes, plantar responses, and age-appropriate abilities such as rolling, sitting, pulling to stand, walking, and running. The statistical analyses focused on three end-points, selected because of their apparent sensitivity to prenatal exposure to methylmercury in the studies in Iraq and the Cree population: overall neurological status, increased muscle tone, and deep-tendon reflexes in the extremities. The result of the overall examination was considered to be 'abnormal' if any findings judged to be pathological were present, including abnormalities of cranial nerves (pupils, extraocular muscles, facial or tongue movement, swallowing, or hearing), increase or decrease in muscle tone or deep-tendon reflexes, incoordination, involuntary movements, or poorly developed speech or functional abilities. Findings that were considered to be neither normal nor pathological were categorized as 'questionable'. Because the frequency of abnormal findings was low (2.8%), the questionable (11%) and abnormal categories were combined. No association was found between the concentration of mercury in maternal hair and questionable or abnormal results, the frequency ranging from 16% for hair concentrations of 0-3 µg/g to 12% for hair concentrations > 12 µg/g. The frequency of abnormalities of limb tone or deep-tendon reflexes was about 8% and did not vary in a dose-dependent manner with the concentration of mercury in maternal hair. In the main study, which involved a cohort of 735 children, one paediatric neurologist who was unaware of the exposure status of the children conducted essentially the same neurological examination that had been used in the pilot study but when the participants were 6.5 months old (Myers et al., 1995b). The results of the overall examination were considered to be abnormal or questionable if changes in muscle tone, deep-tendon reflexes, or other neurological features were pathological or the examiner considered that a child's functional abilities were not appropriate for his or her age. Abnormal or questionable neurological scores were found for 3.4% ( n = 25) of the children, a frequency too low to permit statistical analysis. For both limb tone and deep-tendon reflexes, the frequency of abnormalities was 2%; questionable limb tone was found in approximately 20% of the children and questionable deep-tendon reflexes in approximately 15%. For neither limb tone nor deep-tendon reflexes was the frequency of abnormal or questionable findings significantly associated with the concentration of mercury in maternal hair. In a study carried out in the Faroe Islands (Denmark), a functional neurological examination was administered to children at the age of 7 years as part of a general physical examination. The examination focused in particular on motor coordination and perceptual-motor performance (Dahl et al., 1996). The tests for coordination included rapid pronation or supination, reciprocal coordination (alternately closing and opening the fists), and finger opposition (touching the pulpa of the thumb with the pulpa of the other fingers of the same hand). The perceptual-motor tests included catching a 15-cm ball thrown from a distance of 4 m, finger agnosia, and double finger agnosia. The results were scored as automatic or as questionable or poor. Exposure to mercury was evaluated on the basis of the concentration in maternal hair at delivery, in umbilical cord blood, and in children's hair obtained at about 12 months of age Exposure to mercury was not significantly associated with the number of tests on which a child's performance was considered to be 'automatic', as < 60% of the children achieved such a score on the tests for reciprocal motor coordination, simultaneous finger movement, and finger opposition; however, children with questionable or poor performance for finger opposition had had significantly higher mean exposure to mercury than children with automatic performance (24 versus 22 µg/L; p = 0.04) (Grandjean et al., 1997). 2.3.2.2 Developmental milestones The association between the achievement of developmental milestones and prenatal exposure to methylmercury was evaluated in the main cohort of the study in the Seychelles (Myers et al., 1997; Axtell et al., 1998). Information on the ages at which a child was able to walk without support and to say words other than 'mama' or 'dada' was elicited by means of an interview with the person with whom the child spent five or more nights per week (the 'caregiver'), conducted at an evaluation at 19 months. Such information was available for 738 of the 779 children. The statistical approaches explored included standard multiple regression in which age at achievement of a milestone was log-transformed, hockey-stick models to estimate the threshold concentration of mercury in maternal hair associated with delay in achieving a milestone, and logistic regression analyses of 'delayed walking', a binary variable in which an abnormal response was defined as > 14 months. Prenatal exposure to methylmercury was estimated from the total mercury in the single longest segment of hair dating from the index pregnancy; the mean concentration was 5.8 µg/g (range, 0.5-27), and 22% of the children had been exposed to > 10 µg/g. The mean age at which a child was considered to talk was not significantly associated with the concentration of mercury in maternal hair in any of the models tested. In regression analyses stratified by sex, a positive association was found between age at walking and exposure to mercury for boys ( p = 0.043) but not for girls. The interaction term 'mercury × sex' in analyses of the complete cohort was not statistically significant. The magnitude of the delay in the age at which boys walked--a 10-µg/gincrease in the concentration of mercury in maternal hair associated with an approximately two-week delay in walking--was viewed by the authors as clinically insignificant, and the association was not significant when four statistical outliers were excluded from the analysis. Hockey-stick models provided no evidence of a threshold, as the fitted curves were essentially flat. A child's risk for 'delayed walking' was not associated with the concentration of mercury in maternal hair. In a re-analysis of these data, Axtell et al. (1998) used semiparametric generalized additive models with smoothing techniques to identify lack of linearity. These models are less restrictive than those used by Myers et al., which require strong assumptions about the true functional form of a relationship. The major finding of Axtell et al. was that the association between age at walking and the concentration of mercury in maternal hair in boys was not linear, walking being achieved at a later age as exposure increased from 0 to 7 µg/g but at a slightly earlier age as the concentration increased beyond 7 µg/g. The size of the effect associated with the increase from 0 to 7 µg/g was small, corresponding to a delay of less than one day in the achievement of walking. Because no clear dose-response relationship was seen at concen-trations > 7 µg/g, the authors considered that the association found at lower concentrations did not reflect a causal effect of mercury on the age at walking. Data on developmental milestones were also collected in the study in Peru (Marsh et al., 1995). The ages of the children at the time the mothers were questioned about these events was not stated, although the study was conducted prospectively and data were apparently collected throughout the women's visits to postnatal clinics. Regression analyses, including analyses stratified by sex, showed no significant association between the concentration of mercury in maternal hair and the ages at which the children sat, stood, walked, or talked. The rates of developmental retardation were substantial, especially for speech (13/131), although the criteria used to define this outcome were not stated. The children's birthweight, height, and head circumference were also unrelated to the concentration of mercury in maternal hair. The ages at which children achieved motor milestones were investigated in a birth cohort of 1022 children born during a 21-month period in 1986-87 in the Faroe Islands (Grandjean et al., 1995a). The data were obtained from interviews with the mothers and from the observations of district health nurses who had visited the homes of the children on several occasions during their first year of life. Complete data were available for 583 children (57% of the cohort). Three motor milestones commonly achieved between 5 and 12 months of age were selected for analysis: sitting without support, crawling, and standing with support. The age at achievement of the three milestones was not significantly associated with the concentration of mercury in cord blood or maternal hair, but a significant negative association was found between the age at achievement of all three milestones and the concentration of mercury in children's hair at 12 months. The authors concluded that this association reflected residual confounding by duration of breast-feeding, since nursing was associated with both higher hair mercury concentrations in children at 12 months of age and more rapid achievement of milestones. This finding suggests that the beneficial effects of nursing on early motor development are sufficient to compensate for any slight adverse impact that prenatal exposure to low concentrations of methylmercury may have on these end-points. 2.3.2.3 Early development In the study of Cree people reported by McKeown-Eyssen et al. (1983), the Denver developmental screening test (Frankenburg et al., 1981)was administered to all children aged 12-30 months. The scores were reported as the percentage of items passed on each subscale (gross motor, fine motor, language, personal and social) and on the entire test. Although quantitative estimates of the associations between test scores and the concentration of mercury in maternal hair (mean, 6 µg/g; 6% > 20 µg/g) were not provided, the authors reported that they found no significant association compatible with an adverse effect of methylmercury, before or after adjustment for confounding variables. Kjellström et al. (1986, 1989) studied a cohort of children in New Zealand whose prenatal exposure to methylmercury was estimated on the basis of maternal hair samples and dietary questionnaires collected during the pregnancy. Although nearly 11 000 women participated in the initial phase during which information on exposure was obtained, Kjellström et al. focused on 935 women who had reported eating fish more than three times per week during the pregnancy. The 74 children of 73 women whose concentration of mercury in hair was > 6 µg/g were considered to have had heavy exposure to mercury. Three controls were matched to each of these children on the basis of ethnic group, sex, maternal age, maternal smoking, area of maternal residence, and the duration of maternal residence in New Zealand. The concentration of mercury in maternal hair was 3-6 µg/g for one of each of the controls, whose mother ate fish more than three times per week, and 0-3 µg/g for the other two, whose mothers had a lower consumption of fish. There were 57 fully matched sets of four children and four incomplete sets, for a cohort of 237 children. Evaluations conducted when the children were four years of age indicated that about 50% of children with heavy exposure to mercury and 17% of the children in the control group had an abnormal or questionable result on the Denver developmental screening test. In the pilot phase of the Seychelles study, a revised version of the Denver test was administered to 789 children aged 1-25 months by one examiner who was unaware of their exposure status (Myers et al., 1995a). No association was found between the concentration of mercury in maternal hair during pregnancy (mean, 6.6 µg/g) and the results on the test when normal and questionable results were combined in the conventional manner, although the prevalence of abnormal findings was so low (three children, < 1%) that statistical analysis was not meaningful. When abnormal and questionable (n = 65; 8%) results were grouped, as was done in the study in New Zealand (Kjellström et al., 1986), a higher concentration of mercury in maternal hair was significantly (p = 0.04; one-tailed test) associated with a poor outcome. This result was largely attributable to the higher frequency of abnormal or questionable results (13%) among children with the heaviest exposure to mercury (> 12 µg/g), in contrast to the frequency of approximately 7% among children in each of the other four groups (0-3, 3-6, 6-9, and 9-12 µg/g). In the main study in the Seychelles, the revised Denver developmental screening test was administered to a cohort of 740 children (mean concentration of mercury in maternal hair during pregnancy, 5.9 µg/g; interquartile range, 6 µg/g) aged 6.5 months by one examiner who was unaware of their exposure status (Myers et al., 1995b). The frequency of results considered to be abnormal (three children; 0.4%) or questionable was very low (11; 1.5%), precluding meaningful statistical analysis. The Fagan test of infant intelligence (Fagan, 1987), an assessment of visual recognition memory or novelty preference, was also administered to 723 of the children at the same age. The mean percent novelty preference in the entire cohort was 60%, which is similar to that observed in other cohorts, and varied by < 1% across categories of concentration of mercury in maternal hair. The index of perfor-mance on visual attention (the time required to reach visual fixation criterion in familiarization trials) was also unrelated to the concentration of mercury. The Bayley scales of infant development were administered to children in this cohort at the ages of 19 months ( n =738) and 29 months ( n =736) by examiners who were unaware of their exposure status (Davidson et al., 1995a). Six items of the infant behaviour record, a rating scale, were also completed by the examiner for children aged 29 months, to assess activity, attention span, responsiveness to the examiner, response to the caregiver, cooperation, and general emotional tone. The Bayley scales yield two primary scores: the mental development index and the psychomotor development index. At both ages, the scores for mental development were similar to the expected mean for children in the United States, but the children's psychomotor development index scores were markedly higher: at 19 months, approximately 200 of the children achieved the highest possible score. Accordingly, the psychomotor development scores at both ages were expressed as a binary variable, dividing the distribution at the median score. The mental development scores were not significantly associated with the concentration of mercury in maternal hair during pregnancy. Similar results were obtained in a secondary analysis that included only children with the lowest (< 3 µg/g) or highest (> 12 µg/g) concentration of mercury in maternal hair. The scores at 19 months for the items on the mental development scale designed to assess perceptual skills, dichotomized because of the skewing, were not associated with exposure to mercury. The scores for this index at 29 months could not be evaluated because of 'a pronounced celling effect'. A psychomotor development index score below the median was not significantly associated with the concentration of mercury in maternal hair in the full logistic regression model, but was associated with this exposure index ( p = 0.05) in a reduced model in which adjustment was made for a smaller number of covariates selected a priori. A secondary analysis of the psychomotor development index scores of children with the lowest and highest exposure to mercury was not conducted because statistical significance was not achieved in the full logistic regression model. In analyses of the six items for infant behaviour, the concentration of mercury in maternal hair was significantly associated only with the examiner's ratings of children's activity during the test session and only in boys. The score decreased by one point (on a nine-point scale) for each 10 µg/g. In general, the use of screening tests such as the Denver test in studies of neurobehavioural toxicology is not recommended because of their insensitivity to variations within the range of normal performance (Dietrich & Bellinger, 1994). More detailed instruments, such as the Bayley scales of infant development, have proven to be sensitive to prenatal exposure to a variety of neurotoxicants, including lead (Bellinger et al., 1987; Dietrich et al., 1987; Wasserman et al., 1992) and polychlorinated biphenyls (PCBs; Rogan & Gladen, 1991; Koopman-Esseboom et al., 1996). The only study of exposure to mercury in which the Bayley scales were administered was the study in the Seychelles, which found no significant association between children's scores and prenatal exposure. It is notable that the psychomotor development index scores were so high in this cohort that the distribution had be split at the median and analysed as a categorical variable. The median value was not provided by Davidson et al. (1995a) but was derived from a figure in the paper of Davidson et al. (1995b); it appeared to be approximately 130, or two standard deviations above the expected population mean. The mental development index scores were close to the expected population mean. It is questionable, however, whether statistical analysis of scores > 130 versus < 130 allows assessment of a potential adverse effect of prenatal exposure to mercury on early motor development. 2.3.2.4 Development later in childhood In the study in New Zealand, the 237 children in the 57 fully matched groups participated in a follow-up evaluation of neurodevelopmental status at 6 years of age (Kjellström et al., 1989). The mean concentration of mercury in maternal hair in the group with heavy exposure was was 8.3 µg/g (range, 6-86 µg/g; all but 16, 6-10 µg/g). Extensive information was collected on possible confounding factors such as social class, medical history, and nutrition. A battery of 26 psychological and scholastic tests was administered to assess general intelligence, language development, fine and gross motor coordination, academic attainment, and social adjustment. Multiple regression analyses were conducted of five primary end-points: language development and spoken language; the revised Wechsler intelligence scale for children for both performance and fill-scale intelligence quotient (IQ) (Wechsler, 1974); the McCarthy scales of children's perceptual performance abilities; and the McCarthy scale of motor ability (McCarthy, 1972). In addition, robust regression methods were applied, involving the assignment of weights to observations, depending on their position within the distribution. In these analyses, the concentration of mercury in maternal hair was associated with poorer scores (p values ranging from 0.0034 to 0.074) for full-scale IQ, language development, visual and spatial skills, and gross motor skills. The findings in the unweighted regression analyses were similar in direction although generally less significant. The poorer mean scores of the children with heavier exposure to mercury were largely attributable to those whose mothers had concentrations in their hair < 10 µg/g, for whom the mean average concentration during pregnancy was 13-15 µg/g and the mean peak monthly concentration was about 25 µg/g. The concentration of mercury in maternal hair accounted for relatively little variance in the outcome measures and generally less than covariates such as social class and ethnic group. In additional analyses of this data set, Crump et al. (1998) found that when the concentration of mercury in maternal hair was expressed as a continuous rather than as a binary variable, none of the 26 scores was associated with exposure to mercury at p < 0.10. The results were heavily influenced, however, by the results of a child whose mother had a concentration of mercury of 86 µg/g--more than four times the next highest level--despite the fact that the child's scores were not outliers by the usual criteria. When the data for this child were excluded, the scores on six end-points (Clay reading concepts or reading letters [Clay, 1979], McCarthy general cognitive index, McCarthy perceptual performance index, grammar completion, and grammar understanding) were inversely associated with the concentration of mercury in maternal hair at the 10% level. Several features of the study in New Zealand are noteworthy, including the efforts made to collect data on potential confounding variables and the broad battery of standardized outcome measures, administered by trained examiners. In contrast to the acute, heavy exposure of the Iraqi population, the cohort in New Zealand received chronic, low exposure, which was probably fairly constant over time, reflecting well-established food consumption patterns. In addition, the concentration of mercury in maternal hair was measured prospectively. As part of the pilot phase of the study in the Seychelles, children who reached the age of 66 months underwent developmental assessment (Myers et al., 1995c). Of the 247 eligible children, 217 (88%) were given a battery of tests consisting of the McCarthy scales of children's abilities, a preschool language scale, and two subtests of the Woodcock-Johnson tests of achievement (Woodcock & Johnson, 1989): letter and word identification and applied problems. The median concentration of mercury in maternal hair in 73 children whose mothers had had a concentration of mercury in their hair > 9 µg/gor < 4 µg/g was 7.1 µg/g(range, 1-36). The rate of missing values was substantial for some end-points: e.g. 34% for the general cognitive index of the McCarthy scales. Increased concentrations of mercury in maternal hair were associated with significantly lower general cognitive scores ( p = 0.024), the scores declining approximately five points between the lowest (< 3 µg/g) and the highest (> 12 µg/g) categories of exposure. A similar association was found on the perceptual performance subscale of the McCarthy scales ( p = 0.013). The children's scores on the auditory comprehension scale of the preschool language test were also inversely associated with the concentrations of mercury in maternal hair ( p = 0.0019), the scores declining approximately 2.5 points across the range of exposure to mercury. In additional analyses, exclusion of several outliers or influential data points reduced the estimates of the effect of mercury substantially, sometimes to nonsignificance. It is important to note that in the pilot phase of the study information was not collected on several key variables that frequently confound the association between exposure to neurotoxicants and child development, specifically socioeconomic status, maternal intelligence, and quality of the home environment. In the main study in the Seychelles, 711 children from the original cohort of 779 were evaluated at 66 months of age (± 6 months) by a battery of standardized neurodevelopmental tests (Davidson et al., 1998). The major domains assessed were general cognitive ability (McCarthy scales), expressive and receptive language (preschool language scale), reading achievement (letter and word recognition in the Woodcock-Johnson tests), arithmetic (applied problems test in the Woodcock-Johnson tests), visual and spatial ability (Bender Gestalt test; Koppitz, 1963), and social and adaptive behaviour (child behaviour checklist). The total amount of mercury in a segment of maternal hair during pregnancy served as the index of prenatal exposure to methylmercury (mean, 6.8 µg/g; SD, 4.5, range, 0.5-27), whereas the total amount of mercury in a 1-cm segment of hair obtained from a child at 66 months served as the index of postnatal exposure to methylmercury (mean, 6.5 µg/g; SD, 3.3; range, 0.9-26). For none of the six primary end-points did the pattern of scores suggest an adverse effect of either prenatal or postnatal exposure to mercury, and in fact the associations that were found indicated enhanced performance among children with heavier exposure. Greater prenatal and postnatal exposures to mercury were both significantly associated with better total scores for expressive and receptive language (both p = 0.02), and heavier postnatal exposure was associated with a better score for arithmetic ( p = 0.05). Among boys, higher postnatal exposure to mercury was associated with fewer errors on the test for visual and spatial ability ( p = 0.009). In the study in the Faroe Islands, 917 (90.3%) of the surviving members of the birth cohort of 1022 singleton births were submitted to comprehensive evaluations at approximately 7 years of age (Grandjean et al., 1997). The neuropsychological battery included three computer-administered tests from the neurobehavioural evaluation system (finger tapping, hand-eye coordination, continuous performance test), the tactual performance test, three subtests of the revised Wechsler intelligence scale for children (digit span, similarities, block design), the Bender Gestalt test, the California verbal learning test for children (Delix et al., 1994), the Boston naming test (Kaplan et al., 1983), and the nonverbal analogue profile of mood states. Parents were asked to respond to selected items on the child behaviour checklist. The primary index of exposure to methylmercury was the concentration of mercury in umbilical cord blood (geometric mean, 22.9 µg/L; interquartile range, 13-41; n = 894). Estimates were also available of the con-centration of mercury in maternal hair at parturition (geometric mean, 4.3 µg/g; interquartile range, 2.6-7.7; n = 914); in the child's hair at 12 months of age (geometric mean, 1.1 µg/g; interquartile range, 0.7-1.9; n = 527); and in the child's hair at 7 years (geometric mean, 3 µg/g; interquartile range, 1.7-6.1; n = 903). Not all of the children were able to complete all of the tests, and in some cases (e.g. finger opposition test, mood test) failure was associated with significantly higher mercury concentrations. Sensory functions including visual acuity, contrast sensitivity, auditory thresholds, and visual evoked potentials were not significantly related to prenatal exposure to mercury. Peaks I, III, and V of the brainstem auditory evoked potential at both 20 and 40 Hz ( p = 0.01-0.1) were slightly delayed in children with higher concentrations of mercury in cord blood, although at neither frequency was the interpeak latency associated with exposure. In multiple regression analyses, an increased concentration in cord blood was significantly associated with worse scores on finger tapping (preferred hand, p = 0.05), continuous performance (in the first year of data collection only; false negatives, p = 0.02; mean reaction time, p = 0.001), digit span in the revised Wechsler intelligence scale for children ( p = 0.05), the Boston naming test (no cues, p = 0.0003; with cues, p = 0.0001), and the California verbal learning test (short-term reproduction, p = 0.02; long-term reproduction, p = 0.05). For two end-points (block design and visial-spatial copy errors), associations with mercury in cord blood ( p < 0.05) were found when an alternative approach to adjustment for confounders was applied. The results were similar when the 15% of the cohort whose mothers had had > 10 µg/g of mercury in their hair were excluded from the analyses. No significant interactions between mercury and sex were identified, indicating that the associations were similar for boys and girls. In general, the children's test scores were more strongly associated with the concentration of mercury in cord blood than in maternal hair or in samples of children's hair collected at 1 and 7 years of age, but it was not stated whether any of the associations was significant. In an additional set of analyses (Grandjean et al., 1998), the investigators compared the neuropsychological scores of two groups of children: 112 whose mothers' hair had contained 10-20 µg/g (median, 12 µg/g) of mercury at the time of parturition and 272 children whose mothers' hair had contained < 3 µg/g (median, 1.8). The two groups were matched by age, sex, year of examination, and maternal IQ. The median concentrations of mercury in cord blood also differed substantially: 59 µg/L versus 12 µg/L, respectively. The group with heavier exposure scored significantly lower than the other children on 6 of the 18 end-points (one-tailed p value, 0.05): finger tapping (both hands), hand-eye coordination (average of all trials), block design in the revised Wechsler intelligence scale for children, the Boston naming test (no cues, cues), and the California verbal learning test (long-term reproduction). The results of these analyses differ in certain respects from those of the main analyses. First, the set of end-points on which the two groups differed is similar to but not completely identical with the set found in the main analyses to be significantly associated with the concentration of mercury in cord blood. Moreover, in contrast to the main analyses, interaction terms between mercury concentration and sex were significant for several scores, including errors in the test for visual-spatial ability, short-term reproduction in the California verbal learning test, all three finger-tapping conditions, reaction time in the continuous performance test, and average hand-eye coordination. In all these tests, associations were found for boys but not for girls. In a cross-sectional study, Grandjean et al. (1999) evaluated 351 children aged 7-12 who were living in villages in the Amazon Basin. In three of the villages, in which the population frequently consumed fish contaminated by gold-mining activities downstream, the concentration of mercury in the hair of 80% of children was > 10 µg/g. In a fourth village, where the fish was not contaminated, only 1% of children had concentrations of mercury in their hair > 10 µg/g. The aspects of neurobehavioural function evaluated included manual dexterity, short-term auditory memory, nonverbal memory, and visual-spatial skills. The concentration of mercury was associated with worse performance on the Santa Ana formboard test for manual dexterity (Lezak, 1995) and a copying test for visual-spatial skills. 2.3.2.5 Sensory, neurophysiological, and other end-points In the study in the Faroe Islands, the evaluation at seven years also included assessments of visual acuity and near-contrast sensitivity, otoscopy and tympanometry, neurophysiological tests (pattern reversal visual evoked potentials at 30' and 15', brainstem auditory evoked potentials at 20 and 40 clicks/s, postural sway), and cardiovascular function (Grandjean et al., 1997; Sorensen et al., 1999). Peaks I, III, and V of the brainstem auditory evoked potential at 20 and 40 Hz were slightly delayed in children who had had higher concentrations of mercury in their cord blood ( p < 0.01-0.1), although the interpeak latency was not associated with the mercury concentration at either frequency. In additional analyses (Murata et al., 1999a), data from the second year of data collection (1994) were excluded because of concern about the accuracy of electromyography. Higher concentrations of mercury in maternal hair and cord blood were associated with lower peak III latencies and longer peaks I-III latencies. Of the four conditions under which postural sway was assessed, only that with the eyes closed and not standing on foam approached significance ( p = 0.09). Visual acuity, contrast sensitivity, and variation in heart rate were not related to exposure. Additional preliminary analyses suggested that both systolic and diastolic blood pressure increased with concentrations of mercury in cord blood < 10 µg/L (14 and 15 mm Hg for an increase from 1 to 10 µg/L), and that, in boys, the variation in heart rate decreased with increasing concentration in cord blood (47% for an increase in cord blood mercury from 1 to 10 µg/L) (Sorensen et al., 1999). In a cross-sectional study of 149 children in the Madeira Islands (Portugal), Murata et al. (1999b) examined the association between the concentrations of mercury in maternal and children's hair and visual and brainstem auditory evoked potentials. As the dietary habits were stable, the current concentration of mercury in maternal hair was assumed to be a reliable estimate of the concentration during pregnancy. The children's hair concentrations were not significantly associated with any peak latencies and with only one interpeak interval. The concentrations of mercury in maternal hair were significantly associated with the I-III and I-V interpeak intervals at both 20 and 40 Hz and with the latencies of peaks III and V at both frequencies. Only the latency of pattern reversal visual enoked potential at 15 min was significantly associated with the concentration of mercury in maternal hair. The relationship between blood mercury concentration and auditory function was investigated by Counter et al. (1998) in 36 children and 39 adults living in a gold-mining region in Ecuador and 15 children and 19 adults living in a control area. Mercury is liberated as a vapour in the process by which gold is extracted from alluvial sediments, making occupational exposure among gold miners a significant problem. Some of the mercury is methylated by aquatic organisms, enters the food chain, is biomagnified, and is consumed in fish. The concentration of mercury in blood was significantly higher in the individuals in the gold-mining area (18 µg/L) than in the control area (3 µg/L). Neurological and otological examinations were carried out on all persons, and audiological evaluations consisting of determinations of the conduction thresholds of pure tones in air in each ear at 0.25, 0.5, 1, 2, 3, 4, 6, and 8 kHz were carried out on 40 individuals in the study area; brainstem auditory evoked potentials were measured on 19 subjects. The absolute latencies of waves I, II, III, IV, and V and the interpeak latencies of I-III, III-V, and I-V were measured for the left and right sides. The concentration of mercury in blood was significantly associated with the hearing threshold at 3 kHz in the right ear for children only. A borderline association was found between blood mercury and I-III interpeak transmission time on the left side. 2.3.3 Adult neurological, neurophysiological, and sensory function The effects of chronic exposure to methylmercury on adult neurological function are being assessed by Lebel and colleagues in fish-eating populations living along the Tapajos River in the Amazon Basin who were exposed to mercury released during the extraction of gold from soil or river sediments. Lebel et al. (1996) studied 29 young adults aged 15-35 years (14 female and 15 male), randomly selected from among participants in a previous survey. The geometric mean concentration of mercury in hair was 14 µg/g (range, 5.6-38). The subjects underwent a battery of quantitative behavioural sensory and motor tests, including tests of visual function (near and far acuity, chromatic discrimination, near-contrast sensitivity, peripheral visual fields) and motor function (maximum grip strength, manual dexterity). Individuals with elevated concentrations of mercury in hair had reduced chromatic discrimination; the three persons with concentrations > 24 µg/g had reduced contrast sensitivity, while those with concentrations > 20 µg/g tended to have reduced peripheral visual fields. The associations found between hair mercury concentration and motor function were sex-specific, as more heavily exposed women but not men tended to have lower scores in tests for manual dexterity and grip strength. In a subsequent study, Lebel et al. (1998) assembled another sample of 91 individuals aged 15-81 years, representing approximately 38% of the adult population of the village being studied. Four indices of exposure were derived on the basis of the concentration of mercury in a hair sample: mean total concentration averaged over all 1-cm segments of the sample, total mercury in the first centimeter, maximum total mercury in any segment, and methylmercury in the first centimeter. People who had > 50 µg/g in at least 1 cm of hair were excluded. The mean concentration of methylmercury in hair was approximately 13 µg/g. The assessments included the same tests of motor and visual function that were used in the previous study and, in addition, a clinical neurological examination which was administered to a random sample of 59 members of the cohort. The examination included the Branches' alternate movement task, which requires imitation of a prescribed sequence of hand movements. Abnormal performance on the test was significantly associated with all indices of exposure to mercury, while abnormal visual fields were associated with mean and peak concentrations of mercury. Patellar and bicepital hyperreflexia were not associated with any index. Higher concentrations of mercury, most notably peak concentrations, were associated with poorer scores in the intermediate and higher frequencies of near visual contrast sensitivity (in the absence of near visual acuity loss) and in the test for manual dexterity, with greater muscular fatigue. In women, but not men, grip strength varied with peak mercury concentration. For many end-points, the associations with mercury in hair were stronger in younger (< 35 years) than in older subjects. Beuter and Edwards (1998) studied the association between the concentration of mercury in hair and the frequencies of four types of tremor: resting, kinetic, postural with visual feedback (static), and postural without visual feedback (proprioceptive). The subjects were adults aged > 40 whose mercury levels had been monitored annually for 25 years (1970-95). The group with heavy exposure consisted of 36 Cree people from northern Quebec, Canada (26 women and 10 men). The maximum individual concentration of mercury in hair ranged from 2.2 to 61 µg/g, while the mean annual maximum concentration ranged from 2.2 to 31 µg/g. The group considered to have light exposure to mercury consisted of 30 adults from the Montreal area (18 women and 12 men), but the mercury levels for this group were not reported. Significant differences between the two groups were found in several aspects of static tremor (drift, amplitude differences, skewness, asymmetry, one-dimensional entropy, asymmetric decay of the autocorrelation function) and of kinetic tremor (mean tracking error, power in the 3-4-Hz range, peaked velocity distribution). 2.3.4 Bias: Covariates, confounders, and effect modifiers Analysis of the potential biases that may have occurred in the major epidemiological studies of exposure to methylmercury forms part of the assessment. The three main studies are those in the Faroe Islands, the Seychelles, and the Amazon Basin, for which information bias, selection bias, and confounding factors are reviewed, with the methods of control used. Short descriptions of new data or analyses in the studies in New Zealand, Peru, and Iraq are also reviewed. Such biases could affect the internal and/or the external validity of the studies. Selection bias could occur, for example, if a portion of the population had a different probability of participating in the study than the general population or if individuals with particular health conditions did not participate. Information bias can occur when the outcome measure is affected by knowledge of exposure status. Confounding factors, the major potential sources of bias in these studies, are associated with both exposure and outcome but are not part of their causal relationship. 2.3.4.1 Study in the Faroe Islands Selection bias: Selection bias could have occurred in the study in the Faroe Islands at the time of recruitment or during the follow-up. The children who were examined were comparable to those in the full birth cohort, which represented 75% of all 1367 births that occurred during during the sampling period. The non-participants were born mainly in two small hospitals (with respective participation rates of 46 and 33%; Grandjean & Weihe, 1993) and had had heavy exposure to mercury, especially in one hospital (275 nmol/L vs 114 nmol/L in the capital city, Torshavn). Because of this problem, the exposure of the overall cohort is lower than that of the background population. The loss of subjects from the study was low (9.7%), and the non-participants (106 persons) having somewhat lower exposure (18 µg/L) than the participants (23 µg/L), owing to the lower participation rate of children born in Torshavn. Some tests, such as the paper-and-pencil and tactual performance tests, were not performed by 85 of the children who had heavier exposure to methylmercury (30 µg/L) than those who completed these tests (22 µg/L). The results of these tests were not considered in the final analyses, however, because of problems in scoring and unusual distributions of data. In general, the very high participation rate obtained in the study reduces the likelihood of major selection bias. Information bias: This type of bias was not likely to occur in the study since the children's exposure status was not known to the examiners, the children, or their parents. The report does not, however, state whether the parents were told the concentrations of mercury in cord blood or in maternal or children's hair. Some of the responses on the questionnaire could have been affected by this kind of bias. Confounding factors: In such studies, numerous confounding factors could affect associations between exposure to mercury and neurodevelopmental outcomes. Those most relevant to the study in the Faroe Islands are as follows: * Mother's age: Since mercury accumulates in the body and older people tend to have a more traditional diet, age is potentially positively associated with exposure to mercury. No data were provided on the relationship between the mother's age and the body burden of mercury, and it is not clear whether maternal age is associated with child development. Factors such as prematurity and maternal cognitive function may differ according to a mother's age at the time of the birth of a child. Maternal age was not taken into account in the regression analyses. * Birth weight: Low birth weight is known to be associated with delayed neurodevelopment, particularly in premature infants (body weight < 2500 g). Birth weight could also be associated with fish consumption, as in some observational studies and clinical trials, omega-3 fatty acids in fish oil or in fish meal were reported to increase the duration of gestation and increase birth weight (Olsen et al., 1993), although Foldspang and Hansen (1990) reported an association between lower birth weight and mercury concentration in Greenland. Low birth weight is generally rare among newborns in the Faroe Islands, whose weights are on average 200 g higher than in Denmark (Olsen et al., 1993). In the Faroe Islands cohort, the number of fish dinners was positively associated with birth weight. This potential confounder would bias the results towards the null hypothesis: that seafood increases both exposure to mercury and birth weight. Birth weight was not taken into account in the final analysis. * Breast-feeding: Breast-feeding was not considered as a confounding factor in the analysis, as methylmercury is not transferred to nursing infants. The concentrations of mercury in hair were two to three times higher among infants who were breast-fed for > 12 months than those breast-fed for 0-3 months (Grandjean et al., 1995b). Breast-feeding is related to parental behaviour that could affect brain development, and breast milk provides essential nutrients, such as docosahexanoic acid, which are important for brain development. Because the statistical analyses were based on the concentrations of mercury in children's hair at 12 months of age, however, the effects of breast-feeding were taken into account indirectly. * omega-3 fatty acids: omega-3 fatty acids are polyunsaturated, long-chain (20-22 C) fatty acids with five or six double-bonds starting from the third carbon after the methyl terminal group. They are essential lipids and are not synthesized by the human organism but are derived from the diet, seafood being the major source. The main polyunsaturated fatty acids are eicosapentanoic acid and docosahexanoic acid, although docosapentanoic acid is also found in sea mammals. In sea mammal blubber or lipids, polyunsaturated fatty acids represent 25-30% of all lipids, with a lower proportion in pilot whales. Eicosapentanoic acid is reported to protect against cardiovascular disease, and docosahexanoic acid is a major component of brain lipids and retina and is essential for visual acuity and optimal brain development. It is now added to most infant formulas. The concentration of polyunsaturated fatty acids in the phospholipids of newborns and mothers in this cohort is not known but would be expected to be higher than that in urban populations. Olsen et al. (1986) reported that erythrocyte membranes from pregnant women in the Faroe Islands contained 20% more polyunsaturated fatty acids than those of women on the mainland and that the quantity was related to the consumption of fatty fish and sea mammals. Since mercury and PCBs are both found in seafood, their concentrations would be expected to correlate with that of polyunsaturated fatty acids. Since the latter enhance brain development and vision, this confounding effect would bias the results towards the null hypothesis. Polyunsaturated fatty acids were not considered in the final analysis. * Selenium: Selenium is an essential trace element, of which seafood is a good source. The concentrations of selenium vary considerably in human populations, presumably reflecting selenium levels in the environment. Although the efficacy of this element as an antidote against mercury in humans remains controversial (WHO, 1990), selenium has been shown to counteract the toxicity of methylmercury in many experimental systems (reviewed by Whanger, 1992), including neuron cultures (Park et al., 1996). Both selenium and vitamin E reduced the toxic response of the nervous system to exposure to mercury (WHO, 1990). Studies in rodents suggest that supplementation of the maternal diet with selenite provides partial protection against some adverse effects resulting postnatally from exposure to methylmercury in utero (Frederiksson et al., 1993). In the study in the Faroe Islands, the median concentration of selenium in whole umbilical cord blood was 1.4 µmol/L, and a slight but significant increase was seen with the number of fish dinners per week. The authors reported that the concentration of selenium in this population was high. Although most of the available data on selenium are derived from measurements in plasma samples, and are therefore underestimates of the whole-blood concentrations, comparative geometric means are available for Norway (Saami; 1.5 µmol/L), the Russian Federation (Kola Peninsula; 1.1 µmol/L), and Canada (Nunavik; 3.7 µmol/L) (Arctic Monitoring and Assessment Programme, 1998). In the Faroe Islands cohort, selenium concentration was positively associated with mercury concentration ( r = 0.35; p < 0.001), indicating that exposure to mercury is associated with that to selenium. Although selenium cannot be considered a confounder per se (because it is not known to be associated with the outcomes), it could bias the study results towards the null hypothesis. Selenium was not considered at the final step of the regression analysis. * Polychlorinated biphenyls and persistent organic pollutants: Tooth whales are known to accumulate lipophilic compounds such as PCBs and other persistent organochlorine environmental pollutants. The average concentration of PCBs (expressed as Aroclor 1254) in 39 samples of pilot-whale blubber from the Faroe Islands was 17 mg/kg (Simmonds et al., 1994), and the average intake was 1700 µg/person per week (3.5 µg/kg bw per day). As the total average concentration of DDE, a ubiquitous persistent organic pollutant, was 12 mg/kg, the intake of both these compounds and PCBs might be expected to be high among pregnant women and their offspring in the Faroe Islands. Extensive epidemiological data are available on the neurodevelopmental effects of prenatal exposure to PCBs and persistent organic pollutants (Rogan& Gladen, 1991; Koopman-Esseboom et al., 1996; Jacobson & Jacobson, 1997), although controversy persists about the long-term effects of prenatal exposure to PCBs. Since PCBs may be a risk factor for adverse neurobehavioural development, however, and since they are found in large quantities in pilot whales, they should be considered an important potential confounder. The PCB concentration in cord tissue was strongly correlated with that of mercury (r = 0.38 when PCBs were expressed on the basis of lipid and 0.44 when expressed as wet weight). As serum samples were not taken, PCBs were measured in a subsample of 436 stored samples of cord tissue from the 443 children seen in 1993. This adjustment decreased the size of the cohort by 50% and consequently decreased the power of the study. The samples were divided, and PCBs were measured in two laboratories, but data on the duplicate analysis have not been reported. The total concentration of PCBs was calculated by multiplying the sum of PCB congeners 138, 153, and 180 by two. The relative reliability of measurements in cord tissue as compared with plasma or serum lipids is not known. No paired measurements of lipophilic compounds were made in cord tissue or established tissue matrices (e.g. cord blood and tissue). It would have been desirable to express all concentrations on the basis of lipids because umbilical cord thickness and lipid content vary among newborns; the cord length is generally around 58 cm but can range from 20 to 100 cm (Abgoola, 1978). A short cord is associated with fetal akinesis or maldevelopment of the central nervous system (Ente & Penzer, 1991). As the water content of cord tissue (89%) varies according to the content of Wharton's jelly, this tissue is a poor biomarker for lipophilic compounds like PCBs and persistent organic pollutants. Furthermore, the water content decreases with length of gestation (Sloper et al., 1979); thus, if the lipid content of cord tissue increases with gestational age, the amount of PCBs measured in whole cord tissue will be affected not only by the actual exposure but also by newborn developmental factors. In the Faroe Islands cohort, the lipid content of cord tissue was 2.2 mg/g (0.22%); no SD was given. The mean total concentration of PCBs in the subsamples was 1.1 ng/g wet weight, and the lipid concentration can be calculated to be 1.1 × 454 = 508 µg/kg or 0.51 µg/g. The value should, however, have been reported as 1.02 µg/g, since the authors did not multiply the sum of the three PCB congeners by 2, as was done previously (P. Grandjean, personal communication, 1999). This calculated concentration is still less than the previously reported concentration of PCBs in breast-milk samples from women in the Islands, which were analysed in four pools: range, 1.9-3.5 µg/g; average of four pools, 2.5 µg/g lipid basis (Grandjean et al., 1995a). This concentration is close to those found in consumers of Arctic sea mammals (Dewailly et al., 1989, 1993). Thus, umbilical cord appears to be unreliable tissue for measuring exposure to PCBs; however, the effect of expressing PCBs on a whole weight basis on the statistical power of the study is mitigated by the wide variation in PCB concentrations between individuals. The fact that mercury correlates less with PCBs expressed on a lipid basis than when expressed on a whole weight basis probably reflects this imprecision, and PCBs should have been adjusted for on a lipid basis. The reliability of cord tissue for measuring PCB and persistent organic pollutants needs to be clearly demonstrated. Because PCBs and persistent organic pollutants are associated with both exposure to methylmercury and child development in this study, and because any confounding effects of PCBs will lead to a false-positive association between exposure to methylmercury and child development, the confounding role of PCBs and persistent organic pollutants should be reassessed in order to determine the role of methylmercury in the adverse effects reported in this study. * Smoking: Smoking is unlikely to be an important confounding factor in this study as it is not known to be a source of mercury. It is, however, strongly associated with low birth weight, which in turn is a risk factor for poor cognitive development. In the cohort study, 40% of the women smoked while pregnant, but smoking was not associated with mercury concentration or with outcome. * Alcohol consumption: Alcohol consumption during pregnancy is a major cause of abnormal fetal brain development. It is also often related to dietary habits. It is well known that alcohol consumption among pregnant women is difficult to measure. In the study in the Faroe Islands, alcohol consumption during pregnancy was considered to be low; occasional consumption was reported by 24% of the women. Alcohol consumption was negatively associated with exposure to mercury and was unexpectedly associated with the results of some of the tests. The association may be due to the inclusion of women in Torhavn, who drink more and eat less pilot whale, thus having less exposure to mercury. The means by which alcohol consumption was measured is not described, even in the reference cited (Grandjean et al., 1992), and this factor was not considered in the final analysis. Since exposure to alcohol and mercury were negatively associated, any confounding effect would lead to the null hypothesis. * Maternal cognitive level: Since maternal cognition is associated with child development and could affect dietary habits, it is considered to be an important potential confounding factor. The maternal score on Raven's progressive matrices was available for 92.5% of the mothers, and a significant negative association (r = -0.13; p < 0.001) was found with exposure to mercury. Maternal cognitive level was included in the final regression analysis. * Socioeconomic status: Exposure to mercury and consumption of pilot whale could be associated with socioeconomic status and health outcomes. Most of the association between mercury and socioeconomic status is due to the fact that the women in Torshavn, who may have been better educated, were less exposed to mercury because their diet was less traditional. Thus, more highly exposed children were likely to belong to families of lower socioeconomic status, as was found in analyses in which mothers in unskilled occupations had significantly greater exposure while children in day care had significantly less exposure. Day care, maternal education, paternal education, and paternal employment were therefore included in the final analysis. The methods used to measure socioeconomic status were not described. Such details would be valuable since the association between concentration of mercury and neurological outcomes decreased after adjustment for socioeconomic variables. * Age of the children: The age of the children at the time of testing was also included in the final analysis since age was associated with the results of the neuropsychological tests. A review of all the potential confounding factors indicates that PCBs and socioeconomic factors were the most probable sources of bias in the study in the Faroe Islands. Adjustment for the city of residence (Torshavn or settlements) and for PCBs expressed on the basis of lipids may decrease the impact of these factors. 2.3.4.2 Study in the Seychelles In the study in the Seychelles, the confounding factors that were identified and used in the final regression analyses were the same at testing at 6.5, 19, 29, and 66 months. The concentration of mercury in maternal hair was used as the marker of prenatal exposure. In general, most of the confounding factors were selected for their potential association with childhood development but not with exposure to mercury and were as follows: intelligence of the caregiver (Raven's score), birth weight, gestational age, sex, birth order, history of breast-feeding, medical history of the child and of the mother, age of the mother, maternal tobacco and alcohol use during pregnancy, home environment, parental education, family income, and language spoken at home. A reduced model with a limited number of variables was also used. No association was found between prenatal exposure to mercury and developmental outcomes at 6.5, 19, 29, or 66 months of age. The following section focuses on whether potential biases can explain the lack of association. Selection bias: As the study population comprised 50% of all births, some selection bias could have occurred. Recruitment was restricted to Mahé Island for practical reasons and because 90% of the population live on it. No information was provided about the reason for the non-participation of 45% of the eligible population. The authors speculated that the reasons may have included no contact with the family, lack of understanding of the study, conflicting responsibilities, refusal to allow their child to be examined, or superstition about removal of hair from themselves or their child. The second reason stated raises the possibility that the selected population was better educated than the non-participants, as suggested by the low percentage (3%) of abnormal or questionable scores on the revised Denver developmental screening test when compared with other studies. Exclusion of 18 children from the study could have resulted in a 'healthy child' effect. There is no major potential information bias, because both the mothers and the examiners were unaware of the exposure status of the children to mercury. Confounding factors: The most relevant confounding factors for the study in the Seychelles are as follows: * Polychlorinated biphenyls: PCBs (28 congeners) were measured in 49 randomly selected serum samples from children aged 5.5 years, and no PCBs were detected, as was to be expected on an island in the Indian Ocean. It would, however, have been helpful to know whether other potentially neurotoxic chlorinated compounds were detected, as they are often present in the Southern Hemisphere. For example, DDT is used extensively for malaria control in Mauritius and Madagascar and other islands of the Indian Ocean. * omega-3 fatty acids: omega-3 fatty acids were not measured in the study in the Seychelles. Most studies on the fatty acid content of fish have been conducted in the Northern Hemisphere, but analysis of the fatty acids in lipid extracts from tropical seafood in Australia showed that the content of arachidonic acid represented 4.8-14% of the total. The seafood contained almost no linoleic acid but was a rich source of omega-3 fatty acids (14-31% of the total). Thus, seafood from tropical waters, unlike seafood from colder waters, is a natural source of polyunsaturated fatty acids in both the omega-6 and omega-3 series (O'Dea & Sinclair, 1982). Since omega-3 fatty acids are concentrated in fatty fishes, and these predators often contain high concentrations of mercury, the concentration of omega-3 fatty acids in the blood of Seychellois can be expected to correlate strongly with the concentrations of mercury in blood or hair. In a report of a workshop on methylmercury (National Institute of Environmental Health Sciences, 1998), it was noted that omega-3 fatty acids had been measured in randomly selected cord blood samples and found to be 'in the normal range'; however, there is no abnormal range for these fatty acids, and the toxicological paradigm does not apply to nutrients. It remains to be determined whether the concentration of docosahexanoic acid in cord plasma phospholipids approaches 1.5%, as observed in western urban areas with low fish intake, or is closer to 7-8%, as observed in Inuit newborns. The range, the distribution, and the correlation with mercury should also be measured. omega-3 fatty acids thus appear to be a major potential confounding factor, which could explain the absence of associations, although some positive correlations were seen between mercury concentration and child development. Since fatty acids can be analysed in only 0.5 ml of serum, plasma, or erythrocyte membranes, they could be measured in a large number of archived cord blood samples. An alternative option will be to measure them in the blood of mothers attending the next evaluation. * Selenium: As mentioned above, selenium could counteract the neurotoxicity of mercury but is not a true confounder since it is not known to be related to child development. A high selenium intake could therefore explain the lack of an association. No data were available on the selenium status of inhabitants of the region or of the concentration in fish. The workshop report (National Institute of Environmental Health Sciences, 1998) notes that selenium was measured in randomly selected cord blood samples and found to be 'in the normal range', but it is unclear whether that refers to values of 1.2, 1.5, or 4 µmol/L. It remains to be determined whether the concentration of selenium correlates strongly to fish consump-tion and to exposure to mercury. The role of fish nutrients (mainly omega-3 fatty acids and, to a lesser extent, selenium) could have masked an association between exposure to mercury and child development. It is also possible that the participants in the study were better educated than the non-participants and that the study did not have sufficient power because of the low background prevalence of abnormal test results. 2.3.4.3 Study in the Amazon Basin In the preliminary study (Lebel et al., 1996), neurological dysfunction (sensory and motor performance) was investigated in 29 adults selected randomly from two villages. Little effort was made to document potential confounding factors, and only age, location, and alcohol and tobacco consumption were included in the regression analysis. In the second study (Lebel et al., 1998), on 91 adults in one village, near visual contrast sensitivity and manual dexterity were investigated. The participation rate was 40%. Although sociodemographic information, smoking and drinking habits, medical and work histories, and level of education were recorded, the only potential confounder associated with the results of clinical examination and neurofunctional tests was age, although other relevant exposures may not have been considered. As malaria is endemic in the region, various pesticides (DDT, organophosphates, carbamates, and pyrethroids) may have been used, most of which are neurotoxic. Thus, some of the participants may have been exposed to these pesticides either directly (sprayed) or from consumption of contaminated fish. It is not known whether exposure to pesticides was associated with the fish diet or the area of residence. The reliability of the measurement of alcohol consumption, another potential confounding factor, is questionable since only three participants reported taking two drinks or more per week. 2.3.4.4 Study in New Zealand The study carried out in New Zealand has basic weaknesses (Kjellström et al., 1986, 1989). Although no confounding was found from socioeconomic factors, health status, and maternal smoking (Kjellström et al., 1986), smoking was not graded, and neither alcohol consumption nor previous pregnancy outcomes were reported. Maternal consumption of alcohol can cause borderline mental deficiency (see, e.g. Berkow, 1988), and the children of smokers have lower scores than those of nonsmokers on most tests of intellectual function and intelligence at four and seven years of age. Moreover, minor neurological disorders are more common in children of women who smoke (Murphy, 1984). Additionally, a matching problem was recognized by the authors when they reduced the number of pair comparisons from the original 31 to 23 for ethnic differences or pairing of a New Zealand-born mother with an immigrant or both, and thus the results of 11 and not 12 of the Denver tests were positive in the group exposed to mercury. The correct numbers show no significant difference between children exposed to mercury and reference children: three and not two positive results and eight and not ten negative results were found (chi2 = (8-2)2/(8 + 2) = 3.6; p > 0.05). Thus, nine Pacific Islander pairs were responsible for 10 of the positive responses, and the other 14 pairs were responsible for only six, indicating that the effect of ethnic group in this study should be analysed thoroughly. Irrespective of exposure, the scores on the Denver developmental screening test were significantly higher among Pacific Islanders than people of other ethnic groups: 16 positive responses in Pacific Islanders (57%) and 6 in others (37%) and 12 negative responses in Pacific Islanders and 28 in others (chi2 = 8.8; p < 0.005). As 25 of the 28 Pacific Islanders were immigrants, a significant difference would also be expected between the children of immigrant and New Zealand-born mothers, as was the case: positive responses in six children of New Zealand-born mothers (18%) and in 15 of immigrant mothers (54%) and negative responses in 28 and 13, respectively (chi2 = 5.9; p < 0.02). The Pacific Islanders were at greater risk than Europeans or Maoris, with four positive responses among Pacific Islanders and one among others and one negative response among Pacific Islanders and 20 among others (p = 0.034; Fisher exact test). In the second stage of the study, on six-year-old children, the exposed group had been increased to 57 and their performance was compared with that of three groups ( n = 59, 60, and 58) of reference children in a battery of tests. The larger number of children ensured satisfactory matching for ethnic group and length of residence in New Zealand, but the presentation of the data does not allow verification of the distribution of positive responses by ethnic group in the exposed and reference groups. This is unfortunate in view of the results of the first stage of the study and the fact that the ratio of Pacific Islanders to non-Pacific Islanders was 2 (66% of all children were Pacific Islanders). Furthermore, the greatest differences between the exposed and reference groups were found in the tests for spoken language (8.6%) and the Wechsler test for full-scale IQ (5.3%), out of 16 psychological tests, but the differences in the results of these two tests were more than twofold greater between Pacific Islanders and Europeans, 25 and 12%, respectively. Comparison of the results of 16 psychological tests for the children of exposed and of reference mothers (48 comparisons) gave only two significant differences ( p = 0.034 and 0.045), which are approximately those expected by chance. Regression analysis showed significant differences in the test for spoken language, the revised Wechsler intelligence scale for children, and the McCarthy scales for perceptual performance, but a clear association with exposure to mercury was seen only at concentrations in maternal hair >10 µg/g and only when a weighted regression analysis was used and 14 confounding factors were accounted for. The reliability of the 'accounting' is questionable when each of 14 confounding variables introduces its own error; when other statistical manipulations, such as adjusting for outliers, although they are legitimate for eliminating one source of error, may have been the source of another type of error; when at least one confounder (ethnic group) was associated with larger differences in two of the three tests that correlated with maternal exposure to mercury than was maternal exposure; and when the highest concentrations of mercury in hair (> 10 µg/g) accounted for only about 2% of the overall variance. 2.3.4.5 Study in Peru The study in Peru was conducted between 1981 and 1983 in a fishing community (Marsh et al., 1995), and hair samples and clinical data were obtained from 131 mother-infant pairs. Major information bias is unlikely to have occurred because the neurologists were unaware of exposure status, but it is not reported whether the mothers were informed about their exposure to mercury. Recall bias about their children's development is possible if the mothers knew their exposure status. Selection bias could have occurred in this study because hair samples were obtained from 369 mothers and only 194 of their children, and complete data were available for only 131 mother-infant pairs. The reason for this 65% reduction is not described but may have resulted in selection bias, with greater participation of healthier infants. No data are available to compare participants and non-participants. Furthermore, the participation rate among all pregnant mothers in Mancora during the recruitment period was not reported, and selection of healthy mothers might also have occurred. Although information was collected on several potential confounders, including alcohol and tobacco use, none was considered in the final statistical analysis. The authors stated that Mancora women drank little or no alcohol, that the group did not contain any smokers, and that there was little socioeconomic diversity. In this study, the role of nutrients in fish is of major importance. The authors noted that the difference in the results of their study and that carried out in Iraq could be due to the difference in the origin of mercury. They discussed the possible role of selenium in seafood and the possibility that the infants were protected against the neurotoxic effects of methylmercury by high selenium intake from their mothers during the pregnancy, but no data on selenium concentrations in fish or in biological samples from the infants or their mothers were available. Another potential nutrient, which was not discussed in the report, is polyunsaturated fatty acids and especially docosahexanoic acid, which is present in large quantities in fatty predator fishes, which are known to accumulate methylmercury. Polyunsaturated fatty acids may have acted as a confounding factor in this study, as they are associated with both exposure to methylmercury and infant development. This cohort study was therefore possibly affected by selection bias, and fish nutrients may have masked (polyunsaturated fatty acids) or mitigated (selenium) the neurotoxicity of methylmercury. 2.3.4.6 Reanalysis of the study in Iraq The importance of the study in Iraq is that it is still used as the basis for the assessment of risks to human health risk by WHO and regulatory agencies. The consequences of exposure were investigated in adults and in 81 30-month-old children who had been exposed prenatally (Marsh et al., 1987). Although the heavily exposed infants showed deficits similar to those reported in Minamata Bay, Japan, efforts were made to investigate the group with lighter exposure. Selection bias could have occurred, for example, if the participants had experienced patent clinical symptoms and volunteered to participate, leading to an overrepresentation of severe cases. No data are available on how representative of the background population the participating children were. Information and recall bias are, however, the most important biases in this retrospective study, since precise information on ages at walking and talking and even age at testing was difficult to obtain, as there was no birth registry, and it had to be obtained from the mothers. It has been reported elsewhere that mothers underestimate the age at walking by 0.4 months (Piles, 1935, cited by Marsh et al., 1987). If such imprecision is equally distributed with respect to exposure status, this error will decrease the power of the study and bias the results towards the null hypothesis. It is unlikely that the mothers were less accurate in their answers to questionnaires because of exposure to mercury. The incident resulted in contaminated bread, and this basic food is expected to be consumed by the entire population regardless of socioeconomic status, level of education, or intelligence. 3. ESTIMATES OF DIETARY INTAKE 3.1 Environmental mercury In the environment, methylmercury is produced from inorganic mercury in natural and anthropogenic sources as a result of microbial activity. Microbial methylation of inorganic mercury occurs in the upper sedimentary layers of lakes and sea bottoms, and the methylmercury formed is rapidly taken up by living organisms in the aquatic environment. A number of studies of mercury forms in air have shown that, except in industrial areas, near volcanoes, and mercury ore deposits, the concentration of total mercury in air is < 10 ng/m3, of which mono-and dimethylmercury account for approximately 22%. As the intake of the general population of methylmercury from air is estimated to be < 0.04 µg/day, air is considered to be an insignificant source (WHO, 1990). The mean concentrations of total mercury in rivers, lakes, and groundwater range from 10 to 50 ng/L. It can form stable complexes with various organic ligands in water, but the resulting methylmercury compounds are rapidly taken up by biota, since < 1 ng/L has been found in unpolluted waters. If consumption of 1.5-2 L of water daily is assumed, the intake of methylmercury from this source would be < 0.002 µg/day (WHO, 1990). Most foods except fish contain very low concentrations of total mercury (< 0.01 µg/g), which is almost entirely inorganic mercury. Fish and shellfish contain higher concentrations, and over 90% is in the form of methylmercury because fish feed on aquatic organisms that contain this compound, ultimately originating from microorganisms which biomethylate inorganic mercury. The amount of methylmercury in fish correlates with a number of factors, including the size and age of the fish, the species (e.g. larger, older, predatory species like shark and swordfish usually contain higher concentrations), and, for freshwater species, the mercury content of water and sediment and the pH of the water. The concentration of methylmercury in most fish is generally < 0.4 µg/g, although fish species higher up the aquatic food chain, such as swordfish, shark, walleye, and pike, may have concentrations up to several micrograms per gram. The intake of methylmercury from fish depends on fish consumption and the concentration of methylmercury in the fish consumed. Many people eat < 20-30 g of fish per day, but certain groups eat 400-500 g per day. Thus, the daily dietary intake of methylmercury can range from < 0.2 to 3-4 µg/kg bw (WHO, 1990). The ranges of concentrations of methylmercury in various fish species are shown in Table 5. 3.2 Biomarkers of exposure Two approaches are used currently to assess the body burden of methylmercury: one based on dietary modelling and the other on biomarkers. Each has limitations which prevent their use in making unequivocal estimates of exposure. The outcomes of dietary models depend on differences in approach and in assumptions, and their reliability remains to be confirmed. Despite the limitations of the existing data sets, biological measures of exposure, such as the concentrations of methylmercury in hair or blood, provide a useful start for discussions of exposure since they allow a biologically based validation of dietary models. The two most popular media for quantifying methylmercury in the body are blood and hair. Quantitative relationships between exposure (daily intake) and concentrations in blood and hair were first established in the study in Iraq and naturally involved many assumptions, for instance that hair grows at a rate of 1 cm per month. The relationship between the concentrations of mercury in blood and hair was verified in several studies, in which the concentrations in hair ranged from 0-13 µg/g (Netherlands) to 20-325 µg/g (Japan). In two communities in the United Kingdom, one being a fishing community, the concentrations in hair ranged from 0.1 to 21 µg/g. These studies showed that every microgram increase in blood concentration resulted in a 140-370-µg/g increase in the concentration in hair, although the regression lines in six of ten studies gave hair:blood concentration ratios of 230-280. Thus, a ratio of 250 gives a relatively acceptable extrapolation from one media to the other (WHO, 1990). Under stable dietary conditions, the concentrations of methylmercury in blood and hair can be used to predict the possible effects of methylmercury on health, since the concentrations are directly proportional to the concentrations of methylmercury in the brain (Phelps et al., 1980; Cernichiari et al., 1995). The concentration in hair is about 250 times greater than that in blood at the time the hair strand is formed. Once formed, a strand grows at a rate of approximately 1 cm per month and thus provides a record of previous exposure to methylmercury. Approximately 80% of the mercury present in the strand is methylmercury (Phelps et al., 1980; Cernichiari et al., 1995). Hair and blood can both be used to document exposure, but hair is preferred because it involves a simple, uninvasive sampling procedure that allows monitoring of the intake of methylmercury. Total mercury concentrations are typically used to characterize exposure to methylmercury from fishery products, since total mercury and methylmercury concentrations are linearly related and it is less costly to determine total mercury. Although measurements of total mercury can provide an upper bound of the concentration of methylmercury in hair, the dose to the brain, and intake from the diet, they may provide misleading evidence of exposure and dose if certain hair treatment formulations (cold-wave solutions and hair relaxers) which extract methylmercury have been used. Reductions of over 60% have been observed (WHO, 1990). Table 5. Estimated concentrations of mercury in fish Species mg/kg of fish Mackerel 0.07-0.25 Sardine 0.02-0.3 Tuna 0.03-1.2 Swordfish 0.06-0.8 Shark 0.004-1.8 Other 0.03-0.3 From WHO (1990) Studies of the concentrations of mercury in hair provide a set of data for describing the range of exposures. Two large studies of women's hair were conducted during the early 1980s. One involved 2000 women aged 15-45 who were part of a dietary panel that was intended to be geographically and demographically representative of the population of the United States (Smith et al., 1997). They maintained monthly diaries of seafood consumption, recording species and amount. At three-month intervals, hair samples were obtained by cutting strands of hair close to the scalp from the occipital region. These were provided by 1437 of the women (72%), were cut into 4-cm segments corresponding to the three-month period associated with each diary (i.e. one month before and one month after the month covered by the diary), and analysed for methylmercury by an electron capture gas chromatographic method. The concentrations in the hair of women who had eaten some seafood during the one-month period covered by the diary were compared with those of women who ate no seafood during that period. The authors reported that the distribution of methylmercury concentrations in the two groups was approximately log-normal and that 99.72% of all hair samples had concentrations < 3.9 µg/g. The concentrations in four samples exceeded 3.9 µg/g (4.4, 5.9, 6.0, and 6.3 µg/g), and the arithmetic mean for all samples was 0.48 µg/g. The distribution of concentrations reveals that 90% of all values were < 1.3 µg/g. In another analysis, the results were statistically weighted to reflect the population and were adjusted by season to provide annual population estimates. The mean, median, and maximum weighted annual concentrations of mercury in hair were 287, 204, and 3505 µg/kg, respectively; the 90th percentile concentration was 531 µg/kg. The mean concentration for men (260 µg/kg) was about 20% lower than that for women (315 µg/kg), suggesting that use of hair treatments that can alter hair mercury concentrations was not widespread in the study population. The mean and median concentrations for children nine years and younger were 177 and 133 µg/kg, respectively. For the 59 women of child-bearing age, the mean was 347 µg/kg and the maximum was 1585 µg/kg. A four-day dietary survey included in the study showed that 21% of the people surveyed reported eating fish during the survey. Those who had eaten fish at least once during the survey had a mean hair concentration of 418 µg/kg, while those who had not eaten fish had a mean concentration of 326 µg/kg(Smith et al., 1997). 3.3 Intake assessment Estimation of the intake of a contaminant is complicated by the skewed distribution of residues, since contaminants do not reach food through controlled or predictable agricultural or manufacturing processes. It is often possible to control contamination, and those controls should achieve the maximum impact on potential intakes. Rational decision-making requires estimates of the major contributors to intake and the likely impact of proposed controls. Methylmercury can be ingested as a result of the presence of mercury in food, water, or air. This assessment is limited to food and is based on the conservative assumption that all of the results reported were for methylmercury. National governments may wish to consider other potential sources of intake and add them to estimates of intake from foods in order to estimate total intake. Virtually all of the available data derived from monitoring are for total mercury. The Committee had received data from 25 countries representative of all regions of the world, and several countries submitted estimates of the intake of mercury by their populations. When data on infant or child intake were available, they were included. The WHO Global Environment Monitoring System-Food Contamination Monitoring and Assessment Programme (GEMS/Food) has collected data on food contamination through a network of participating institutes in over 70 countries around the world since 1976. It has also developed five regional and cultural diets for use in estimating the intakes of a wide range of the world's populations. The diets were derived from food balance sheets compiled by FAO, and thus provide data that are comparable across different countries and regions of the world. They are based on the countries' annual food production, imports, and exports and do not take into account waste at the household or individual level; they are thus expected to be overestimates of consumption of actual food intakes, by about 15%. The data do not, however, permit the analysis of intakes by subgroups such as children and infants. These diets include estimates of fish consumption. The Committee used the diets in combination with available data on residues of mercury to estimate typical mercury intakes. The mercury intake of high consumers of fish was determined on the basis of analyses by Australia and the United States. The potential impact of establishing limits was determined in a Monte Carlo simulation model. 3.3.1 Residues Most of the data on residues were available to the Committee in summarized form. The United States Total Diet Study and the Australian Market Basket studies indicate the ranges of residues in a variety of fish species and products (Table 6; Food & Drug Administration, 1993-96; Australia New Zealand Food Authority, 1998). The United States also provided information on residues in fresh tuna, swordfish, and shark from a survey by the National Marine Fisheries Services. Although data were reported for various oceans, no clear differences were found. These data are similar to those reported by WHO (1990) and also show that some species have higher concentrations than others, including the commonly consumed tinned tuna, flake, and estuarine fish. A true representative average value cannot be selected. Table 6. Mercury in fish from Australia and the United States Fish Concentration (mg/kg) 95th percentile Mean Range Australia Calamari rings 0.02 Trace-0.03 NA Fish, estuarine 0.12 0.09-0.15 NA Flake fillet (fried) 0.33 0.04-0.80 NA Tuna, tinned 0.22 0.08-0.56 NA United States Tuna, tinned 0.18 0.46 Tuna, fresh 0.2 0.45 Shark 0.96 2.4 Swordfish 0.7 1.1 Data for Australia from the Australia New Zealand Food Authority (1998) and those for the United States from Food & Drug Administration (1993-96). Total mercury and not methylmercury was measured in these studies. NA, not available An average or mean concentration of mercury residue is appropriate for estimating the intake of methylmercury in the WHO GEMS/Food regional diets. The Committee concluded that concentrations based on estuarine fish, tuna, or flake fillet would be appropriate for this purpose, and the average values for tinned tuna and flake fillet were used to provide a range of estimates of regional intakes of mercury. 3.3.2 National intake estimates Estimates of the intake of mercury are available for the populations of 25 countries (Table 7), which provide a good measure of differences in intake across populations and subgroups, including infants and children. More than one study was available for some countries. For example, Australia provided estimates of intake from their market basket study (Australia New Zealand Food Authority, 1998) and from their 'diamond' model, and the United States provided an assessment based on their total diet study and a Monte Carlo simulation that included additional data on residues in fish (Carrington, 1999). The 'diamond' model permits assessments for individuals, including high consumers, because it includes data from the 1995 National Nutrition Survey and data on water consumption. The intakes ranged from 0.7 to 5.6 µg/kg bw per week, depending on the method used, the subgroup evaluated, and the residue data used. Australia and New Zealand estimated intake for a variety of age groups, including young children. Slovakia determined the concentrations of mercury in a study which duplicate samples of meals were consumed and statistically representative samples were collected four times a year; estimates of the mercury intake of infants who were breast-fed or who consumed milk formula were also provided (Ursínyová & Hladíková, 1997, 1998). 3.3.3 Estimates of intake based on WHO GEMS/Food diets The Committee estimated the typical intakes of mercury by consumers by using the average total consumption of all species of fish and shellfish from the GEMS/Food regional diets and a range of typical concentrations of methylmercury in fish. For these analyses, it was assumed that all species would contain one of two concentrations of methylmercury: the first analysis (Table 8) assumed a concentration of 0.2 mg/kg of fish, and the second analysis (Table 9) assumed 0.33 mg/kg of fish. These concentrations are in the range of the average and median values in several countries. As some species, such as shark and swordfish, often contain concentrations of mercury residues above these two limits, frequent consumers of these fish will have correspondingly higher intakes of mercury. 3.3.4 Estimates of intake by fish consumers at the 95th percentile Australia and the United States also estimated the intake of high consumers (Table 10). Australia used the actual consumption and two assumptions about the concentrations of mercury in the fish that were consumed. In the first analysis, it was assumed that fish contained 0.2 mg/kg, and in the second analysis it was assumed that predatory fish contained 0.64 mg/kg of fish. The United States took into account variability in both residue concentrations and food consumption patterns, using a Monte Carlo simulation to predict the most likely distribution of mercury intake across each population subgroup. The analysis was repeated after exclusion of residues at concentrations over certain limits to simulate the effect of prohibiting fish containing > 1 or > 0.5 mg/kg. 4. COMMENTS Although methylmercury can occur in other foods, it is found primarily in fish. In other foods, mercury is present mainly as elemental mercury. The Committee noted the variation in concentrations of methylmercury in fish, both within and between species, and also noted that fish from polluted waters usually have higher mercury concentrations than those from unpolluted bodies of water. When intakes of total mercury were provided, the Committee assumed conservatively that all of the mercury was methylmercury. A 'typical' concentration of methylmercury must be established to permit estimation of intake from the WHO GEMS/Food regional diets. A 'typical' concentration should correspond to the concentrations that are consumed 'on average' by consumers and should therefore represent the usual concentrations in commonly consumed species of fish. The Committee concluded that concentrations based on estuarine fish, tuna, or flake fillet would be appropriate for this purpose. For these analyses, the average concentrations found in tinned tuna and flake fillet were used to derive a range of estimates of regional intakes of methylmercury. Data on the concentrations of mercury residues in food and/or assessments of mercury intake were submitted to the Committee by 25 countries which represent the major regions of the world. The WHO GEMS/Food diets include estimates of fish consumption in each of five regional diets. The Committee used information from these sources to estimate typical methylmercury intakes of 0.3-1.1 µg/kg bw per week, depending on the region of the world. These values are predicated on the assumption that all fish and shellfish contain methylmercury at 200 µg/kg of fish. If all fish and shellfish that are consumed contain methylmercury at 330 µg/kg of fish, the intake ranged from 0.5 to 1.8 µg/kg bw per week. The methylmercury intake of consumers in Australia who were considered to have a high intake of fish was estimated on the assumption that the fish contained methylmercury at either 200 or 640 µg/kg of fish. The estimated intakes for consumers in the 95th percentile were 2.1 and 5.6 µg/kg bw per week, respectively. As these values are based on the assumption that all fish contain these concentrations, they are highly conservative estimates of extreme intake. A probability analysis was conducted in the USA to provide a more realistic estimate of the intake of methylmercury by consumers in the 95th percentile, by taking into account variation in both fish consumption and residue concentrations in the fish that are consumed. The analysis covered the entire distribution of consumption and methylmercury residues in fish. An estimate was also provided from a simulation model of the potential impact of establishing limits on intake of methylmercury, by repeating the analysis after excluding residue concentrations that exceeded theoretical regulatory limits of 1000, 500, or 200 µg/kg of fish. The results of the analysis are presented in Table 10 for consumers in the 95th percentile in three population groups. These results suggest that the intake of the adult population will be below the PTWI as long as individuals eat fish with 'typical' concentrations of methylmercury. The Committee also specifically evaluated the potential intake of children and infants. The WHO GEMS/Food diets do not include separate estimates for children, but several countries provided estimates of the intake of mercury by children and infants. Comparison of the intake by adults and children in each country shows that children consume two to three times more mercury than the adult population on the basis of unit body weight. Nevertheless, the concentrations of mercury in the hair of children are similar to those in adult hair, indicating that children have similar body burdens to those of adults. Therefore, the higher intakes of children would not necessarily result in an equivalent increase in risk, and, if children are not more sensitive than adults to methylmercury, the PTWI would be appropriate for both adults and children. In simulations conducted in the USA, children were found to have intakes below the PTWI. Although data were not available to permit equivalent analyses for other countries, the results can be expected to be similar as long as the concentrations in fish and the fish consumption are similar to those seen in the USA. Studies of the kinetics of methylmercury showed that its distribution in tissues after ingestion is more homogeneous than that of other mercury compounds, with the exception of elemental mercury. The most important features of the distribution pattern of methylmercury are high blood concentrations, high ratios of erythrocyte:plasma concentration and high concentrations of deposition in the brain. Another important characteristic is slow demethylation, Table 7. Estimates of intake of methylmercury, assuming all residues measured as mercury are actually methylmercury Country Estimate Populationa Reference (mg/person per week) Australia 0.7-4.3b 9-month-old infants Australia New 0.7-3.4b 2-year-old children Zealand Food 0.4-1.7b Adult women Authority (1998) 0.3-1.8b 12-year-old girls 0.3-1.7b Adult men 0.3-1.6b 12-year-old boys Australia 0.3 Adults WHO (1992) Belgium 1.63 All Jorhem et al. (1998) Belgium 1.6 Adults WHO (1992) China 1.20 All Chen & Gao (1993) China 0.63 Standard man (58 kg) Gao (1999) 1.61 2-7 year-old children (16.5 kg) 1.69 8-12-year-old children (29.4 kg) 0.42 20-50-year-old men (63 kg) 0.41 20-50-year-old women (53 kg) Cuba 1.6 Adults WHO (1992) Denmark 0.09 All Jorhem et al. (1998) Denmark 1.8 Adults WHO (1992) Finland 0.22 All WHO (1992) Finland 0.3 Adults WHO (1992) France 1.4 Adults WHO (1992) Germany 0.07 All Jorhem et al. (1998) Germany 1.6 Adults WHO (1992) Germany 0.6-0.7c Adult Becker et al. (1998) Table 7. (continued) Country Estimate Populationa Reference (mg/person per week) Guatemala 1.26 All WHO (1992) 1.5 Adults Italy 1.5 Adults WHO (1992) Japan 0.50 All (55 kg bw) Jorhem et al. (1998) Netherlands 1.05 All Jorhem et al. (1998) 0.23 All 0.08 All Netherlands 1.2 Adults WHO (1992) New Zealand 0.6 Adults WHO (1992) Poland 2.0 Adults WHO (1992) Slovakiad 0.9 Children (vegetarian) Ursínyová & 0.8 Children (non-vegetarian) Hladikova (1998) Sweden 0.7-0.82 All Jorhem et al. (1998) Sweden 0.3 Adults WHO (1992) Thailand 0.3 Adults WHO (1992) United Kingdom 0.3 Adults WHO (1992) United Kingdom 0.35 All Ministry of Agriculture, Fisheries & Food (1991) Table 7. (continued) Country Estimate Populationa Reference (mg/person per week) United States 0.30 60-65-year-old men Food & Drug 0.23 60-65-year-old women Administration 0.23 70-year-old men (1993-96) 0.20 2-year-old children 0.16 40-45-year old men and women 0.15 25-30-year-old men 0.14 6-year-old children 0.12 70-year-old women 0.11 25-30-year-old women 0.10 14-16-year-old boys 0.08 10-year-old children 0.06 14-16-year-old girls 0.01 Infants a Body weights in parentheses are assumptions. b Low end of range based on assumption that samples with no detectable mercury have none; high end of range based on assumption that the lowest observable concentration of residue is present in samples with no detectable mercury c Low end of range, people who do not eat fish; high end, fish consumers d Low end of range, breast-fed infants; high end, infants fed cow's milk; formula-fed infants had intermediate values. Table 8. Mercury intake if all fish contain 200 µg/kg (mean residue in tuna in Australia and the United States) and consumption levels are those of GEMS-Food regional diets Code Commodity Fish intake (g/person per day) Middle Far African Latin European Eastern Eastern American Fish and seafood WC Crustaceans, fresh frozen 0.3 2.3 0.0 1.5 3.0 MD Dried fish 0.3 2.8 4.4 4.8 0.8 WS Demersal, frozen whole 0.0 0.0 0.9 0.5 3.8 WS Demersal, frozen fillets 0.0 0.0 0.0 1.3 5.0 WS Demersal, cured 0.0 0.3 0.6 4.5 0.5 WS Demersal 2.0 3.0 2.4 0.0 9.0 WF Freshwater, tinned 0.0 0.0 0.0 0.0 0.8 WF Freshwater, frozen whole 0.0 0.0 0.0 0.0 0.3 WF Freshwater, cured 0.3 0.5 1.4 0.0 0.0 WD Freshwater diadrom, fresh 1.3 5.3 4.7 1.3 1.5 WS Marine fish (not otherwise 2.8 5.2 5.1 18.3 2.8 specified), fresh frozen WS Marine fish (not otherwise 0.0 1.0 0.0 0.3 0.0 specified), cured IM Molluscs except 0.0 4.0 0.5 0.8 8.3 cephalopods, fresh IM Molluscs, tinned 0.0 0.0 0.0 0.0 0.8 WS Pelagic, tinned 1.8 0.8 0.5 4.8 4.8 WS Pelagic, frozen whole 0.3 2.0 0.7 0.3 1.3 WS Pelagic, cured 0.0 1.0 2.4 0.0 0.3 WS Pelagic marine fish, fresh 4.3 5.8 13 7.0 3.8 Total fish intake per day (g/person) 13 35 36 45 46 Table 8. (continued) Code Commodity Fish intake (g/person per day) Middle Far African Latin European Eastern Eastern American Estimated intake of mercury Total (µg/person per day) 2.6 7.0 7.2 9.0 9.2 Total (µg/person per week) 18 49 50 63 64 Total (µg/kg bw per week) 0.3 0.8 0.9 1.1 1.1 (for 60-kg adult) % of PTWI (3.3 µg/kg bw) 9% 25% 26% 32% 33% for 60-kg adult Residue concentration that would 2.2 0.82 0.78 0.63 0.61 be less than PTWI (mg/kg of fish) assuming a 60-kg adult consumes fish with this concentration on a long-term basis Table 9. Mercury intake if all fish contain 330 µg/kg (mean residue in flake fish in Australia) and consumption levels are those of GEMS-Food regional diets Commodity Fish intake (g/person per day) Middle Far African Latin European Eastern Eastern American Fish and seafood Crustaceans, fresh frozen 0.3 2.3 0.0 1.5 3.0 Dried fish 0.3 2.8 4.4 4.8 0.8 Demersal, frozen whole 0.0 0.0 0.9 0.5 3.8 Demersal, frozen fillets 0.0 0.0 0.0 1.3 5.0 Demersal, cured 0.0 0.3 0.6 4.5 0.5 Demersal 2.0 3.0 2.4 0.0 9.0 Freshwater, tinned 0.0 0.0 0.0 0.0 0.8 Freshwater, frozen whole 0.0 0.0 0.0 0.0 0.3 Freshwater, cured 0.3 0.5 1.4 0.0 0.0 Freshwater diatom, fresh 1.3 5.3 4.7 1.3 1.5 Marine fish (not otherwise 2.8 5.2 5.1 18.3 2.8 specified), fresh frozen Marine fish (not otherwise 0.0 1.0 0.0 0.3 0.0 specified), cured Molluscs except cephalopods, 0.0 4.0 0.5 0.8 8.3 fresh Molluscs, tinned 0.0 0.0 0.0 0.0 0.8 Pelagic, tinned 1.8 0.8 0.5 4.8 4.8 Pelagic, frozen whole 0.3 2.0 0.7 0.3 1.3 Pelagic, cured 0.0 1.0 2.4 0.0 0.3 Pelagic marine fish, fresh 4.3 5.8 13 7.0 3.8 Total fish intake per day (g/person) 13 35 36 45 46 Table 9. (continued) Commodity Fish intake (g/person per day) Middle Far African Latin European Eastern Eastern American Estimated intake of mercury Total (µg/person per day) 4.3 12 12 15 15 Total (µg/person per week) 30 80 84 100 110 Total (µg/kg bw per week) 0.5 1.3 1.4 1.7 1.8 (for 60-kg adult) % of PTWI (3.3 µg/kg bw) 15% 40% 43% 53% 54% for 60-kg adult Table 10. Estimated intake of methylmercury by fish consumers at the 95th percentile Country Population 95th percentile consumer 1. Using point estimates for consumption and mercury residues in fish Australia Total population 2.1-5.6 µg/kg bw per week Women of child-bearing age 1.4-4.9 µg/kg bw per week 2. Using distributions of consumption and mercury residues in fish and a Monte Carlo simulation model United States Scenario 1: No limit, e.g. assuming current distribution of residues in fish as sampled in the United States Children 2-5 years All seafood 1.5 µg/kg bw per week Women All seafood 0.8 µg/kg bw per week Total US population All seafood 0.9 µg/kg bw per week Scenario 2: Limit of 1 mg/kg of fish, assuming all residues above the limit are eliminated from the food supply Children 2-5 years All seafood 1.4 µg/kg bw per week Women All seafood 0.7 µg/kg bw per week Total US population All seafood 0.9 µg/kg bw per week Scenario 3: Limit of 0.5 mg/ kg of fish, assuming all residues above the limit are eliminated from the food supply Children 2-5 years All seafood 1.4 µg/kg bw per week Women All seafood 0.6 µg/kg bw per week Total US population All seafood 0.8 µg/kg bw per week Table 10. (continued) Country Population 95th percentile consumer Scenario 4: Limit of 0.2 mg/kg of fish assuming all residues above the limit are eliminated from the food supply Children 2-5 years All seafood 0.8 µg/kg bw per week Women All seafood 0.4 µg/kg bw per week Total US population All seafood 0.5 µg/kg bw per week which is a critical detoxification step. Methylmercury and other mercury compounds have a strong affinity for sulfur and selenium. Although selenium has been suggested to provide protection against the toxic effects of methylmercury, no such effect has been demonstrated. A variety of effects have been observed in animals treated with toxic doses of methylmercury. Some of these, such as renal damage and anorexia, have not been observed in humans exposed to high doses. The primary tissues of concern in humans are the nervous system and particularly the developing brain, and these have been the focus of epidemiological studies. Methylmercury induces neurotoxicity in small rodents such as mice and rats at doses that usually also affect other organ systems. Moreover, the maternal dose that damages the nervous system of offspring exposed in utero also results in maternal toxicity. The main neurological signs are impairment of coordination and pathological changes in selected areas of the brain and spinal cord. Similar effects are seen in domestic animals. In cats, no difference in toxicity was observed between methylmercury naturally present in fish and methylmercury added in pure form to the diet. Similar effects of methylmercury were observed in four-year studies in non-human primates, in which the techniques used to detect neuronal damage included pathological and behavioural tests and investigations of the visual and auditory systems. Although the number of animals included in these experiments was small, the NOEL was 10 µg/kg bw per day (expressed as mercury and corresponding to a steady-state blood concentration of 0.4 µg/L).The clearance, half-life and blood concentrations of methylmercury at steady-state depend on the body surface area. On the basis of body weight, small animals are much less sensitive to methylmercury than are humans, while the sensitivity of non-human primates is similar to that of humans. The two biomarkers used most frequently for quantifying the burden of methylmercury in the human body are blood and hair concentrations. Establishment of a quantitative relationship between exposure (daily intake) and concentrations in blood and hair began with a study of accidental consumption of grain treated with methylmercury fungicide in Iraq. Although the weight of evidence suggested that every microgram per litre increase in blood concentration results in an increase of 140-370 µg/kg of hair, in six of ten studies, the ratio of hair:blood concentration was 230-280. The Committee concluded that a ratio of 250 is a reasonable central estimate of the ratio of hair:blood concentration. The approximate relationships between weekly intake and blood concentration of mercury at steady state indicate that intake of 1 µg of mercury per kg bw per week in the form of methylmercury corresponds to a concentration of mercury of 10 µg/L of blood and 2.5 mg/kg of hair. Since the Committee's previous consideration of methylmercury, a considerable amount of data have become available on the possible neurobehavioural effects of prenatal and postnatal exposure. The most relevant data are from two large prospective epidemiological studies of cohorts assembled from the populations of the Faroe Islands and the Seychelles, who eat large amounts of seafood. The prenatal exposure of the two cohorts to mercury appears to have been similar. The geometric mean concentration of mercury in the hair of mothers during pregnancy was 4.3 µg/g (interquartile range, 3-8 µg/g) in the Faroe Islands and 6.8 µg/g (range, 0.5-27 µg/g) in the Seychelles. In the Faroe Islands, the geometric mean concentration in umbilical cord blood was 23 µg/L (interquartile range, 13-41 µg/L). In the Faroes, no association was seen between the extent of prenatal exposure to mercury and performance in clinical or neurophysiological tests, although significant decrements were observed in the children's scores in tests of functions such as fine motor skill, attention, language, visual-spatial skills, and memory. When the 15% of the children whose mothers had had hair concentrations of mercury greater than 10 µg/g were excluded from the analyses, most of the associations were still apparent. In the study in the Seychelles, no adverse effects associated with exposure to mercury were reported. Several differences between the studies may have contributed to the apparent discrepancy in the findings. First, the children were evaluated for neurobehavioural end-points at different ages and with different tests. In the Faroe Islands, the first neurobehavioural evaluation was conducted when the children were 84 months (seven years) of age, whereas in the Seychelles, the children were assessed at 6, 19, 29, and 66 months of age. As the capabilities of young children change rapidly, the scores at different ages may reflect performance in qualitatively different types of tasks, and scores achieved by children of different ages cannot be compared easily. In addition, although early childhood development was assessed in both studies, different batteries of tests were used. In the Faroes, the battery consisted of tests that focus on specific aspects of language, memory, fine motor function, attention, and visual-spatial skills. In the Seychelles, the main test was a general test of development that includes performance in many aspects of neurological function, although general tests of language, visual-spatial skills and academic achievement were also used. Even though some types of neurological function were assessed in both studies (e.g. language and memory), the differences in the specific tests used make the findings difficult to compare. Second, the two study cohorts may also differ with regard to exposure to other factors that can affect the neurobehavioural development of children. In the Faroes, many potential confounding factors were addressed in the analysis, including exposure to polychlorinated biphenyls (PCBs). Pilot whale is the major source of both methylmercury and PCBs in this population, and PCBs are thought to adversely affect the neurodevelopment of children exposed prenatally. When PCBs were measured in samples of umbilical cord tissue (blood and plasma were not available) from one-half of the Faroe Islands cohort, the average PCB concentration in cord tissue lipids was lower than that previously reported in breast milk lipids in the same population, indicating that cord tissue concentration may not be an appropriate indicator of the burden of PCBs. In the Seychelles, potential confounding exposures were not addressed, but it has been suggested that the finding that a higher intake of mercury was associated with higher scores in some tests of development is a result of nutritional factors or mitigating substances present in fish. Third, the intake patterns of the two cohorts may have differed. Most of the methylmercury consumed in the Faroes is from pilot whale, which is eaten less frequently than fish but contains more mercury per serving. In contrast, the source of methylmercury in the Seychelles is fish, which is consumed almost daily. Therefore, the intake of methylmercury in the Faroes may be episodic, with high peak concentrations of intake. Although the effect of methylmercury on neurobehavioural development has generally been presumed to be a function of cumulative intake, short-term peak intake may also be important. Further follow-up of these cohorts, with greater coordination between the study organizers, would be helpful for addressing some of the issues of assessment. For example, the cohort in the Seychelles was evaluated at 96 months with many of the same tests as were used in the Faroe Islands, and the results are expected to become available in the near future. The Environmental Health Criteria monograph on methylmercury (WHO, 1990) cited the need 'for epidemiological studies on children exposed in utero to concentrations of methylmercury that result in peak concentrations of mercury in maternal hair below 20 µg/g, in order to screen for those effects only detectable by available psychological and behavioural tests'. This proposal arose from an evaluation of data from a study in Iraq, which implied that adverse effects were seen with peak concentrations of 10-20 µg/g of maternal hair. 5. EVALUATION The studies in the Faroe Islands and the Seychelles that were evaluated by the Committee did not provide consistent evidence of neurodevelopmental effects in children of mothers whose intake of methylmercury yielded hair burdens of 20 µg/g or less. The Committee could not evaluate the risks for the complex and subtle neurological end-points used in these studies that would be associated with lower intakes. In the absence of any clear indication of a consistent risk in these recent studies, the Committee recommended that methylmercury be re-evaluated in 2002, when the 96-month evaluation of the Seychelles cohort and other relevant data that may become available can be considered. The Committee noted that fish contribute importantly to nutrition, especially in certain regional and ethnic diets, and recommended that nutritional benefits be weighed against the possibility of harm when limits on the methylmercury concentrations in fish or on fish consumption are being considered. 6. REFERENCES Aaseth, J. (1976) Mobilization of methylmercury in vivo and in vitro using N-acetyl-DL-penicillamine and other complexing agents. Acta Pharmacol. Toxicol., 39, 289-301. Aberg, B., Ekman, L., Falk, R., Greitz, U., Persson, G. & Snihs, J.-O. (1969) Metabolism of methylmercury (203)Hg. Arch. Environ. Health, 19, 478-484. Abgoola, A. (1978) Correlates of human cord length. Int. J. Gynaecol. Obstet., 16, 238-239. Akagi, H., Grandjean, P., Takizawa, Y. & Weihe, P. (1998) Methylmercury dose estimation from umbilical cord concentrations in patients with Minamata disease. Environ. Res., 77, 98-103. Amin-Zaki, L., Elhassani, S., Majeed, M.A., Clarkson, T.W., Doherty, R.A. & Greenwood, M. (1974) Intra-uterine methylmercury poisoning in Iraq. Pediatrics, 54, 587-595. Arctic Monitoring and Assessment Program (1998) Assessment Report: Arctic Pollution Issues, Oslo, 845 pp. Arito, H. & Takahashi, M. (1991) Effects of methylmercury in sleep patterns in rats. In: Suzuki, T., Imura, I. & Clarkson, T.W., eds, Advances in Mercury Toxicology, New York: Plenum Press, pp. 381-394. Aschner, M. & Clarkson, T.W. (1987) Mercury 203 distribution in pregnant and nonpregnant rats following systemic infusions with thiol-containing amino acids. Teratology, 36, 4321-4328. Australia New Zealand Food Authority (1998) The Australian Market Basket Survey, Melbourne: Information Australia. Axtell, C.D., Myers, G.J., Davidson, P.W., Choi, A.L., Cernichiari, E., Sloane-Reeves, J., Shamlaye, C., Cox, C. & Clarkson, T.W. (1998) Semiparametric modeling of age at achieving developmental milestones after prenatal exposure to methylmercury in the Seychelles Child Development Study. Environ. Health Perspectives, 106, 559-564. Baatrup, E., Thoraclius-Ussing, O., Nielsen, H.L. & Wilsky, K. (1989) Mercury-selenium interactions in relation to histochemical staining in the rat liver. Histochem. J., 21, 89-98. Bakir, F., Damluji, S.F., Murtadha, M., Khalidi, A., Al-Rawi, N.Y., Tikriti, S., Dhahir, H.I., Clarkson, T.W., Smith, J.C. & Doherty, R.A. (1973) Methylmercury poisoning in Iraq. Science, 191, 230-241. Ballatori, N. & Clarkson, T.W. (1982) Developmental changes in the biliary excretion of methylmercury and glutathione. Science, 216, 61-63. Bayley, N. (1969) Bayley Scales of Infant Development, New York: The Psychological Corporation. Becker, K., Nollke, P.E. Hermann-Kunz, H., Klein, C., Krause, C., Schulze, D. & Schenker, N. (1998) Die Aufnahme von Schadstoffen und Spurenelementen mit der Nahrung--Ergebnis einer Duplikatstudie. Akt. Ernaher.-Med., 23, 142-151. Bellinger D.C., Leviton, A., Waternaux, C., Needleman, H.L. & Rabinowitz, M.B. (1987) Longitudinal analyses of pre and postnatal lead exposure and early cognitive development. New Engl. J. Med., 316, 1037-1043. Berkow, R., ed. (1988) The Merck Manual, 5th ed., Rahway, NJ, Merck Co., p. 1887. Berlin, M. (1963) Renal uptake, excretion, and retention of mercury. II, A study in the rabbit during infusion of methyl and phenylmercuric compounds. Arch. Environ. Health, 6, 626-633. Berlin, M., Jerksell, L.-G. & Nordberg, G. (1965) Accelerated uptake of mercury in brain caused by 2,3-dimercaptopropanol (BAL) after injection into the mouse of methylmercuric compounds. Acta Pharmacol. Toxicol., 23, 312-320. Berlin, M., BIomstrand, C., Grant, C.A., Hamberger, A. & Trofast, J. (1975a) Tritiated methylmercury in the brain of squirrel monkeys. Cellular and subcellular distribution. Arch. Environ. Health, 30, 591-597. Berlin, M., Carlson, J. & Norseth, T. (1975b) Dose-dependence of methylmercury metabolism. A study of distribution, biotransformation and excretion in the squirrel monkey. Arch. Environ. Health, 30, 307-313. Berlin, M., Crawford, A., Grant, D.V.M., Hellberg, J., Hellström, J. & Schütz, A. (1975c) Neurotoxicity of methylmercury in squirrel monkeys. Arch. Environ. Health, 30, 340-348. Beuter, A. & Edwards, R. (1998) Tremor in Cree subjects exposed to methylmercury: A preliminary study. Neurotoxicol. Teratol., 20, 581-589. Björkman, L., Mottet, K., Nylander, M., Vahter, M., Lind, B. & Friberg, L. (1994) Selenium concentrations in brain after exposure to methylmercury between the inorganic mercury fraction and selenium. Arch. Toxicol., 69, 228-234. Burbacher, T.K., Mohamed, M.K. & Mottet, N.K. (1988) Methylmercury effects on reproduction and offspring size at birth. Reprod. Toxicol., 1, 267-278. Cagiano, R., De Salvia, N.A., Renna, G., Tortella, E., Braghiroli, D., Parenti, C., Zanoli, P., Baraldi, M., Annau, Z. & Cuomo, V. (1990) Evidence that exposure to methyl-mercury during gestation induces behavioral and neurochemical changes in offspring of rats. Neurotoxicol. Teratol., 12, 23-28. Carrington, C. (1999) Mercury intake by the US population and subgroups based on US monitoring. Submission to JECFA, 6 pp. Cavanagh, J.B. & Chen, F.C.K. (1971) Amino acid incorporation in protein during the 'silent phase' before organo-mercury and p-bromophenylacetylurea neuropathy in the rat. Acta Neuropathol., 19, 216-224. Cernichiari, E., Brewer, R., Myers, G.J., Marsh, D.O., Lapham, L.W., Cox, C., Shamlaye, C.F., Berlin, M., Davidson, P.W. & Clarkson, T.W.. (1995) Monitoring methylmercury during pregnancy: Maternal hair predicts fetal brain exposure. NeuroToxicology, 16, 705-710. Chang, L.W. (1977) Neurotoxic effect of mercury--A review. Environ Res., 14, 329-373. Chang, L.W. & Hartmann, H.A. (1972) II. Pathological changes in nervous fibers. Acta Neuropathol., 20, 316-334. Chang, L.W. & Yamaguchi, S. (1974) Ultrastructural changes in the liver after long term diet of mercurycontaminated tuna. Environ. Res., 7, 133-148. Chang, L.W., Reuhl, K. & Lee, G.V. (1977) Degenerative changes in the developing nervous system as a result of in utero exposure to methylmercury. Environ. Res., 14, 414-423. Charbonneau, S.M., Munro, I.C., Nera, E.A., Villes, R.F., Kuiper-Goodman, T., Iverson, F., Moodie, C.A., Stoltz, D.R., Armstrong, F.A.J., Uthe, J.F. & Grice, H.C. (1974) Subacute toxicity of methylmercury in the adult cat. Toxicol. Appl. Pharmacol., 27, 569-581. Charleston, J.S., Bolender, R.P., Mottet, I.K., Body, R.L., Vahter, M.E. & Burbacher, T.M. (1994) Increase in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. Toxicol. Appl. Pharmacol., 129, 196-206. Charleston, J.S., Body, R.L., Mottet, N.K., Vahter, M.E. & Burbacher, T.M. (1995) Autometallographic determination of inorganic mercury distribution in the cortex of the calcarine sulcus of the monkey Macaca fascicularis following long-term subclinical exposure to methylmercury and mercuric chloride. Toxicol. Appl. Pharmacol., 129, 196-206. Chen, J. & Gao, J. (1993) The Chinese total diet study in 1990. Part I. Chemical contaminants. J. AOAC Int., 76, 1193-1205. Chen, R.W., Lacy, V.L. & Whanger, P.D. (1975) Effect of selenium on methylmercury binding to subcellular and soluble proteins in rat tissues. Res. Commun. Chem. Pathol. Pharmacol., 12, 297-307. Childs, E.A. (1973) Kinetics of transplacental movement of mercury fed in a tuna matrix in mice. Arch. Environ. Health, 27, 50-52. Cikrt, M., Magos, L. & Snowden, R.T. (1984) The effect of interaction between subsequent doses of MeHgCl and HgCl2 on the biliary excretion of mercury from each individual dose. Toxicol. Lett., 20, 189-194. Clarkson, T.W., Small, H. & Norseth, T. (1973) Excretion and absorption of methyl mercury after polythiol resin treatment. Arch. Environ. Health, 26, 173-175. Clarkson, T.V., Magos, L., Cox, C., Greenwood, M.R., Amin-Zaki, L., Majeed, M.A. & Al-Damluji, S.F. (1981) Tests of efficacy of antidotes for the removal of methylmercury during the Iraq ouforeak. J. Pharmacol. Exp. Ther., 218, 74-83. Clay, M.M. (1979) The Early Detection of Reading Difficulties, 2nd Ed., Auckland: Heineman Education Books. Counter, S.A., Buchanan, L.H., Laurell, G. & Ortega, F. (1998) Blood mercury and auditory neuro-sensory responses in children and adults in the Nambija gold mining area of Ecuador. Neurotoxicology, 19, 185-196. Cox, C., Clarkson, T.W., Marsh, D.O., Amin-Zaki, L., Al-Tikriti, S. & Myers, G.J. (1989) Dose-response analysis of infants prenatally exposed to methylmercury: An application of a single compartment model to single-strand hair analysis. Environ. Res., 49, 318-332. Cox, C., Marsh, D., Myers, G. & Clarkson, T. (1995) Analysis of data on delayed development from the 1971-72 ouforeak of methylmercury poisoning in Iraq: Assessment of influential points. Neurotoxicology, 16, 727-730. Crump, K., Viren, J., Silvers, A., Clewell, H., III, Gearhart, J. & Shipp, A. (1995) Reanalysis of dose-response data from the Iraqi methylmercury poisoning episode. Risk Anal., 15, 523-532. Crump, K.S., Kjellström, T., Shipp, A.M., Silvers, A. & Stewart, A. (1998) Influence of prenatal mercury exposure upon scholastic and psychological test performance: Benchmark analysis of a New Zealand cohort. Risk Anal., 18, 701-713. Dahl, R., White, R.F., Weihe, P., Sorensen, N., Letz, R., Hudnell, K., Otto, D.A. & Grandjean, P. (1996) Feasibility and validity of three computer-assisted neurobehavioral tests in 7-year-old children. Neurotoxicol. Teratol., 18, 413-419. Dalgard (1994) Davidson, P.W., Myers, G.J., Cox, C., Shamlaye, C.F., Marsh, D.O., Tanner, M.A., Berlin, M., Sloane-Reeves, J., Cernichiari, E., Choisy, O., Choi, A. & Clarkson, T.W. (1995a) Longitudinal neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from maternal fish ingestion: Outcomes at 19 and 29 months. Neurotoxicology, 16, 677-688. Davidson, P.W., Myers, G.J., Cox, C., Shamlaye, C., Choisy, O., Sloane-Reeves, J., Cernchiari, E., Marsh, D.O., Berlin, M., Tanner, M. & Clarkson, T.W. (1995b) Neurodevelopmental test selection, administration, and performance in the main Seychelles Child Development Study. Neurotoxicology, 16, 665-676. Davidson, P.W., Myers, G.J., Cox, C., Axtell, C., Shamlaye, C., Sloane-Reeves, J., Cernichiari, E., Needham, L., Choi, A., Wang, Y., Berlin, M. & Clarkson, T.W. (1998) Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment. J. Am. Med. Assoc., 280, 701-707. Davies, T.S. & Nielsen, S.W. (1977) Pathology of subacute methylmercurialism in cats. Am. J. Vet. Res., 38, 59-67. Davies, T.S., Nielsen, S.W. & Kircher, C.H. (1976) The pathology of subacute methyl mercurialism in swine. Cornell Vet., 66, 32-55. Davies, T.S., Nielsen, S.W. & Jortner, B.S. (1977) Pathology of chronic and subacute canine methylmercurialism. J. Am. Anim. Hosp. Assoc., 13, 369-381. Delix, D.C., Kramer, J.H., Kaplan, E. & Ober, B.A. (1994) California Verbal Learning Test (Children), San Antonio: Psychological Corp. Desnoyers, P.A. & Chang, L.W. (1975) Ultrastructural changes in rats following acute methylmercury intoxication. Environ. Res., 9, 224-239. Dewailly, E., Nantel, A.J., Weber, J.P. & Meyer, F. (1989) High levels of PCBs in the breast milk of Inuit women from Arctic Quebec. Bull. Environ. Contam. Toxicol., 43, 641-646. Dewailly, E., Ayotte, P., Bruneau, S., Laliberté, C., Muir, D.C.G. & Norstrom, R. (1993) Inuit exposure to organochlorines through the aquatic food chain in Arctic Québec. Environ. Health Perspectives, 10, 618-620 Dietrich, K.N. & Bellinger, D. (1994) The assessment of neurobehavioral development in studies of the effects of prenatal exposure to toxicants. In: Needleman, H.L. & Bellinger, D., eds, Prenatal Exposure to Toxicants: Developmental Consequences, Baltimore: Johns Hopkins University Press, pp. 57--85. Dietrich, K.N., Krafft, K.M., Bornschein, R.L., Hammond, P.B., Berger, O., Succop, P.A. & Bier, M. (1987) Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics, 80, 721-730. Dock, L. Rissanen, R. & Vahter, M. (1994a) Demethylation and placental transfer of methylmercury in the pregnant hamster. Toxicology, 94, 131-142. Dock, L., Mottet, K. & Vahter, M. (1994b) Effect of methylmercury exposure on the uptake of radiolabeled inorganic mercury in the brain of rabbits. Pharmacol. Toxicol., 74, 158-161. Doi, R. & Kobayashi, T. (1982) Organ distribution and biological half-time of methylmercury in four strains of mice. Jpn. J. Exp. Med., 32, 307-314. Doi, R. & Tagawa, M. (1983) A study on the biochemical behavior of methylmercury. Toxicol. Appl. Pharmacol., 69, 307-483. Eccles, C.U. & Annau, Z. (1982a) Prenatal methyl mercury exposure: I. Alterations in neonatal activity. Neurobehav. Toxicol. Teratol., 4, 371-375. Eccles, C.U. & Annau, Z. (1982b) Prenatal methylmercury exposure: II. Alterations in learning and psychotropic drug sensitivity in adult offspring. Neurobehav. Toxicol. Teratol., 4, 377-382. El-Fawal, A.N., Gong, Z., Little, A.R. & Evans, H.L. (1996) Exposure to methylmercury results in serum autoantibodies to neurotyptic and gliotypic proteins. Neurotoxicology, 17, 531-540. Elsner, J. (1991) Tactile-kinesthetic system of rats as an animal model for minimal brain dysfunction. Arch. Toxicol., 55, 465-473. Ente, G. & Penzer, P.H. (1991) The umbilical cord: Normal parameters. J. R. Soc. Health, 111, 138-140. Evans, J.L., Garman, R.H. & Weiss, B. (1977) Methylmercury: Exposure duration and regional distribution as determinants of neurotoxixcity in nonhuman primates. Toxicol. Appl. Pharmacol., 41, 15-33. Fagan, J.F. (1987) Fagan Test of Infant Intelligence: Training Manual, Cleveland: Infantest Corp. Falk, S.A., Klein, R., Haseman, J.K., Sanders, G.M. & Talley, F.A. (1974) Acute methyl-mercury intoxication and ototoxicity in guinea pigs. Arch. Pathol., 97, 297-305. Fang, S.C. (1974) Induction of C-Hg cleavage enzymes in rat liver by dietary selenite. Res. Commun. Chem. Pathol. Pharmacol., 9, 579-582. Fang, S.C. (1980) Comparative study of uptake and tissue distribution of methylmecury in female rats by inhalation and oral routes of administration. Bull. Environ. Contam. Toxicol., 24, 65-72. Farris, F.F., Poklis, A. & Griesmann, G.E. (1977) Effect of dietary cysteine on toxicity, tissue distribution, and elimination of methylmercury in the rat. In: Drucker, H. & Wildung, R.E., eds, Biological Implications of Metals in the Environment, Washington DC: Energy Research and Development Administration, pp. 465-477. Farris, F.F., Dedrick, R.L., Allen, P.V. & Smith, J.C. (1993) Physiological model for the pharmacokinetics of methyl mercury in the growing rat. Toxicol. Appl. Pharmacol., 119, 74-90. Fehling, C., Abdulla, M. Brun, A., Dictor, M., Schutz, A. & Skerfving, S. (1975) Methylmercury poisoning in the rat: A combined neurological, chemical, and histopathological study. Toxicol. Appl. Pharmacol., 33, 27-37. Fenson, L., Dale, P.S., Reznick, J.S., Thal, D., Bates, E., Hartung, J.P., Pethick, S. & Reilly, J.S. (1993) MacArthur Communicative Development Inventory: User's Guide and Technical Manual, San Diego: Singular Publishing Group. Finocchio, D.V., Luschei, E.L., Mottet, N.K. & Body, R. (1980) Effects of methylmercury on the visual system of rhesus macaque ( Macaca mulatta). I. Pharmacokinetic of chronic methylmercury related to changes in vision and behavior. In: Merigan, W.H. & Weiss, H., eds, Neurotoxicity of the Visual System, New York: Raven Press, pp. 113-122. Foldspang, A. & Hansen, J. (1990) Dietary intake of methylmercury as a correlate of gestational length and birth weight among newborn in Greenland. Am. J. Epidemiol., 132, 310-317. Food & Drug Administration (1993-1996) Residue monitoring. J. AOAC Fowler, B.A. (1972) The morphologic effects of dieldrin and methyl mercuric chloride on pars recta segments of rat kidney proximal tubules. Am. J. Pathol., 69, 163-174. Frankenburg, W.K., Fandal, A.W., Sciarillo, W. & Burgess, D. (1981) The newly abbreviated and revised Denver development screening test. J. Pediatr., 99, 995-999. Frederiksson, A., Dencker, L., Archer, T. & Danielsson. B.G.R. (1996) Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats. Neurotoxicol. Neuroteratol., 18, 129-134. Frederiksson, A., Gardlund, A.T., Bergman, K., Oskarsson, A., Ohlin, B., Danielsson, B. & Archer, T. (1993) Effects of maternal dietary supplementation with selenite on the postnatal development of rat offspring exposed to methylmercury in utero. Pharmacol. Toxicol., 72, 377-382. Friberg, L. (1959) Studies on the metabolism of mercuric chloride and methylmercury dicyandiamide. Arch.Environ. Health, 20, 42-49. Friberg, L., Skog, E. & Wahlberg, J.E. (1961) Resorption of mercuric chloride and methylmercury dicyandiamide in guineapigs through normal skin and through skin pretreated with acetone, alkylaryl sulphonate and soap. Acta Derm. Venereol., 41, 40-50 Friedheim, E. & Corvi, C. (1975) Mesodimercaptosuccininc acid, a chelating agent for the treatment of mercury poisoning. J. Pharm. Pharmacol., 27, 624-626. Fuyuta, M., Fujimoto, T. & Hirata, S. (1978) Embryotoxic effects of methylmercuric chloride administered to mice and rats during organogenesis. Teratology, 18, 353-366. Gao, J. (1999) Mercury intake by 5 subgroups of the Chinese population. Report submitted to JECFA. Grandjean, P. & Weihe, P. (1993) Neurobehavioral effects of intrauterine mercury exposure: Potential sources of bias. Environ. Res., 61, 176-183. Grandjean, P. Weihe, P., Jorgensen, P.J., Clarkson, T., Cernichiari, E. & Videro, T. (1992) Impact of maternal seafood diet on fetal exposure to mercury, selenium, and lead. Arch. Environ. Health, 47, 185-195. Grandjean, P., Weihe, P. & White, R.F. (1995a) Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology, 16, 27-34. Grandjean, P., Weihe, P., Needham, L.L., Burse, V.W., Patterson, D.G., Jr, Sampson, E.J., Jorgensen, P.J. & Vahter, M. (1995b) Effect of a seafood diet on mercury, selenium, arsenic, and PCBs and other organochlorines in human milk. Environ. Res., 71, 29-38. Grandjean, P., Weihe, P., White, R.F., Debes, F., Araki, S., Yokoyama, K., Murata, K., Sorensen, N., Dahl, R. & Jorgensen, P.J. (1997) Cognitive deficit in 7-year-old children with prenatal exposure to mercury. Neurotoxicol. Teratol., 19, 417-428. Grandjean, P., Weihe, P., White, R.F. & Debes, F. (1998) Cognitive performance of children prenatally exposed to 'safe' levels of methylmercury. Environ. Res., 77, 165-172. Grandjean, P., White, R., Nielsen, A., Cleary, D. & deOliveira-Santos, E. (1999) Methylmercury neurotoxicity in Amazonian children downstream from gold mining. Environ. Health Perspectives, 107, 587-591. Greenwood, M.R., Clarkson, T.W., Doherty, R.A., Gates, A.H., AminZaki, L., Elhassani, S. & Majeed, M.A. (1978) Blood clearance half times in lactating and nonlactating members of a population exposed to methylmercury. Environ. Res., 16, 48-54. Gregus, Z. & Varga, F. (1985) Role of glutathione and hepatic glutathione Stransferase in the biliary excretion of methylmercury, cadmium and zinc: A study with enzyme inducers and glutathione depletors. Acta Pharmacol. Toxicol., 56, 398-401. Groth, D.H., Stettler, L. & Mackay, G. (1976) Interactions of mercury, cadmium, selenium, tellurium, arsenic and beryllium. In: Nordberg, G., ed., Effects and Dose-Response Relationships of Toxic Metals, Amsterdam: Elsevier Science Publishers, pp. 527-543. Gunderson, V.M., GrantWebster, K.S. & Burbacher, T.M. (1988) Visual recognition deficits in methylmercuryexposed Macaca fascicularis infants. Neurotoxicol. Teratol., 10, 373-379. Gyrd-Hansen, N. (1981) Toxicokinetics of methyl mercury in pigs. Arch. Toxicol., 48, 173-181. Hansen, J.C., Tarp, U. & Bohm, J. (1990) Prenatal exposure to methylmercury among Greenlandic polar Inuits. Arch. Environ. Health, 45, 355-358. Harada, M. (1995) Minamata disease: Methylmercury poisoning in Japan caused by environmental pollution. Crit. Rev. Toxicol., 21, 1-24. Harris, S.B., Wilson, J.G. & Printz, R.H. (1972) Embryotoxicity of methylmercuric chloride in golden hamsters. Teratology, 5, 139-142. Herigstad, R.R., Whitehair, C.K., Beyer, N., Mickelsen, O. & Zabik, M.J. (1972) Chronic methylmercury toxicosis in calves. J. Am. Vet. Med. Assoc., 160, 173-182. Herman, S.P., Kleid, R., Talley, F.A. & Krigman, M.R. (1973) An ultrastructural study of methylmercury induced primary sensory neuropathy in the rat. Lab. Invest., 28, 104-118. Hirano, M., Mitsumori, K., Maita,, K. & Shirasu, Y. (1986). Further carcinogenic study on methylmercury chloride in ICR mice. Jpn. J. Vet. Sci., 48, 127-135. Hollins, J.G., Willes, R.F., Bryce, F.R., Carbonneau, S.M. & Munro, I.C. (1975) The whole body retention and distribution of [203Hg]methylmercury in adult cats. Toxicol. Appl. Pharmacol., 33, 438-449. Hoskins, B.B. & Hupp, E.W. (1978) Methylmercury effects in rat, hamster, and squirrel monkey. Lethality, symptoms, brain mercury, and amino acids. Environ. Res., 15, 5-19. Hunter, D. & Russel, D.S (1954) Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. J. Neurol. Neurosurg. Psychiatr., 17, 235-241. Hunter, D., Bamford, R.R. & Russel, D.S. (1940) Poisoning by methylmercury compounds. Q. Med. New Ser., 9, 193-213. Ikeda, Y., Tobe, M., Kobayashi, K., Suzuki, S., Kawasaki, Y. & Yonemaru, H. (1973) Longterm toxicity study of methylmercuric chloride in monkeys (First report). Toxicology, 1, 361-375. Ilbäck, N.-G. (1991) Effect of methylmercury exposure on spleen and blood natural killer (NK) cell activity in the mouse. Toxicology, 67, 117-124. Ilbäck, N.-G., Sundberg, J. & Oskarsson, A. (1991) Methylmercury exposure via placanta and milk impairs natural killer (NK) cell function in newborn rats. Toxicol. Lett., 58, 149-158. Inouye, M., Mourao, K. & Kajiwara, Y. (1985) Behavioral and neuropathological effects of prenatal exposure in mice. Neurobehav. Toxicol. Teratol., 7, 227-232. Inouye, M., Kajiwara, Y. & Hirayama, K. (1986) Dose-and sex-dependent alterations in mercury distribution in fetal mice following methylmercury exposure. J. Toxicol. Environ. Health, 19, 425-435. Iverson, F., Downie, R.H., Paul, C. & Trenholm, H.L. (1973) Methylmercury: Acute toxicity, tissue distribution and decay profiles in the guinea pig. Toxicol. Appl. Pharmcol., 24, 545-554. Iverson, F., Downie, R.H., Trenholm, H.L. & Paul, C. (1974) Accumulation and tissue distribution of mercury in the guinea pig during subacute administration of methylmercury. Toxicol. Appl. Pharrnacol., 27, 60-69. Iwata, H., Masukawa, T., Kito, H. & Hayashi, M. (1982) Degradation of methylmercury by selenium. Life Sci., 31, 859-866. Jacobs, J.M., Cavanagh, J.B. & Carmicheal, I. (1977) Ultrastructural changes in the nervous system of rabbits poisoned with methylmercury. Toxicol. Appl. Pharmacol., 39, 249-261. Jacobson, J. & Jacobson, S. (1997) Evidence for PCBs as neurodevelopmental toxicants in humans. Neurotoxicology, 18, 415-424. Jorhem, L., Becker, W. & Slorach, S. (1998) Intake of 17 elements by Swedish women, determined by a 24-h duplicate portion study. J. Food Composition Anal., 11, 32-46. Kaplan, E., Goodglass, H. & Weintraub, S. (1983) The Boston Naming Test, Philadelphia: Lea & Febiger. Kawasaki, Y., Ikeda, Y. Yamamoto, T. & Ikeda, K. (1986) Longterm toxicity study of methylmercury chloride in monkeys. J. Food Hyg. Soc. Jpn, 27, 528-552. Kerper, L.A., Ballatori, I.V. & Clarkson, T.W. (1992) Methylmercury transport across the blood:brain barrier by an amino acid carrier. Am. Physiol. Soc., 162, R761-R765. Kershaw, T.G., Clarkson, T.W. & Dhahir, P.H. (1980) The relationship beween blood levels and dose of methylmercury in man. Arch. Environ. Health, 35, 28-36. Khera, K.S. (1973) Reproductive capability of male rats and mice treated with methyl mercury. Toxicol. Appl. Pharmacol., 24, 167-177. Khera, K.S. & Tabacova, S.A. (1973) Effects of methymercuric chloride on the progeny of rats treated before and during gestation. Food Cosmet. Toxicol., 11, 245-254. King, R.B., Robkin, M.A. & Shepard, T.H. (1976) Distribution of 203Hg in pregnant and fetal rats. Teratology, 13, 275-280. Kjellström, T., Kennedy, P., Wallis, S. & Mantell, C. (1986) Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Stage 1: Preliminary Tests at Age 4 (Report No. 3080), Solna: National Swedish Environmental Protection Board. Kjellström, T., Kennedy, P., Wallis, S., Stewart, A., Friberg, L., Lind, B., Wutherspoon, T. & Mantell, C. (1989) Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Stage 2: Interviews and Psychological Tests at Age 6 (Report No. 3642), Solna: National Swedish Environmental Protection Board. Klein, R., Herman, S.P., Bullock, B.C. & Talley, F. (1973) Methylmercury intoxication in rat kidney. Functional and pathological changes. Arch. Pathol., 96, 83-90. Koeman, J.H., Peeters, W.H.M., KoudstaalHol, C.H.M., Tjioe, P.S. & de Goeij, J.J. (1973) Mercury-selenium correlations in marine mammals. Nature, 254, 385-386. Konishi, T. & Hamrick, P.E. (1979) The uptake of methylmercury in guinea pig cochlea in relation to its ototoxicity. Acta Otolaryngol., 88, 203-210. Koopman-Esseboom, C., Weisglas-Kuperus, N., de Ridder, M.A., Van der Paauw, C.G., Tuinstra, L.G.M. & Sauer, P.J. (1996) Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants' mental and psychomotor development. Pediatrics, 97, 700-706. Koppitz, E.M. (1963) The Bender Gestalt Test for Young Children, London: Grune & Stratton. Kosta, L., Byrne, A.R. & Zelenko, V. (1975) Correlation between selenium and mercury in man following exposure to inorganic mrcury. Nature, 254, 238-239. Kostyniak, P.J. (1980) Differences in elimination rates of methylmercury between two genetic variant strains of mice. Toxicol. Lett., 6, 405-410. Kostyniak, P.J. (1983) Pharmacokinetics of methylmercury in sheep. J. Appl. Toxicol., 3, 45-38. Kostyniak, P.J., Clarkson, T.W., Cestero, R.V. Freeman, R.B. & Abbasi, A.H. (1975) An extracorporeal complexing hemodialysis system for the treatment of methylmercury poisoning. I. In vitro studies on the effects of four complexing agents on the distribution and dialyzability of methylmercury in human blood. J. Pharmacol. Exp. Ther., 192, 260-269. Lebel, J., Mergler, D., Lucotte, M., Amorim, M., Dolbec, J., Miranda, D., Arantes, G., Rheault, I. & Pichet, P. (1996) Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methylmercury. Neurotoxicology, 17, 157-168. Lebel, J., Mergler, D., Branches, F., Lucotte, M., Amorim, M., Larribe, F. & Dolbec, J. (1998) Neurotoxic effects of low-level methylmercury contamination in the Amazonian Basin. Environ. Res., 79, 20-32. Lee, J.-H. & Han, D.-H. (1995) Maternal and fetal toxicity of methylmercuric chloride administered to pregnant Fischer 344 rats. J. Toxicol. Environ. Health, 45, 415-425. Lezak, M.D. (1995) Neuropsychological Assessment, 3rd Ed., Oxford: Oxford University Press. Lin, F.M., Malaiyandi, M. & Romero-Sierra, C. (1975) Toxicity of methylmercury: Effects on different ages of rats. Bull. Environ. Contam. Toxicol., 14, 140-148. Lind, B., Friberg, L. & Nylander, M. (1988) Preliminary studies on methylmercury biotransformation and clearance in the brain of primates: II. Demethylation of mercury in brain. J. Trace Elem. Exp. Med., 1, 49-56. Lindström, H., Luthman, J., Oskarsson, A., Sundberg, J. & Olson, L. (1991) Effects of long-term treatment with methylmercury on the developing rat brain. Environ. Res., 56, 158-169. Lögdberg, B., Berlin, M. & Brun, A. (1993) Effects of methylmercury on the fetal brain in the squirrel monkey. In: Lögdberg, B., Fetal Lead and Brain Development--Studies in a Nonhuman Primate Model, Doctoral Dissertation, Lund University, pp. 85-113 Luschei, R., Mottet, N.K. & Shaw, C.M. (1977) Chronic methylmercury exposure in the monkey (Macaca mulatta). Arch. Environ. Health, 32, 126-131. Magos, L. (1976) The effect of dimercaptosuccinic acid on the excretion and distribution of mercury in rats and mice treated with mercuric chloride and methylmercury chloride. Br. J. Phamacol., 56, 479-464. Magos, L. & Butler, W.H. (1972) Cumulative effects of methylmercury dicyandiamide given orally to rats. Food Cosmet. Toxicol., 10, 513-517. Magos, L. & Butler, W.H. (1976) The kinetics of methylmercury administered repeatedly to rats. Arch. Toxicol., 35, 25-39. Magos, L. & Clarkson, T.W. (1976) The effect of oral doses of a polythiol resin an the excretion of methylmercury in mice treated with cysteine, D-penicillamine or phenobarbitane. Chem-Biol. Interactions, 14, 325-335. Magos, L. & Webb, M. (1977) The effect of selenium on the brain uptake of methylmercury. Arch. Toxicol., 38, 201-207. Magos, L., Clarkson, T.W. & Allen, J. (1978) The interrelationship between nonprotein bound thiols and the biliary excretion of methylmercury. Res. Chem. Pharmacol., 97, 2203-2208. Magos, L., Clarkson, T.W., Allen, J. & Snowden, R. (1979a) The effects of bromosulphothalein, indocyanine green and bilirubin on the biliary excretion of methylmercury. Chem.-Biol. Interactions, 26, 317-320. Magos, L., Webb, M. & Hudson, A.R. (1979b) Complex formation between selenium and methylmercury. Chem.-Biol. Interactions, 28, 359-362. Magos, L., Peristianis, G.C., Clarkson, T.V., Snowden, R.T. & Majeed, M.A. (1980a) Comparative study of the sensitivity of virgin and pregnant rats to methylmercury. Arch. Toxicol., 43, 282-291. Magos, L., Peristianis, G.C., Clarkson, T.W. & Snowden, R.T. (1980b) The effect of lactation on methylmercury intoxication. Arch. Toxicol., 45, 143-148. Magos, L., Peristianis, G.C., Clarkson, T.V., Brown, A., Preston, S. & Snowden, R.T. (1981) Comparative study of the sensitivity of male and female rats to methylmercury. Arch. Toxicol., 48, 11-20. Magos, L., Clarkson, T.W. & Hudson, A.R. (1983) Differences in the effects of selenite and biological selenium on the chemical form and distribution of mercury after the subcutaneous administration of HgCl2 and selenium to rats. J. Pharmacol. Exp. Ther., 228, 478-483. Magos, L., Brown, A.W., Sparrow, S., Bailey, E., Snowden, R.T. & Skipp, W.R. (1985a) The comparative toxicology of ethyl and methylmercury. Arch. Toxicol., 57, 260-267. Magos, L. Cikrt, M. & Snowden, R. (1985b) The dependence of biliary methylmercury secretion on liver GSH and ligandin. Biochem. Pharmacol., 34, 301-305. Magos, L., Clarkson, T.V. & Hudson, A.R. (1989) The effect of dose of elemental mercury and firstpass circulation time on exhalation and organ distribution of inorganic mercury in rats. Biochim. Biophys. Acta, 991, 85-89. Markowski, V.P., Flaugher, C.B., Baggs, R.B., Rawleigh, R.C., Cox, C. & Weiss, R.B. (1998) Prenatal and lactational exposure to methylmercury affects select parameters of mouse cerebellar development. Neurotoxicology, 39, 879-892. Marsh, D.O., Clarkson, T.W., Cox, C., Myers, G.J., Amin-Zaki, L. & Al-Tikriti, S. (1987) Fetal methylmercury poisoning: Relationship between concentration in single strands of maternal hair and child effects. Arch. Neurol., 44, 1017-1022. Marsh, D.O., Turner, M.D., Smith, J.C., Perez, V.M.H., Allen, P. & Richdale, N. (1995) Fetal methylmercury study in a Peruvian fish eating population. Neurotoxicology, 16, 717-726. Martoja, R. & Viale, D. (1977) Accumulation de granules de séléniure mercurique dans le foie d'odontorecetes (mammifères cétacés): Un mechanisme possible de détoxication du methylmercure par le sélénium. C.R. Acad. Sci. Paris Cétacés D, 285, 109-112. McCarthy, D. (1972) McCarthy Scales of Children's Abilities, New York, Psychological Corp. McConnell, K. & Roth, D.M. (1966) Respiratory excretion of selenium. Proc. Soc. Exp. Biol. Med., 123, 919-921. McDonald, J.S. & Harbison, R.D. (1977) Methylmercuryinduced encephalopathy in mice. Toxicol. Appl. Pharmacol., 39, 195-205. McKeown-Eyssen, G., Ruedy, J. & Neims, A. (1983) Methylmercury exposure in northern Quebec. II. Neurologic findings in children. Am. J. Epidemiol., 118, 470-479. Miettinen, J.K. (1973) Absorption and elimination of dietary mercuric mercury (Hg2+) and methylmercury in man. In: Miller, M. & Clarkson, T.W., eds, Mercury, Mercurials and Mercaptans, Springfield, IL: Charles C. Thomas, pp. 233-243. Ministry of Agriculture, Fisheries and Food (1982-1991) UK Total Diet Study. Surveillance results. Submitted to CCFAC. Mitsumori, K., Hirano, M., Ueda, H., Maita, K. & Shirasu, Y. (1990) Chronic toxicity and carcinogenicity of methylmercury in B6C3Fl mice. Fundam. Appl. Toxicol., 14, 179-190. Miyama, T., Minowa, K., Seki, H., Tamura, Y., Mizoguchi, I., Ohi, G. & Suzuki, T. (1983) Chronological relationship between neurological signs and electrophysiological changes in rats with methylmercury poisoning--Special reference to selenium protection. Arch. Toxicol., 52, 173-181. Mohamed, Y.A., Burbacher, T.M. & Mottet, N.K. (1987) Methylmercury on testicular functions in Macaca fascicularis monkeys. Pharmacol. Toxicol., 62, 29-36. Moller-Madsen, B. (1990) Localization of mercury in CNS of the rats. II. Intraperitoneal injection of methylmercuric chloride (CH3HgCl) and mercuric chloride. Toxicol. Appl. Pharmacol., 103, 303-323. Moller-Madsen, B. (1991) Localization of mercury in CNS of the rat. III. Oral administration of methylmercuric chloride (CH3HgCl). Fundam. Appl. Toxicol., 16, 172-187. Moller-Madsen, B. & Danscher, G. (1991) Localization of mercury in CNS of the rat. IV. The effect of selenium on orally administered organic and inorganic mercury. Toxicol. Appl. Pharmacol., 108, 457-473. Munro, I.C., Nera, E.A., Charbonneau, S.M., Junkins, B. & Zavidzka, Z. (1980) Chronic toxicity of methylmercury in the rat. J. Environ. Pathol. Toxicol., 3, 437-447. Murata, K., Weihe, P., Araki, S., Budtz-Jorgensen, E. & Grandjean, P. (1999a) Evoked potentials in Faroese children prenatally exposed to methylmercury. Neurotoxicol. Teratol., 21, 471-472. Murata, K., Weihe, P., Renzoni, A., Debes, F., Vasconcelos, R., Zino, F., Araki, S., Jorgensen, P.J., White, R.F. & Grandjean, P. (1999b) Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol. Teratol., 21, 343-348. Murphy, J.F. (1984) The effects of maternal smoking on the unborn child. In Studd, J.W.W., ed., Progress in Obstetrics and Gynaecology, 4th Ed., London: Churchill & Livingstone, pp. ??. Myers, G.J., Marsh, D.O., Cox, C., Davidson, P.W., Shamlaye, C.F., Tanner, M.A., Choi, A., Cernichiari, E., Choisy, O. & Clarkson, T.W. (1995a) A pilot neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet. Neurotoxicology, 16, 629-638. Myers, G.J., Davidson, P.W., Cox, C., Shamlaye, C.F., Tanner, M.A., Choisy, O., Sloane-Reeves, J., Marsh, D.O., Cernichiari, E., Choi, A., Berlin, M. & Clarkson, T.W. (1995b) Neurodevelopmental outcomes of Seychellois children sixty-six months after in utero exposure to methylmercury from a maternal fish diet, pilot study. Neurotoxicology, 16, 639-652. Myers, G.J., Marsh, D.O., Davidson, P.W., Cox, C., Shamlaye, C.F., Tanner, M., Choi, A., Cernichiari, E., Choisy, O. & Clarkson, T.W. (1995c) Main neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from a maternal fish diet. Outcome at six months. Neurotoxicology, 16, 653-664. Myers, G.J., Davidson, P.W., Shamlaye, C.F., Axtell, C.D., Cernichiari, E., Choisy, O., Choi, A., Cox, C. & Clarkson, T.W (1997) Effects of prenatal methylmercury exposure from a high fish diet on developmental milestones in the Seychelles child development study. Neurotoxicology, 18, 819-830. Naganuma, A. & Imura, I. (1980) Bis(methyl mercuric) selenide a reaction product from methylmercury and selenite in rabbit blood. Res. Commun. Chem. Pathol. Pharmacol., 27, 291-299. National Institute of Environmental Health Sciences (1998) Scientific Isues Relevant to Assessment of Health Effects from Exposure to Methylmercury, Washington DC, Government Printing Office. Newland, M.C., Yezhou, S., Lodgdberg, B. & Berlin, M. (1994) Prolonged behavioral effects of in utero exposure to lead and methylmercury reduced sensitivity to changes in reinforcement contingencies during behavioral transitions and steady state. Toxicol. Appl. Pharmacol., 126, 6-15. Nielsen, J.B. & Andersen, O. (1992) The toxicokinetics of mercury in mice offspring after maternal exposure to mercury--The effects of selenamethionine. Toxicology, 74, 233-234. Nielsen, J.B. & Andersen, O. (1995) A comparison of the lactational and transplacental deposition of mercury in offspring from methylmercury-exposed mice--The effects of selenomethionine. Toxicol. Lett., 7, 165-171. Nielsen, J.B. & Andersen, O. (1996) Elimination of recently absorbed methylmercury depends on age and gender. Pharm. Toxicol., 79, 60-64. Nielsen, J.B., Andersen, O. & Grandjean, P. (1994) Evaluation of mercury in hair, blood and muscle as biomarkers for methylmercury exposure in male and female mice. Arch. Toxicol., 68, 317-321. Nishikido, N., Furuyashiki, K., Naganuma, A., Suzuki, T. & Imura, N. (1987) Maternal selenium deficiency enhances the fetolethal toxicity of methylmercury. Toxicol. Appl. Pharmacol., 88, 322-328. Nixon, J.E. (1977) Toxic synergism of methylmercury with sodium nitrite and ethylurea on reproduction and survival of progeny in rats. Food Cosmet. Toxicol., 15, 283-288. Nobunaga, T., Satoh, H. & Suzuki, T. (1979) Effects of sodium selenite on methylmercury embryotoxicity and teratogenecity in mice. Toxicol. Appl. Pharmacol., 47, 79-88. Nordenhäll, K., Dock, L. & Vahter, M. (1995a) Lactational exposure to methylmercury in the hamster. Arch. Toxicol., 69, 235-241. Nordenhäll, K., Dock, L. & Vahter, K. (1995b) Transplacental and lactational exposure to mercury in hamster pups after maternal administration of methylmercury in late gestation. Pharmacol. Toxicol., 77, 130-135. Nordenhäll, K., Dock, L. & Vahter, M. (1998) Cross-fostering study of methylmercury retention, demethylation and excretion in the neonatal hamster. Pharmacol. Toxicol., 82, 132-136. Norseth, T. & Clarkson, T.W. (1970) Studies on the biotransformation of (203)Hglabeled methylmercury chloride in rats. Arch. Environ. Health, 21, 717-727. Norseth, T. & Clarkson, T.Y. (1971) Intestinal transport of (Hg203)-labeled methylmercury chloride. Roles of biotransfomation in rats. Arch. Environ. Health, 22, 568-577. Null, D.H., Gartside, P.S. & Wei, E. (1973) Methylmercury accumulation in brains of pregnant, non-pregnant and fetal rats. Life Sci., 12, 65-72. O'Dea, K. & Sinclair, A.J. (1982) Increased proportion of arachidonic acid in plasma lipids after two weeks on a diet of tropical seafood. Am. J. Clin. Nutr., 36, 868-872. Ogawa, E., Tsuzuki, H. & Yamazaki, Y. (1976) Acceleration of elimination of methylmercury chloride by chelating agents: A study with 14CH3HgCl and CH3203HgCl in mice. Radioisotopes, 29, 19-22. Ohsawa, M. & Magos, L. (1974) The chemical form of the methylmercury complex in the bile of the rat. Biochem. Pharmacol., 23, 1903-1906. O'Kusky, J.R. (1985) Synaptic degeneration in the visual cortex after neonatal administration of methylmercury. Exp. Neurol., 89, 32-47. O'Kusky, J.R., Radke, J.M. & Vincent, S.R. (1988a) Methylmercuryinduced movement and postural disorders in developing rat: Loss of somatostatin immunoreactive interneurons in the striatum. Dev. Brain Res., 40, 1-28. O'Kusky, J.R., Boyes, B.E. & McGreer, E.G. (1988b) Methylmercuryinduced movement and postural disorders in developing rat: Regional analysis of brain catecholamines. Brain Res., 439, 139-146. Olsen, S.F., Hansen, H.S., Sorensen, T.I.A., Jensen, B., Secker, N.J., Sommer, S. & Knudsen, L.B. (1986) Intake of marine fat rich in (n-3)-polyunsaturated fatty acids, may increase birth weight by prolonging gestation. Lancet, ii, 367-369. Olsen, S.F., Grandjean, P., Weihe, P. & Videro, T. (1993) Frequency of seafood intake in pregnancy as a determinant of birth weight: Evidence for a dose dependent relationship. J. Epidemiol. Community Health, 47, 436-440. Omata, S., Kasama, H., Hasegawa, H., Kasegawa, K., Ozaki, H. & Sugano, H. (1986) Species differences between rat and hamster in tissue accumulation of mercury after administration of methylmercury. Arch. Toxicol., 59, 249-254. Oskarsson, A., Schütz, A., Skerfving, S., Palminger Hallén, I., Ohlin, B. & Lagerkvist, B.J. (1996) Total and inorganic mercury in breast milk and blood and relation to fish consumption and amalgam fillings in lactating women. Arch. Environ. Health, 51, 234-241. Östlund, K. (1969) Studies on the metabolism of methylmercury in mice. Acta Pharmacol. Toxicol., 27 (Suppl. l), 5-132 Park, S.T., Lim, K.T., Chung, Y.T. & Kim, S.U. (1996) Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology, 17, 37-45. Petersson, K., Dock, L. & Vahter, M. (1989) Metabolism of methylmercury in rabbits and hamsters. Biol. Trace Elements Res., 21, 219-226. Phelps, R.N., Clarkson, T.W., Kershaw, T.G. & Wheatley, B. (1980) Interrelationship of blood and hair mercury concentrations in a North American population exposed to methylmercury. Arch. Environ. Health, 35, 161-168. Planas-Bohne, F. (1981) The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats. J. Pharmacol. Exp. Ther., 217, 500-504. Platonow, N. (1968) A study of the fate of methylmercuric acetate. Occup. Health Rev., 20, 9-19. Prohaska, J.R. & Ganther, H. (1977) Interactions between selenium and methylmercury in rat brain. Chem.-Biol. Interactions, 16, 155-167. Rabenstein, D.L. & Evans, C.A. (1978) The mobility of methylmercury in biological systems. Bioinorg. Chem., 8, 107-114. Raven, J. (1958) Standard Progressive Matrices, Cambridge: H.K. Lewis. Refsvik, T & Norseth, T. (1975) Methyl mercuric compounds in rat bile. Acta Pharmacol. Toxicol., 36, 67-78. Reuhl, K.R., Chang, L.V. & Townsend, J.W. (1981a) Pathological effects of in utero methylmercury exposure on the cerebellum of the golden hamster. I. Early effects upon the neonatal cerebellar cortex. Environ. Res., 26, 281-306. Reuhl, K.R., Chang, L.V. & Townsend, J.V. (1981b) Pathological effects of in utero methylmercury exposure on the cerebellum of the golden hamster. II. Residual effects on the adult cerebellum. Environ. Res., 26, 307-327. Rice, D.C. (1996) Evidence for delayed neurotoxicity produced by methylmercury. Neurotoxicology, 117, 583-596. Rice, D.C. (1998) Age-related increase in auditory impairment in monkeys exposed in utero plus postnatally to methylmercury. Toxicol. Sci., 44, 191-196. Rice, D.C. & Gilbert, S.G. (1982) Early chronic low-level methylmercury poisoning in monkeys impairs spatial vision. Science, 216, 759-761. Rice, D.C. & Gilbert, S.G. (1990) Effects of developmental exposure to methylmercury on spatial and temporal visual function in monkeys. Toxicol. Appl. Pharmacol., 102, 151-163. Rice, D.C. & Gilbert, S.G. (1992) Exposure to methylmercury from birth to adulthood impairs highfrequency hearing in monkeys. Toxicol. Appl. Pharmacol., 115, 6-10. Rice, D.C., Krewski, D., Collins, B.T. & Willes, R.T. (1989) Pharmacokinetics of methylmercury in the blood of monkeys ( Macaca fascicularis). Fundam. Appl. Toxicol., 12, 23-33. Rogan, W.J. & Gladen, B.C. (1991) PCBs, DDE, and child development at 18 and 24 months. Ann. Epidemiol., 1, 407-413. Rose, M.S. & Aldridge, W.N. (1968) The interaction of triethyltin with components of animal tissues. Biochem. J., 106, 821-828. Rothstein, A. (1970) Mercaptans, the biological targets for mercurials. In: Miller, M. & Clarkson, T.W., eds, Mercury, Mercurials and Mercaptans, Springfield, IL, Charles C. Thomas, pp. 233-243. Rowland, I.R., Davies, M. & Grasso, P. (1977) Biosynthesis of methylmercury compounds by intestinal flora of the rat. Arch. Environ. Health, 32, 24-28. Rowland, I.R., Davies, M.J. & Evans, J.G. (1980) Tissue content of mercury in rats given methylmercury chloride orally: Influence of intestinal flora. Arch. Environ. Health, 35, 155-160. Rowland, I.R., Robinson, R.D., Doherty, R.A. & Landry, T.D. (1983) Are developmental changes in methylmercury metabolism and excretion mediated by the intestinal microflora? In: Clarkson, T.W., Nordberg, G.F & Sager, P.R., eds, Reproductive and Developmental Toxcity of Metals, New York: Plenum Press, pp. 745-758. Sager, P.R., Doherty, R.A. & Rodier, P.M. (1982) Effects of methylmercury on developing mouse cerebellar cortex. Exp. Neurol., 77, 179-193. Sager, P.R., Aschner, M. & Rodier, P.M. (1984) Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Dev. Brain Res., 12, 1-11. Salvaterra, P., Lown, B. & Massaro, E. (1973) Alteration in neurochemical behavioural parameters in the mouse induced by low doses of methylmercury. Acta Pharmacol. Toxicol., 33, 177-190. Sasser, L.B., Jarboe, G.E., Walter, B.K. & Kelman, B.J. (1978) Absorption of mercury from ligated segments of the rat gastrointestinal tract. Proc. Soc. Exp. Biol. Med., 157, 57-60. Satoh, H. & Suzuki, T. (1979) Effects of sodium selenite on methylmercury distribution in mice of late gestational period. Arch. Toxicol., 42, 275-279. Satoh, H. & Suzuki, T. (1983) Embryonic and fetal death after in utero methylmercury exposure and resultant organ mercury concentrartions in mice. Ind. Health Jpn, 21, 19-24. Satoh, H., Shimai, S. & Yasuda, I. (1985a) Mercury metabolism and development of offspring prenatally exposed to methylmercury and selenite. Nutr. Res., Suppl. 1, 580-586. Satoh, H., Yasuda, N. & Shimai, S. (1985b) Development of reflexes in neonatal mice prenatally exposed to methylmercury and selenite. Toxicol. Lett., 25, 199-203. Schalock, R.L., Brown, W.J., Kark, R.A.P. & Menon, I.F.K. (1980) Perinatal methylmercury intoxication: Behavioral effects in rats. Dev. Psychobiol., 14, 213-219. Shaw, C.N., Mottet, K., Body, R.L. & Luschei, E.S. (1975) Variability of neuropathological lesions in experimental methylmercurial encephalopathy in primates. Am. J. Pathol., 80, 451-469. Simmonds, M.P., Johnston, P.A., French, M.C., Reeve, R. & Hutchinson, J.D. (1994) Organochlorines and mercury in pilot whale blubber consumed by Faroe Islanders. Sci. Total Environ., 149, 97-111. Skerfving, S. (1988) Mercury in women exposed to methylmercury through fish consumption, and in newborn babies and breast milk. Bull. Environ. Contam. Toxicol., 41, 475-482. Sloper, K.S., Brown, R.S. & Baum, J.D. (1979) The water content of the human umbilical cord. Early Hum. Dev., 3, 205-210. Slotkin, T.A., Pachman, S., Bartholomew, J. & Kavlock, R.J. (1985) Biochemical and functional alteration in renal and cardiac development resulting from neonatal methylmercury treatment. Toxicology, 36, 231-241. Smith, J.C., Allen, P.V., Turner, M.D., Most, B., Fisher, H.L. & Hall, L.L. (1994) The kinetics of intravenously administered methylmercury in man. Toxicol. Appl. Pharmacol., 128, 251-256. Smith, J.C., Von Burg, R. & Allen, P.V. (1997) Hair methylmercury levels in US women. Arch. Environ. Health, 52, 476-480. Somjen, G.G., Herman, S.P., Klein, R., Brubaker, P.E., Briner, W.H., Goodrich, J.K., Krigman, M.R. & Haseman, J.K. (1973a) The uptake of methylmercury (203Hg) in different tissues related to its neurotoxic effects. J. Pharmacol. Exp. Ther., 187, 602-611. Somjen, G.G., Herman, S.P. & Klein, R. (1973b) Electrophysiology of methylmercury poisoning. J. Pharmacol. Exp. Ther., 186, 579-592. Sorensen, N., Murata, K., Budtz-Jorgensen, E., Weihe, P. & Grandjean, P. (1999) Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology, 10, 370-375. Stoltenberg-Didinger, G. & Markwort, S. (1990) Prenatal methylmercury exposure results in dendritic spine dysgenesis in rats. Neurotoxicol. Teratol., 12, 573-576. Stein, A.F., Gregus, Z. & Klaassen, C.D. (1988) Species variation in biliary excretion of glutathione-related thiols and methylmercury. Toxicol. Appl. Pharmacol., 93, 351-359. Stinson, S.H., Shen, D.M., Burbacher, T.M., Mohamed, T.K. & Mottet, N.R. (1989) Kinetics of methylmercury in blood and brain during chronic exposure in the monkey Macaca fascicularis. Pharmacol. Toxicol., 65, 223-230. Su, M.-Q. & Okita, G.T. (1976) Behavioral effects on the progeny of mice treated with methylmercury. Toxicol. Appl. Pharmacol., 38, 195-205. Suda, I. & Hirayama, K. (1992) Degradation of methyl-and ethylmercury into inorganic mercury by hydroxyl radical produced from rat liver microsomes. Arch. Toxicol., 66, 397-402. Suda, I. & Takahashi, H. (1992) Degradation of methyl and ethyl mercury into inorganic mercury by other reactive oxygen species besides hydroxyl radicals. Arch. Toxicol., 66, 34-39. Sundberg, J., Oskarsson, A. & Albanus, L. (1991) Methylmercury exposure during lactation: Milk concentration and tissue uptake of mercury in the neonate rat. Bull. Environ Contam. Toxicol., 46, 255-262. Sundberg, J., Jönson, S., Karlsson, M.O. & Oskarsson, A. (1998a) Lactational exposure and neonatal kinetics of methylmercury and inorganic mercury in mice. Toxicol. Appl. Pharmacol., 154, 160-169. Sundberg, I., Jönson, S., Karlsson, M.O., Palminger Hallen, I. & Oskarsson, A. (1998b) Kinetics of methylmercury and inorganic mercury in lactating and nonlactating mice. Toxicol. Appl. Pharmacol., 151, 319-329. Suter, K.E. (1975) Studies on the dominant-lethal and fertility effects of heavy metal compounds methylmercuric hydroxide, mercuric chloride, and cadmium chloride in male and female mice. Mutat. Res., 30, 365-374. Suzuki, T. & Miyama, T. (1971) Neurological symptoms and mercury concentration in the brain of mice fed with methylmercury salt. Ind. Health, 9, 51-58. Suzuki, T., Matsumoto, N., Miyama, T. & Katsunuma, H. (1967) Placental transfer of mercuric chloride, phenyl mercury acetate and methylmercury acetate in mice. Ind. Health Jpn, 5, 149-155. Suzuki, T., Shishido, S. & Ishihara, I. (1976) Different behaviour of inorganic and organic mercury in renal excretion with reference to effects of D-penicillamine. Br. J. Ind. Med., 33, 88-101. Syversen, Y. (1982) Effects of repeated dosing of methylmercury on protein synthesis in isolated neurons. Acta Pharmacol. Toxicol., 50, 391-397. Syversen, T.L., Totland, G. & Flood, P.R. (1981) Early morphological changes in rat cerebellum caused by a single dose of methylmercury. Arch. Toxicol., 47, 101-111. Tanaka, T., Naganuma, A., Kobayashi, K. & Imura, N. (1991) An explanation for strain and sex differences in renal uptake of methylmercury in mice. Toxicology, 69, 317-329. Thomas, D.J & Smith, J.C. (1982) Effects of coadministered low-molecularweight thiol compounds on shortterm distribution of methylmercury in the rat. Toxicol. Appl. Pharmacol., 62, 104-110. Thomas, D.J., Fisher, H.L., Sumler, M., Marcus, A.H., Mushak, P. & Hall, L.L. (1986) Sexual differences in the distribution and retention of organic and inorganic mercury in methylmercury-treated rats. Exp. Res., 41, 219-234. Thomas, D.J., Fisher, H.L., Sumler, M.R., Hall, L.L. & Mushak, P. (1988) Distribution and retention of organic and inorganic mercury in methylmercurytreated neonatal rats. Environ. Res., 47, 59-71 Thuvander, A., Sundberg, J. & Oskarsson, A. (1996) Immunomodulating effects after exposure to methylmercury in mice. Toxicology, 11, 163-175. Triphonas, L. & Nielsen, N.O. (1973) Pathology of chronic alkylmercurial poisoning in swine. Am. J. Vet. Res., 34, 379-392. Ulfvarson, U. (1962) Distribution and excretion of some mercury compounds after long term exposure. Int. Arch. Gewerbapathol. Gewerbehyg., 12, 412-422. Urano, T., Naganuma, A. & Imura, N. (1988) Methylmercurycysteinylglycine constitutes the main form of methylmercury in rat bile. Res. Commun. Chem. Pathol. Pharmacol., 60, 197-210. Ursínyová, M. & Hladíková, V. (1997) The intake of selected toxic elements from milk in infants. Fresenius Environ. Bull., 6, 627-632. Ursínyová, M. & Hladikova, V. (1998) Dietary intake of cadmium, lead and mercury in vegetarian and non-vegetarian children. Fresenius Environ. Bull., 7, 585-592. Vahter, M., Mottet, N.K., Friberg, L., Lind, B., Shen, D.D. & Burbacher, T. (1994) Speciation of mercury in the primate blood and brain following longterm exposure to methylmercury. Toxicol. Appl. Pharmacol., 12A, 221-229. Verschuuren, H.G., Kroes, R., Den Tankalaar, E.M., Berkvens, J.M., Helleman, P.W., Rauws, A.G. & Schuller, P.L. (1976a) Toxicity of methylmercury chloride in rats. I. Short-term study. Toxicology, 6, 85-96 Verschuuren, H.G., Kroes, R., Den Tonkalaar, E.M., Berkvens, J.M., Helleman, P.W., Rauws, A.G. & Schuller, P.L. (1976b) Toxicity of methylmercury chloride in rats. II. Reproduction study. Toxicology, 6, 97-106. Verschuuren, H.G., Kroes, R., Den Tonkalaar, E.M., Berkvens, J.M., Helleman, P.W., Rauws, A.G. & Schuller, P.L. (1976c) Toxicity of methylmercury chloride in rats. III. Long-term study. Toxicology, 6, 107-123. Vostal, J.J. & Clarkson, T.V. (1973) Mercury as an environmenal hazard. J. Occup. Med., 15, 649-656. Walsh, C.T. (1982) The influence of age on the gastrointestinal absorption of mercuric chloride and methylmercury chloride in the rat. Environ. Res., 27, 412-420. Wannag. A. (1976) The importance of organ blood mercury when comparing foetal and maternal rat organ distribution of mercury after methylmercury exposure. Arch. Toxicol., 38, 289-298. Ware, R.A., Burkholder, P. & Chang, L.W. (1975) Ultrastructural changes in renal proximal tubules after chronic organic and inorganic mercury intoxication. Environ. Res., 10, 121-140. Wasserman, G., Graziano, J., Factor-Litvak, P., Popovac, D., Morina, N., Musabegovic, A., Vrenezi, N., Capuni-Paracka, S., Lekic, V., Preteni-Redjepi, E., Hadjialjevic, S., Slavkovich, V., Kline, J., Shrout, P. & Stein, Z. (1992) Independent effects of lead exposure and iron deficiency anemia on developmental outcome at age 2 years. J. Pediatr., 121, 695-703. Wechsler, D. (1974) Wechsler Intelligence Scale for Children, rev. Ed, New York, Psychological Corp. Whanger, P. D. (1992) Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. J. Trace Elem. Electrolytes Health Dis., 6, 209-221. WHO (1976) Environmental Health Criteria 1. Mercury, Geneva: International Programme on Chemical Safety. WHO (1990) Environmental Health Criteria 101. Methylmercury, Geneva: International Programme on Chemical Safety. WHO (1992) Assessment of Dietary Intake of Chemical Contaminants (WHO/HPP/FOS/92.6/UNEP/GEMS/92.F2), Genenva: Joint UNEP/FAO/WHO Food Contamination Monitoring and Assessment Programme (GEMS/Food). Wicklund Glynn, A. & Lind, Y. (1995) Effect of longterm sodium selenite supplementation on levels and distribution of mercury in blood, brain and kidneys of methylmercury-exposed female mice. Pharmacol. Toxicol., 7, 741-747. Willes, R.F., Truelove, J.F. & Nera, E.A. (1978) Neurotoxic response of infant monkeys to methylmercury. Toxicology, 9, 125-135. Woodcock, R. & Johnson, M. (1989) Woodcock-Johnson Tests of Achievement, Allen, Texas: DLM. Yamaguchi, S. & Nunotani, H. (1974) Trans-placental transport of mercurials in rats at the subclinical levels. Environ. Physiol. Biochem., 4, 7-15. Yamamoto & Suzuki (1978) Yasutake, Y., Hirayama, K. & Inouye, M. (1991) Sex differences of nephrotoxicity by methylmercury in mice. In: Bach, P.H., Gregg, N.J., Wilks, M.F. & Delacruz, L., eds, Nephrotoxicity: Mechanisms, Early Diagnosis, and Therapeutic Management, New York: Marcel Dekker, pp. 389-396. Yip, R.K. & Chang, L.W. (1981) Vulnerability of dorsal root neurons and fibers toward methylmercury toxicity: A morphological evaluation. Environ. Res., 26, 132-167. Yonemoto, J., Webb, M. & Magos, L. (1985) Methylmercury stimulates the exhalation of volatile selenium and potentiates the toxicity of selenite. Toxicol. Lett., 24, 7-14. Yoshida, X., Watanabe, C., Satoh, H., Kishimoto, T. & Yamamura, Y. (1994) Milk transfer and tissue uptake of mercury in suckling offspring after exposure of lactating maternal guinea pigs to inorganic or methylmercury. Arch. Toxicol., 68, 174-178. Zanoli, P., Truzzi, C., Veneri, C., Braghiroli, D. & Baraldi, M. (1994) Methylmercury during late gestation affects temporarily the development of cortical muscarinic receptors in rat offspring. Pharmacol. Toxicol., 75, 261-264. Zenick, H. (1974) Behavioral and biochemical consequences in methylmercury chloride toxicity. Pharmacol. Biochem. Behav., 2, 709-713. Zenick, H. (1976) Evoked potential alterations in methylmercury chloride toxicity. Pharmacol. Biochem. Behav., 5, 253-255.
See Also: Toxicological Abbreviations Methylmercury (EHC 101, 1990) Methylmercury (WHO Food Additives Series 52) Methylmercury (WHO Food Additives Series 24) METHYLMERCURY (JECFA Evaluation)